TW205504B - - Google Patents

Download PDF

Info

Publication number
TW205504B
TW205504B TW80108379A TW80108379A TW205504B TW 205504 B TW205504 B TW 205504B TW 80108379 A TW80108379 A TW 80108379A TW 80108379 A TW80108379 A TW 80108379A TW 205504 B TW205504 B TW 205504B
Authority
TW
Taiwan
Prior art keywords
patent application
item
glyceryl
composition according
composition
Prior art date
Application number
TW80108379A
Other languages
Chinese (zh)
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Application granted granted Critical
Publication of TW205504B publication Critical patent/TW205504B/zh

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

經濟部屮央標準局貝工消費合作社印製 ^05504 A6 _B6__ 五、發明説明(1 ) 本案為1990年10月30日所提出,予以參考併入本文 之美國專利申請案07/605,899號之部份迫加案。 1 .兹明:> 铕城 本發明係開於供婦女値人衛生用之産品,諸如灌洗 液、塞藥、凝膠、洗劑、以及避孕劑。本發明尤指一種 有效成份,在結合於婦女衛生産品時,此有效成份將會 減少細菌所産生之某些毒素之量。 2 .發昍背軎 婦女使用很多主要為液體形式之婦女衛生及内部淸 潔産品。更明確而言,很多婦女使用陰道灌洗液注洗及 清潔陰道,並防止陰道感染,用於避孕、減菌以及促進 流産(請見THOMAS A. Gossel所著”婦女衛生産品•♦為何 需要您的意見”,美國藥劑師,1986年5月,20-27頁)。 陰道灌洗成份可由各種不同成份構成。醋為最常見供清 潔陰道灌洗用途之物質。醋包含約4-6¾醋酸。然而並無 足夠數據決定性證明醋有效改變陰道Ph足夠時間長度以 促進正常陰道®叢增長,並藉以阻止慼染。 1974年11月13日所發表,名稱為”泡騰成份”之英國 專利說明書1374, 105號說明内含矽膠之陰道灌洗成份。 此等成份可予以製成片劑,並使用作為金副假齒清潔劑 、制酸劑、止痛輕瀉藥及陰道灌洗劑。該專利中所詋明 之成份包含二氣化磺及(或)産生氣之材料,例如過硫酸 (請先閱讀背面之注意事項再塡寫本頁) 裝· 訂 太蚯铬K疳ϋί丨II Ψ团B3宅找進(CNS) V4姒格(21(1x297公处) Λ 6 13 6 五、發明説明2[) 盥/過硼酸鹽混合物,以及最佳藥品,稀釋劑,例如, 氛化鈉、整合劑諸如乙二胺四醋酸、表面活化劑、潤滑 劑、香料及氣味。 1971年6月8日授予Diniel B. Langley之美國專利 2,584,119號說明陰道灌洗成份,包含3-8重量份數水可 溶去垢劑、十二烷基苯磺化鈉、月桂硫酸鉀或納,或 2-5重量份數齡性單過硫酸鹽或5-10重量份數鹺金屬或 硼酸鹽,使用作為每公升5-60克之水溶液。 1965年11月23日授予Samuel G. Berkow等人之美國 專利3,219,525號説明一種加壓容器,其中有一包含 1.5至2.5克陽離子季銨殺菌表面活化 30-6 0克防腐潤濕 劑之溶液。所産生之成份為一種氣溶膠泡沫。 曾經有人報導,每天使用酸性或鹼性溶液灌洗,在 陰道Ph或陰道黏膜並無總體性受化。也曾有人導,並且 證明,在灌洗期間,陰道Ph呈現灌洗溶液之Ph。在以酸 性溶液灌洗後三十分鍾,Ph便實際變成齡性。 經濟部屮央標準局员工消费合作社印製 (請先閱讀背面之注意事項再填寫本頁) 線*Printed by the Beigong Consumer Cooperative of the Bureau of Standards and Economics of the Ministry of Economic Affairs ^ 05504 A6 _B6__ V. Description of the Invention (1) This case was proposed on October 30, 1990, and is incorporated by reference in the US Patent Application No. 07 / 605,899 A forced case. 1. Ziming: > EU City The present invention is developed for products for hygienic use of women, such as lavage fluids, plugs, gels, lotions, and contraceptives. The present invention particularly refers to an effective ingredient which, when combined with feminine hygiene products, will reduce the amount of certain toxins produced by bacteria. 2. Hair loss Women use many women's hygiene and internal cleaning products, mainly in liquid form. More specifically, many women use vaginal lavage fluid to inject and clean the vagina, and to prevent vaginal infections, for contraception, sterilization, and to promote miscarriage (see THOMAS A. Gossel's "Women's Hygiene Products • Why You Opinions ", American Pharmacist, May 1986, pages 20-27). The components of vaginal lavage can be composed of various different components. Vinegar is the most common substance used for cleaning vaginal lavage. Vinegar contains about 4-6¾ acetic acid. However, there is not enough data to decisively prove that vinegar effectively changes the vaginal Ph for a sufficient length of time to promote normal vaginal plexus growth and thereby prevent Qi infection. Published on November 13, 1974, British Patent Specification No. 1374, 105, titled "Effervescent Ingredients", describes vaginal lavage ingredients containing silicone. These ingredients can be made into tablets, and used as gold deputy denture cleaner, antacid, analgesic laxative and vaginal lavage. The patented ingredients in this patent include two gasification sulfonates and / or gas-generating materials, such as persulfuric acid (please read the precautions on the back before writing this page). Packing and ordering Taizhao chromium K 疳 ϋί 丨 II Ψ Mission B3 Zhaijinjin (CNS) V4 Sige (21 (1x297)) Λ 6 13 6 V. Description of invention 2 [) Toilet / perborate mixture, as well as the best medicines, diluents, for example, sodium nitrate, Integrating agents such as ethylenediaminetetraacetic acid, surfactants, lubricants, fragrances and odors. US Patent No. 2,584,119 issued to Diniel B. Langley on June 8, 1971 describes vaginal lavage ingredients, containing 3-8 parts by weight of water-soluble detergent, sodium dodecylbenzenesulfonate, potassium or sodium lauryl sulfate , Or 2-5 parts by weight of age-specific monopersulfate or 5-10 parts by weight of radon metal or borate, used as an aqueous solution of 5-60 grams per liter. U.S. Patent No. 3,219,525 issued to Samuel G. Berkow et al. On November 23, 1965 describes a pressurized container in which there is a solution containing 1.5 to 2.5 grams of cationic quaternary ammonium bactericidal surface active 30-60 grams of antiseptic wetting agent. The resulting component is an aerosol foam. It has been reported that daily lavage with acidic or alkaline solutions does not cause generalized phlegm or vaginal mucosa in the vagina. It has also been directed and proved that during lavage, the vaginal Ph presents the Ph of the lavage solution. Thirty minutes after lavage with an acidic solution, Ph actually becomes age-appropriate. Printed by the Employee Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) line *

Strobino等人曽報導,有些灌洗劑對精子具有毒性 ,因此被使用作為一種避孕劑。反之,硪酸氫納灌洗劑 為另一型灌洗劑,用以增進精子生存,並因而增強生育 力(請見An sari, Gould及Ansari所著”硝酸氳納灌洗用 以改善性交後試驗”,生育與不育,33卷6期,1980年6 月,608-612頁)。 -4 - 本紙張尺度边用中國國家標準(CNS)甲4規格(210X297公垃) Λ 6 η 6 五、發明説明3() 經期發生之中毒性休克激候群(Toxic Shock Syndrome,簡稱TSS)為一種觳重,有時並為致命之多条 统疾病,此型疾病與金黃色蕕萄球菌感染及移殖具有鼷 聯。此病與行經時使用棉塞有關。此病據倍為中毒性休 克撤候群毒素(T 〇 >{丨c S h 〇 c k S y n d r 〇 m e Τ ο X i η -1 ,簡稱 TSST-1)所引起,該毒素傜由經期TSS病人分離之大多數 «§萄球菌種所産生。 經濟部屮央標準局员工消费合作社印製 (請先閲讀背面之注意事項再填寫本頁) 丁 在中毒性休克戡候群與使用棉塞具有關聯之報告發 表後,若干研究人員曾箸手研究,其目的為估量棉塞對 金黃色葡萄球菌增長之作用,以及棉塞對此細菌産生 TSST-1之作用。研究人員致力闌釋棉塞在TSS所扮演之角 色,此等早期努力曾産生矛盾之數據。Schlievert等人 (産婦科醫學,64卷,666-670頁,1984年11月)曾研究 棉塞對金黃色蕕萄球菌之作用,以評量棉塞組成部份是 否增加金黃色葡萄球菌之增長及中毒性休克徵候群毒素 -1之産生。他們推斷,在其研究之試驗狀況下,棉塞組 成部份既無供中毒性休克擞候群金黃色葡萄球菌增長之 營養物,也非引起産生中毒性休克擻候群毒素-1高於控 制水準之因素。在六小時培育期後,接受試驗之若干市 售棉塞對细菌增長具有抑制性並曾遏止毒素産生。其他 棉塞遏止毒素産生但不抑制細胞增長。一種棉塞抑制細 胞增長但增加所産生之毒素量。在另一方面,Tierno及 本紙張尺度逍用中國國家標準(CNS)甲4規格(210x297公;¢) Λ 6 Β6 五、發明説明(4 )Strobino et al. Reported that some lavage agents are toxic to sperm and are therefore used as a contraceptive. Conversely, sodium bicarbonate lavage is another type of lavage used to improve sperm survival and thus enhance fertility (see An sari, Gould and Ansari, "Na nitrate lavage is used to improve sexual intercourse "Experiment", Fertility and Infertility, Volume 33, Issue 6, June 1980, pages 608-612). -4-This paper uses the Chinese National Standard (CNS) A4 specifications (210X297 public waste) Λ 6 η 6 V. Description of invention 3 () Toxic Shock Syndrome (TSS) It is a heavy and sometimes fatal multi-lineage disease. This type of disease is associated with Staphylococcus aureus infection and colonization. This disease is related to the use of tampons during menstruation. This disease is caused by the toxic shock withdrawal group toxin (T 〇> {丨 c S h 〇ck S yndr 〇me Τ ο X i η -1, referred to as TSST-1), the toxin is caused by menstrual TSS Most «§ Staphylococcus species isolated from patients. Printed by the Employee Consumer Cooperative of the Bureau of Standards of the Ministry of Economic Affairs (please read the notes on the back before filling out this page) Ding published a report on the toxic shock group and the use of tampons. Several researchers have conducted research. The purpose is to estimate the effect of tampons on the growth of Staphylococcus aureus and the effect of tampons on TSST-1 produced by the bacteria. Researchers are committed to the role of tampons in TSS, and these early efforts have produced conflicting data. Schlievert et al. (Obstetrics and Gynecology, Vol. 64, pages 666-670, November 1984) studied the effects of tampons on Staphylococcus aureus to assess whether the components of tampons increased the growth of S. aureus And the production of toxic shock syndrome group toxin-1. They concluded that, under the experimental conditions of their research, the components of the tampon had neither nutrients for the growth of toxic shock staphylococcus aureus nor caused the production of toxic shock staphylococcus toxin-1 higher than the control Factors of standard. After the six-hour incubation period, several commercially available tampons tested had inhibitory effects on bacterial growth and had suppressed toxin production. Other tampons suppress toxin production but do not inhibit cell growth. A tampon inhibits cell growth but increases the amount of toxins produced. On the other hand, Tierno and this paper standard use the Chinese National Standard (CNS) A4 specifications (210x297 g; ¢) Λ 6 Β6 V. Invention description (4)

Hanna(避孕,31卷,185-194頁,1985年)則報導在其》 驗中,棉塞曾促進金黃色葡萄球産生TSST-1。Hanna (Contraception, Volume 31, pages 185-194, 1985) reported that in its test, the tampons had promoted the production of TSST-1 in golden grapes.

Reiser等人(臨床撤生物學期刊,25卷8期,1450-1452頁,1987年8月)其後曾報告試驗之結果,此等試驗 為其所進行以確定四種品牌棉塞對産生中毒性休克擞候 群毒素一1之作用者。接受試驗之棉塞,其現有之空氣量限 於囊中所含者(囊係由分子量減為小於10, 〇〇〇之纖維素 圖柱外殼所作成),棉塞在試驗時予以包封。此方法被 認為具有優點,因為有限量之現有空氣據倍為較之先前 所使用之方法更駸密模擬行經時陰道内棉塞在定位之體 内狀況,以及因為接受試驗之棉塞在試驗前未有所改變。 Reise「等人所作試驗之结果指出棉塞增加金黃色葡萄球 菌增長之表面積並提供足夠氣供毒素産生。報告中未曾 提及所試驗之任何棉塞對蒱萄球菌增長或TSST-1産生具 有顯著之抑制作用。 經濟部屮央標準局员工消#合作社印製 (請先閱讀背面之注意事項再塡寫本頁) 丁Reiser et al. (Journal of Clinical Withdrawal of Biology, Volume 25, Issue 8, 1450-1452 pages, August 1987) subsequently reported the results of these trials, which were conducted to determine the four brands of tampons in production The role of toxic shock and toxin-1. The existing air volume of the tampon subjected to the test is limited to what is contained in the bladder (the bladder is made of a cellulose chart shell with a molecular weight reduced to less than 10,000). The tampon is encapsulated during the test. This method is considered to be advantageous because the limited amount of existing air is more compact than the previously used method and simulates the internal body condition of the vaginal tampons during menstruation, and because the tampon under test is tested before the test No change. Reise "The results of experiments conducted by others pointed out that cotton plugs increase the surface area of Staphylococcus aureus growth and provide sufficient gas for toxin production. The report did not mention that any cotton plugs tested had a significant effect on the growth of staphylococcus aureus or TSST-1 production. Inhibition effect. Printed by the Ministry of Economic Affairs, Bureau of Standards, Employee Consumer #Cooperative (Please read the precautions on the back before writing this page) Ding

Robbins等人(發表於臨床微生物學期刊,25卷8期 ,1446-1449頁,1987年8月)在與Reiser等人同時報告 使用盤-膜-理脂(disk-membrane-agra,簡稱DMA)法, 在空氣中5%C02狀況下,在攝氏39°培育19小時,17種 市售棉塞對TSST-1産生之作用。過濾暌覆蓋瓊脂培養基 (有或無血液)攤開於小平淺培養皿中,予以接種一種産 生TSST-1之金黃色葡萄球菌種。Robbins等人推斷,棉 本紙張尺度逍用中國國家標準(CNS)甲4規格(210x297公垃)Robbins et al. (Published in the Journal of Clinical Microbiology, Volume 25, No. 8, pages 1446-1449, August 1987) and Reiser et al. Reported the use of disk-membrane-agra (DMA for short) Method, under the condition of 5% CO2 in the air, incubating at 39 ° C for 19 hours, the effect of 17 commercially available cotton tampons on TSST-1. Spread the filter-covered agar medium (with or without blood) in a small flat petri dish and inoculate it with a strain of Staphylococcus aureus producing TSST-1. Robbins et al inferred that the cotton paper scale used the Chinese National Standard (CNS) A4 specifications (210x297 public waste)

五、發明説明(5) 塞在TSS之主要作用可能為提供纖維表面供大規楔移殖 ,及提供足夠空氣供TSST-1産生。另外,他們發現一種 市替脫f帛臭塞中所使用之添加物諸如脱臭劑/表面活化劑 抑制TSST-1産生,以及如在一種不同市售棉塞之案例所 見,藉抑制金黃色葡萄球薗增長而減少TSST-1産生之證 據。抑制TSST-1産生及抑制金黃色葡萄球薗增長據信均 證明對於減低TSS之危險為很重要。 S. Notermans等人(食品安全期刊,3卷,1981年, 83-88頁)報導甘油一月桂酸酯在以每公斤肉漿(Ph 6.0- 6. 2) 5克之比例使用時,曾抑制腦腸毒桿菌A型、 B型及E型所致之毒素産生。此文未提及金黃色葡萄球菌 ,或自其所産生之任何毒素,也未提及使用甘油一月桂 酸_之婦女衛生成份或中毒性休克擞候群。 經濟部Ψ央標準局员工消费合作社印製 (請先閱讀背面之注意事項再塡寫本頁) 線’ 在中毒性休克欺候群(TSS),不論與月經是否具有 駢睇,症狀包括發熱、高血壓、皮瘆、及脱皮。TSST -1與月經病例具有高度關聯,但在非月經病例則較不常 由金黃色葡萄球菌分離出此種毒素。由於TSST-1可能在 兔子及其他動物引起TSS之很多臨床特擻,故通常被認 為是TSS之致病毒素(Schlievert, ”葡萄球菌腸毒素 B及中毒性休克擞候群毒素-1與非且經TSS具有顯著關聯 ”, Lancet, 1卷(8490), 1986年5月 17日)。然而, Garbe(Garbe, Arko, Reingold等人,”自非月經性中毒 -7 - 本紙張尺度逍用中國因家標準(CNS)甲4規格(210><297公没) 經濟部中央標準局β工消费合作社印製 Λ 6 ___Β_6_ 五、發明説明(6 ) 性休克擞候群病人分離之金黃色葡萄球菌:另外毒素之 證據”,美國醫學協會期刊,1985年,253卷,2538-42 頁)提及自非月經病例分離之很多TSS並不表示TSST-1, 雖然其引起兔型之似TSS症狀。在金黃色葡萄球菌非月 經性分離物所形成之毒素中,TSST-1傜由SchlievertA 報告者之40¾所産生。 金黃色葡萄球菌産TSST-1,人們大多聯想到月經性 TSS與使用棉塞有關。吾人曾著手實驗,以確定可否在 吸收性纖雒材料内使TSST-1之産生減至最少或使其中止 。出乎意料,吾人發現一組在1989年4月27日提出之待 決美國專利申請案343,965號及1990年4月27日提出之 3 16,742號(均予參考併人本文)中所說明之化合物。 然而,吾人需要找到一種能夠在陰道腔内剋制金黃 色蕕萄球菌産生TSST-1之灌洗成份。 發明夕枏沭 本發明傜關於注洗陰道用之無吸收性成份,内含一 種選自下列類組之化合物: (a) —種多羥基脂族醇及一種含八至十八個原子之 脂肪酸之單酯類,其中該單酯類至少一羥基與 其脂族醇殘留物相締合; (b) —種多羥基脂族醇及一種含八至十八値碩原子 之脂肪酸之二酯類,其中該二酯類至少有一羥 本紙張尺度边用中國國家標準(CNS)甲4規格(210X297公货) (請先閲讀背面之注意事項再塡寫本頁) 裝. 經濟部屮央標準局A工消费合作社印製 Λ 6 ___\i 6 五、發明説明(7 ) 基與其脂族醇殘啻物相締合,以及 (c)上述單酯類及二酯類之混合物。 上述單酯類及二酯類之脂肪酸部份可自辛酸、癸酸 、月桂酸、肉豆兹酸、棕櫊酸、及硬脂酸獲得,此等酸 係鍵長分別為Ce、Cio、Cl2、C|4、Cte及Cl8之飽和脂肪酸。 上述單酯類及二酯類之脂肪酸部份同樣可自硪鋪長範圍 也為c8至c18之未飽和脂肪酸獲得,油酸即為此等未飽和 脂肪酸之一例。用於實施本發明之較佳之脂肪酸為月桂 酸,其化學式為Cu H23 C00H之一種飽和脂肪酸。 在本說明書及後附申請專利範圍中所稱”脂族” 一 詞,其恵義通常為與有機化學相一致,亦即”脂族"指特 擻為組份磺原子直鏈或支鐽排列之有機化合物。 在本說明害及後附申請專利範圍中所稱”多羥基”一 詞指在化合物中至少存在二羥(0H)基。因此,多羥基脂 族醇為一種至少有二羥基並且其中磺構架為直型或支型 之脂族醇。 適合形成單酯類及(或)二酯類以供用於實施本發明 之多元醇為1,2-乙二醇;1,2,3-丙三醇(甘油);1,3-丙 二醇;1,4-丁二醇;1,2,4-丁三醇及類似者。用以形成 單酯類及二酯類以供用於實施本發明之多羥基脂族醇為 1,2,3 -丙三醇(通稱甘油),其、化學式為 H0CH2CH(0H)CH20H。 -9 - 本紙張尺度逍用中國國家標準(CNS)甲4規格(210x297公货) (請先閲讀背面之注意事項再填寫本頁) 裝· 經濟部屮央標準扃貞工消费合作社印製 Λ 6 Π 6 五、發明説明(8 ) 可用於實施本發明之酯類至少有一羥基與其脂族醇 殘留物相締合。因此,請予瞭解,1,2-乙二醇之單酯及 上述脂妨酸之一可用於實施本發明,因為通式為5. Description of the invention (5) The main function of the plug in TSS may be to provide the fiber surface for large-scale wedge colonization, and to provide enough air for TSST-1 to produce. In addition, they found that an additive such as a deodorant / surfactant used in a commercial deodorant suppresses TSST-1 production, and, as seen in a case of a different commercially available tampon, by suppressing the golden grape ball Evidence for growth of scrofula to reduce TSST-1 production. Inhibition of TSST-1 production and inhibition of staphylococcus aureus growth are believed to prove important in reducing the risk of TSS. S. Notermans et al. (Journal of Food Safety, Volume 3, 1981, pages 83-88) reported that glycerol monolaurate had inhibited the brain when used at a rate of 5 grams per kilogram of meat slurry (Ph 6.0-6.2) Toxin production caused by Enterobacterium type A, B and E. This article does not mention Staphylococcus aureus, or any toxins produced therefrom, nor does it mention feminine hygiene ingredients or toxic shock phenotypes using glycerol monolaurate. Printed by the Employee Consumer Cooperative of ΨCentral Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before writing this page) Line 'In the Toxic Shock Bullying Group (TSS), regardless of whether it has menstrual symptoms with menstruation, symptoms include fever High blood pressure, skin rash, and peeling. TSST -1 is highly correlated with menstrual cases, but in non-menstrual cases it is less common to isolate this toxin from Staphylococcus aureus. Because TSST-1 may cause many clinical features of TSS in rabbits and other animals, it is generally considered to be the virin of TSS (Schlievert, "Staphylococcal Enterotoxin B and Toxic Shock Syndrome Toxin-1 are not TSS has significant association ", Lancet, Volume 1 (8490), May 17, 1986). However, Garbe (Garbe, Arko, Reingold et al., "From Non-menstrual Poisoning-7-This paper scale uses the Chinese Family Standard (CNS) A 4 specifications (210 > < 297 public) Central Standards Bureau of the Ministry of Economic Affairs Printed by β Industry Consumer Cooperative Society Λ 6 ___ Β_6_ V. Description of the invention (6) Staphylococcus aureus isolated from patients with sexual shock syndrome: evidence of additional toxins, Journal of the American Medical Association, 1985, Vol. 253, pages 2538-42 ) Mentioning many TSSs isolated from non-menstrual cases does not mean TSST-1, although it causes rabbit-like TSS symptoms. Among the toxins formed by non-menstrual isolates of Staphylococcus aureus, TSST-1 was produced by SchlievertA reporter 40¾. Staphylococcus aureus produces TSST-1, and most people associate menstrual TSS with the use of tampons. We have embarked on experiments to determine whether the production of TSST-1 can be minimized or discontinued within the absorbent fiber material. Unexpectedly, I discovered a group of compounds described in the pending US Patent Application No. 343,965 filed on April 27, 1989 and 3,742 filed on April 27, 1990 (both are referenced and incorporated herein) . However, we need to find a lavage ingredient that can restrain TSST-1 production by Staphylococcus aureus in the vaginal cavity. Invention Xiyashu The present invention relates to non-absorbable ingredients for vaginal rinsing, which contains a compound selected from the following group: (a)-a polyhydroxy aliphatic alcohol and a fatty acid containing eight to eighteen atoms Monoesters, in which at least one hydroxyl group of the monoester is associated with the residue of aliphatic alcohol; (b) a polyhydroxy aliphatic alcohol and a diester of fatty acids containing eight to eighteen atomic atoms, Among them, the diesters have at least one hydroxybook paper, and the Chinese National Standard (CNS) A4 specifications (210X297 public goods) are used (please read the precautions on the back before writing this page). The Central Standards Bureau of the Ministry of Economic Affairs A Printed by the Industry and Consumer Cooperatives Λ 6 ___ \ i 6 V. Description of the invention (7) The group is associated with the aliphatic alcohol residue, and (c) a mixture of the above monoesters and diesters. The fatty acid parts of the above monoesters and diesters can be obtained from caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, and stearic acid. The lengths of these acid bonds are Ce, Cio, and Cl2, respectively , C | 4, Cte and Cl8 saturated fatty acids. The fatty acid parts of the monoesters and diesters mentioned above can also be obtained from unsaturated fatty acids with a length ranging from c8 to c18. Oleic acid is an example of such unsaturated fatty acids. The preferred fatty acid used in the practice of the present invention is lauric acid, and its chemical formula is a saturated fatty acid of Cu H23 C00H. The term "aliphatic" in this specification and the appended patent application usually means the same as organic chemistry, that is, "aliphatic" refers to the special sulfonic atom as a straight chain or branched chain. The organic compounds that are arranged. The term "polyhydroxy" in the scope of the patent application attached to this description refers to the presence of at least a dihydroxy (OH) group in the compound. Therefore, a polyhydroxy aliphatic alcohol is a kind of at least dihydroxy In addition, the sulfonic framework is a straight or branched aliphatic alcohol. The polyol suitable for forming monoesters and / or diesters for the implementation of the present invention is 1,2-ethylene glycol; 1, 2, 3 -Glycerin (glycerin); 1,3-propanediol; 1,4-butanediol; 1,2,4-butanetriol and the like. Used to form monoesters and diesters for the implementation of this The invented polyhydric aliphatic alcohol is 1,2,3-glycerol (commonly known as glycerin), and its chemical formula is H0CH2CH (0H) CH20H. -9-This paper scale uses the Chinese National Standard (CNS) A4 specifications ( 210x297 public goods) (Please read the precautions on the back before filling out this page) Outfit · Printed by the Ministry of Economic Affairs, Standards, and Consumers ’Cooperative Society Λ 6 Π 6 5 Description of the invention (8) The esters which can be used to implement the present invention have at least one hydroxyl group associated with the aliphatic alcohol residue. Therefore, please understand that the monoester of 1,2-ethylene glycol and one of the aforementioned fatty acids can be used For implementing the present invention, because the general formula is

CnH2n+1-C-0-CH2-CH20H 0 之上述酯至少有一羥基(亦即在以上所示結構式最右邊 之羥基)在該酯獲自脂族醇1,2-乙二酵之部份。在另一 方面,請予瞭解,1,2-乙二醇之二酯及上述脂肪酸之一無 法用於實施本發明,因為通式為The above-mentioned ester of CnH2n + 1-C-0-CH2-CH20H 0 has at least one hydroxyl group (that is, the hydroxyl group on the far right side of the structural formula shown above) in the part of the ester obtained from the aliphatic alcohol 1,2-glyoxan . On the other hand, please understand that 1,2-ethylene glycol diester and one of the above fatty acids cannot be used in the practice of the present invention because the general formula is

CnH2n+l_C~0-CH2*CH20~C-CnII2n+l 0 之上述酯不至少有一羥基在該酯獲自1 ,2-乙二醇之部份 0 甘油之單酯及指定脂肪酸之一可用於實施本發明, 因為該酯將會有二獲自甘油之羥基與其相締合。甘油之 二酯及指定脂肪酸之一也可使用,因為該酯將會有一獲 自脂族醇甘油之羥基與其相締合。的確,如在下文將會 明白,甘油基一月桂酸酯及甘油二月桂酸酯之摻合物經發 現為可用於實施本發明。最後,請予瞭解,甘油之三酯 及指定脂肪酸之一無法用於實施本發明,因為該醋不至 -10 - 本紙張尺度逍用中國國家標準(CNS)甲4規格(210X297公货) (請先閱讀背面之注意事項再填寫本頁) 裝· 經濟部屮央橾準局ΚΧ工消t合作社印製 0·‘:ί Λ 6 ______η 6__ 五、發明説明(9 )CnH2n + l_C ~ 0-CH2 * CH20 ~ C-CnII2n + l 0 The above-mentioned ester does not have at least one hydroxyl group in the ester obtained from 1,2-ethylene glycol part 0 Monoglyceride and one of the specified fatty acids can be used for The present invention is practiced because the ester will have two hydroxyl groups derived from glycerin associated with it. Diglycerides and one of the specified fatty acids can also be used because the ester will have a hydroxyl group derived from the aliphatic alcohol glycerol associated with it. Indeed, as will be understood below, blends of glyceryl monolaurate and glyceryl dilaurate have been found to be useful in the practice of the present invention. Finally, please understand that the triglyceride and one of the specified fatty acids cannot be used to implement the present invention, because the vinegar is less than -10-this paper scale is used in China National Standard (CNS) A4 specifications (210X297 public goods) ( Please read the precautions on the back first and then fill out this page) Outfit · Printed by the quasi-bureau of the Ministry of Economic Affairs KX Gongxiaot Cooperative Society 0 · ': ί Λ 6 ______ η 6__ V. Description of the invention (9)

少有一羥基在其獲自脂肪醇(亦即甘油)之部份D 用於實施本發明之較佳酯類為甘油基一月桂酸酯、 甘油基二月桂酸酯及其混合物。 特別較佳者為Henke丨公司以商品名稱"Monomuls 90 L-12”發售之甘油基-月桂酸酯。此化合物包含以重 量計約96«甘油基-月桂酸酯。在使用於以下諸實例之此 化合物樣本未檢出甘油基二月桂酸酯。甘油基一月桂酸 酯為一種經食品藥物管理(FDA) GRAS登列供使用作為食 品乳化劑之化合物。此材料對人類無毒性並具有抗微生 物持性。 供根據本發明使用之其他較佳酯類包括C-3烷醇之 —月桂酸酯衍生物,諸如2-羥基-卜丙基月桂酸酯及3-羥基-1-丙基月桂酸酯。預期C-3烷醇之二月桂酸酯諸如 甘油基-1,3-二月桂酸酯,甘油基-1,2-二月桂酸酯也減 少所産生之腸毒素A、B、C及有腸毒素A之TSST-1之量。 乙二醇衍生物諸如乙二醇一月桂酸酷以及聚乙二醇月桂 酸酯,例如二甘醇一月桂酸酯及三甘醇一月桂酸酯也預 期為有效。有些聚合物也預期為具有毒素減少作用,例 如,聚乙三醇(分子量200)—月桂酸酯、聚乙二醇(分子 置400)—月桂酸酷、聚乙二醇(分子量1000)—月桂酸酯 、以及聚丙二醇月桂酸酯諸如聚丙醇一月桂酸酯。 在本發明之成份中據信為對TSST-1毒素有效之其他 -11 - 本紙張尺度边用中國圉家標準(CNS)甲4規格(210x297公垃) ..............^.........^.....玎:· ·線· . ί (請先閲讀背面之注意事項再填寫本頁) 〇u Λ 6 Β6 經濟部中央標準局员工消t合作社印製 五、發明説明(10) 化合物有i甘油基一辛酸酯、甘油基一癸酸酯、甘油基 一辛酸酯及甘油基一癸酸酯之混合物、甘油基一肉豆寇 酸酯、甘油基一棕榈酸酯、甘油基一硬脂酸酯及甘油基 一油酸酯。 根據本發明,本發明之無吸收性成份包含在該産品 暴露於金黃色葡萄球菌時可有效抑制中毒性休克擻候群 毒素l(TSST-l)之適量上述酯。例如,有效量經發現為 約自0.1¾及更高,而較佳為.依據所調製之溶液重量, 至少約為0.5S:重/重((W/W)之指定一酯或二酯化合物(或 其混合物)。 較佳為,本發明化合物之甘油基一月桂酸酯/甘油 基二月桂酸酯混合物包含至少90¾甘油基一月桂酸酯; 更佳為包含至少95¾甘油基一月桂酸酯。最佳為,該化 合物混合物應為實際全部由甘油基一月桂酸酯所組成。 本發明成份之有效組份可為多種不同配方,諸如目 前市售灌洗液配方或較高黏度灌洗液中所採用者。例如 ,本發明成份之有效組份可配方為有表面活化劑,較佳 為非離子表面活化劑,諸如Cremophos RH60, Tween 20 或類似者。 本發明之成份也可包含防腐劑諸如甲基paraben或 丙基paraben或類似者。可産生較大黏性之化合物,諸 如丙二醇,也可加至本發明之成份。通常以較高黏性成 -12 - 本紙張尺度通用中國圉家標準(CNS)甲4規格(210x297公没) (請先閱讀背面之注意事項再填寫本頁) 裝· 線· 經濟部屮央標準局员工消t合作社印製 r 〇5〇〇<:;_nt_Less than one hydroxyl group in part D obtained from fatty alcohols (ie glycerol). Preferred esters for use in the practice of the invention are glyceryl monolaurate, glyceryl dilaurate and mixtures thereof. Particularly preferred is glyceryl-laurate sold under the trade name " Monomuls 90 L-12 " by Henke Company. This compound contains about 96 «glyceryl-laurate by weight. It is used in the following examples No glyceryl dilaurate was detected in this compound sample. Glyceryl monolaurate is a compound listed by the Food and Drug Administration (FDA) GRAS for use as a food emulsifier. This material is non-toxic and resistant to humans Microorganisms. Other preferred esters for use in accordance with the present invention include C-3 alkanol-laurate derivatives, such as 2-hydroxy-propyl laurate and 3-hydroxy-1-propyl laurate It is expected that the dilaurates of C-3 alkanols such as glyceryl-1,3-dilaurate, glyceryl-1,2-dilaurate also reduce the production of enterotoxins A, B, C and The amount of TSST-1 for enterotoxin A. Ethylene glycol derivatives such as ethylene glycol monolaurate and polyethylene glycol laurate, such as diethylene glycol monolaurate and triethylene glycol monolaurate are also expected Is effective. Some polymers are also expected to have a toxin reducing effect, for example, poly Triol (molecular weight 200)-laurate, polyethylene glycol (molecular home 400)-lauric acid, polyethylene glycol (molecular weight 1000)-laurate, and polypropylene glycol laurate such as polypropylene alcohol monolaurate Ester. Among the ingredients of the present invention, it is believed to be other -11 effective to TSST-1 toxins.-This paper uses the Chinese Standards (CNS) A4 specifications (210x297 public waste) ....... ...... ^ ......... ^ ..... 玎: · · line ·. Ί (please read the precautions on the back before filling this page) 〇u Λ 6 Β6 Ministry of Economic Affairs Printed by the Central Bureau of Standards' Staff Cooperative V. Description of the invention (10) The compounds are i-glyceryl monocaprylate, glyceryl monocaprate, glyceryl monocaprylate and a mixture of glyceryl monocaprate, glycerin Based on myristic acid, glyceryl monopalmitate, glyceryl monostearate and glyceryl monooleate. According to the present invention, the non-absorbable ingredients of the present invention are included in the product exposed to golden yellow grapes Cocci can effectively inhibit the above-mentioned esters of toxic shock syndrome toxin 1 (TSST-1). For example, the effective amount has been found to be about 0.1¾ and higher, Preferably, according to the weight of the prepared solution, at least about 0.5S: weight / weight ((W / W) specified monoester or diester compound (or a mixture thereof). Preferably, the glyceryl group of the compound of the present invention The monolaurate / glyceryl dilaurate mixture contains at least 90¾ glyceryl monolaurate; more preferably it contains at least 95¾ glyceryl monolaurate. Preferably, the compound mixture should actually consist of glyceryl monolaurate. Composed of laurate. The effective component of the ingredients of the present invention can be a variety of different formulations, such as those currently used in commercially available lavage fluid formulations or higher viscosity lavage fluids. For example, the effective component of the ingredients of the present invention may be formulated with a surfactant, preferably a non-ionic surfactant, such as Cremophos RH60, Tween 20 or the like. The ingredients of the present invention may also contain preservatives such as methyl paraben or propyl paraben or the like. Compounds that produce greater viscosity, such as propylene glycol, can also be added to the ingredients of the present invention. Usually it is -12 with higher viscosity-This paper standard is common to China National Standards (CNS) A4 specifications (210x297) (Please read the precautions on the back before filling out this page) Installation · Line · Ministry of Economic Affairs Printed by the Bureau of Standards' Staff Cooperative Society 〇5〇〇 <:; _ nt_

五、發明説明(ID 份為較佳,俥産生在施用後將會留在陰道内相當長時間 之配方。一種樣本配方如下:0.30S! W/W甘油基一月桂酸 酯,0.50¾ W/W Cremophos RH60, 2.00¾ W/W Tween 20 ,0.30¾ W/W 甲基 paraben, 0..10¾ W/W 丙基 paraben, 1.0¾ W/W丙二醇,0.04¾ W/W FD&C Blue «Π(—種染料 )及95.76¾ W/W除離子水。另一樣本配方包含〇.5(U W/W甘油基一月桂酸酯,1.50¾ W/W Cremophos RH60, 1.00¾ W/W Tween20, 0.30¾ W/W 甲基paraben, 0.10¾ W/W 丙基 paraben, 0.043! W/W PD&C Blue (—種染 料)及96.56¾ W/W除離子水。 在198 9年4月27日提出之待決美國專利申請案 343,965號及1990年4月27日提出之316,742號中(均予 參考併入本文)曾說明甘油基一月桂酸酯為一種可用於 剋制中毒性休克擻候群毒素1之有效成份。此二申請案 說明甘油基一月桂酸酯在暴露於吸收性産品中之金色葡 萄球菌時,為一種可減少形成TSST-1毒素之材料。本發 明成份中之活性化合物也據佶可有效剋制其他類型葡萄球 菌毒素之産生,特別是«萄球薗腸毒素A, B, C,及有 A之TSST-1。在該活性化合物置於吸收性材料上時,便 發現對上述諸腸毒素之有效性。本發明之化合物有效防 止形成葡萄球菌A、B、C及有A之TSST-1,在1990年10月 30日提出之待決美國專利申請案07/605,910號(律師案 -13 - 本紙張尺度逍用中a a家標準(CNS)甲4規格(210x297公龙) (請先閱讀背面之注意事項再塡寫本頁) 裝- -線· 經濟部+央揲準局貝工消#合作社印製 五、發明説明(12) 號PPC369)中有所說明。甘油基一月桂酸酯也經發現可 有效抑制産生鐽球菌生熱性外毒素(Streptococcal Pyrogenic Exotoxins,簡稱 SPE)A, B,及 C,以及 A, B, F,及G屬鏈球菌所産生之溶血素。甘油基一月桂酸 酯之類似物據信也可有效抑制此等毒素之産生。甘油基 一月桂酸酯使用於溶液及吸收性産品時有效抑制鏈球菌 産生毒素,在1991年5月3日提出之待決美國專利申請案 號(律師案號PPC 389)中有例證說明。 下列實例例證本發明之成份對TSST-1産生之作用。當 然,此等實例僅例證本發明之産品而非限制本發明之範 圍。 Λ 6 13 6 (請先閱讀背面之注意事項再填寫本頁) 裝· -14 - 本紙張尺度遑用中闽國家標準(CNS)甲4規格(210x297公度) 經濟部屮央標準局κχ工消費合作社印製 Λ6 ___Π_6__ 1 ·5 五、發明説明() w m 1 將甘油基一月桂酸酯加至市售灌洗液,並將此等混 合物加熱以使甘油基一月桂酸酯溶解。灌洗液成份僳予 组成為包含以灌洗液重量計濃度0.1,1.0及10.ox之甘 油基一月桂酸酯。明確而言,在此實例,僅含醋及水之 Massengi 1 1醋及水灌洗液與甘油基一月桂酸酯相混合。 此實例之溶液包括只有Massengill醋及水灌洗液,此為 賓夕凡尼州匹兹堡市B e e c h a m P r o d u c t s,a d i v丨s ί ο η of Beecnam Inc.所産製之一種市售産品,以及三種溶 液包含Massengill醋及水灌洗液以重量計有0.U甘油基 一月桂酸酯,MassengiH醋及水灌洗液以重量計有 1.0¾甘油基一月桂酸酯,以及Massengi 1 1醋及水灌洗液 以重量計有10X甘油基一月桂酸酯。 吾人曾使用Reiser等人在臨床徹生物學期刊,25卷 ,1 987年8月,1450-1452頁所報告之棉塞囊法試驗甘油 基一月桂酸酯之作用。該方法曾予調整,以允許利用此 程序,而無需如下文所述之棉塞或吸收性材料。 吾人在試驗中揉用由美國威斯康辛州麥迪遜市威斯 康辛大學食品研究所Mer 1 in Bergdol 1博士獲得之凍乾 形式之金黃色葡萄球菌種FR 1-1169。吾人以一毫克凍乾 金黃色葡萄球菌種澈底混合至一毫升腦心浸液(Bra i η Heart Infusion,簡稱ΒΗΙ)肉湯(由美國密歇根州底特 -15 - 本紙張尺度逍用中Η國家標準(CNS)甲4規格(210><297公沒·) (請先閲讀背面之注意事項再填寫本頁) 裝· 經濟部屮央標準局A工消費合作社印製 五、發明説明(14) 律市Difco Laboratories獲得),將上述混合物轉移至 一含有五毫升BHI肉湯之試管内,再次澈底混合,並在 使用前在攝氏37°培育二十四小時,而配製成一種金黃 色《萄球菌懸浮液。 其後將徹生物與培餐基加至無菌離心管,在冷凍離 心機中以毎分鐘2,000轉旋壓成九狀歴時二十分鐘,倒 除上層清液,使九重新戀浮於磷酸缓衝之鹽水((PH4.0) 。此過程予以重複五次連缠之10分鐘清洗。Ph4.0溶液 予以接種而不轉移營養物,並且防止細菌在暴露於 PH4.0溶液時受到藤鹽。Massengil丨及Summer's Eve灌 洗産品均如上述執行此項程序。 將一百毫升BHI現脂(也獲自Difco Laboratories} 置入十支3.8公分x 20公分培養管之每一管内。以 Reiser等人所報告之方式作成纖維素滲析袋並予以滅菌 。無薗缕維素滲析袋(限為分子量8.000)以量為足夠在 試驗開始時提供5.20 X 10 cfu/毫升金黃色蕕萄球菌 潺度之上述金黃色《萄球菌懸浮液予以接種。 試驗溶液之製法為將固體甘油基一月桂酸酯加至市 售灌洗溶液(Massengill及summer’s Eve),加熱至攝 氏60° ,濃度為將會在已加熱之灌洗溶液内産生以重量 計0.1、1.0、1.¾之甘油基一月桂酸酯含量。此等溶液 在攪拌時予以冷卻,隨後予以加至含有以重量計1 . 0克 Λ 6 13 6 (請先閱讀背面之注意事項再填寫本頁) 裝- 訂· 線. 本紙張尺度逍用中国國家標準(CNS)甲4規格(210x297公泜) Λ 6 Β6 五、發明説明(Μ 金黃色葡萄球菌之已接種滲析袋。 單獨將一克無薗蒸餾水加至已接種金黃色葡萄球菌 之滲析袋,而不加任何另外添加物,此稱之為對照接種 物。然後將每一滲析袋插入含有ΒΗΙ瓊脂之培養管内, 並容許其硬化。吾人曾使用二對照接種物,各為雯份。 因此,在此試驗中曾使用十支培養管,四支含對照物( 二支有Massengill醋及水灌洗液,二支無),及六支培 餐管含甘油基一月桂酸酯加至市售灌洗液,其濃度為産 生燹份具有0.10¾甘油基一月桂酸酯W/W之Massengill 灌洗液,具有1.0¾甘油基一月桂酸酯tf/W之Massengill 灌洗液,以及具有10¾甘油基一月桂酸酯W/W之 Massengill灌洗液。在24小時培育期後,測定培養管之 细胞濃度及TSST-1瀠度。此樣本之結果列示於表1。 (請先閲讀背面之注意事項再填寫本頁) 裝- 經濟部+央標準局员工消t合作社印製 17 本紙張尺度逍用中國國家標準(CNS)甲4規格(210x297公垃) 五、發明説明( 16 表 Λ 6 1)6 加至Massengill灌洗液之甘油基一月桂酸酯 對TSST-1形成及金黃色葡萄球菌增長之作用 揉 球度Ϊ 萄濃«?) #後/i 色最FU 黃之C 金菌10 X /C 本Fifth, the description of the invention (ID part is better, and it will produce a formula that will stay in the vagina for a long time after application. A sample formula is as follows: 0.30S! W / W glyceryl monolaurate, 0.50¾ W / W Cremophos RH60, 2.00¾ W / W Tween 20, 0.30¾ W / W methyl paraben, 0..10¾ W / W propyl paraben, 1.0¾ W / W propylene glycol, 0.04¾ W / W FD & C Blue «Π (A kind of dye) and 95.76¾ W / W deionized water. Another sample formula contains 0.5 (UW / W glyceryl monolaurate, 1.50¾ W / W Cremophos RH60, 1.00¾ W / W Tween20, 0.30 ¾ W / W methyl paraben, 0.10 ¾ W / W propyl paraben, 0.043! W / W PD & C Blue (a kind of dye) and 96.56 ¾ W / W deionized water. Proposed on April 27, 1998 Pending U.S. Patent Application No. 343,965 and No. 316,742 filed on April 27, 1990 (both of which are incorporated herein by reference) have stated that glyceryl monolaurate is a kind of poison that can be used to suppress toxic shock 1 The effective ingredients of these two applications indicate that glyceryl monolaurate is a material that reduces the formation of TSST-1 toxin when exposed to Staphylococcus aureus in absorbent products The active compounds in the ingredients of the present invention can also effectively suppress the production of other types of staphylococcal toxins, especially «staphylococcal enterotoxins A, B, C, and TSST-1 with A. The active compound is placed in When it was on the absorbent material, it was found to be effective against the above-mentioned enterotoxins. The compound of the present invention effectively prevents the formation of Staphylococcus A, B, C and TSST-1 with A, proposed on October 30, 1990 US Patent Application No. 07 / 605,910 (Attorney Case-13-AA Family Standard (CNS) A4 Specification (210x297 Male Dragon) in this paper standard for easy use (please read the precautions on the back before writing this page) -Line · Ministry of Economic Affairs + 揲 揲 准 局 贝 工 消 # Printed in the cooperative society V. Invention Instructions (12) No. PPC369). The glyceryl monolaurate has also been found to be effective in inhibiting the production of pyrococcus Streptococcal Pyrogenic Exotoxins (SPE) A, B, and C, and A, B, F, and G are hemolysins produced by Streptococcus. Glyceryl monolaurate analogs are believed to be effective in inhibiting these Toxin production. Glyceryl monolaurate is used in solution and absorption Effectively inhibit streptococcal toxin production when the product is presented in the May 3, 1991 pending US patent application Ser. No. (Attorney Docket No. PPC 389) have illustration. The following examples illustrate the effects of the components of the present invention on TSST-1. Of course, these examples only illustrate the products of the present invention and do not limit the scope of the present invention. Λ 6 13 6 (Please read the precautions on the back before filling out this page) 装 · -14-This paper uses the National Minority National Standards (CNS) A 4 specifications (210x297 degrees). Printed by consumer cooperatives Λ6 ___ Π_6__ 1 · 5 5. Description of the invention () wm 1 Add glyceryl monolaurate to a commercially available lavage fluid, and heat these mixtures to dissolve the glyceryl monolaurate. The composition of the lavage fluid is composed of glyceryl monolaurate at concentrations of 0.1, 1.0 and 10.ox by weight of the lavage fluid. Specifically, in this example, Massengi 11 vinegar and water lavage containing only vinegar and water are mixed with glyceryl monolaurate. The solution in this example includes only Massengill vinegar and water irrigating solution, which is a commercially available product produced by Beecham Products, adiv 丨 s η of Beecnam Inc. in Pittsburgh, Pennsylvania, and three solutions Massengill vinegar and water lavage fluid have 0.U glyceryl monolaurate by weight, MassengiH vinegar and water lavage fluid have 1.0¾ glyceryl monolaurate by weight, and Massengi 1 1 vinegar and water lavage The liquid has 10X glyceryl monolaurate by weight. We have used the cotton tampon method reported by Reiser et al. In the Journal of Clinical Biology, Volume 25, August 1987, pages 1450-1452 to test the effect of glyceryl monolaurate. The method has been adjusted to allow the use of this procedure without the need for tampons or absorbent materials as described below. In our experiment, we used the freeze-dried Staphylococcus aureus species FR 1-1169 obtained by Dr. Mer 1 in Bergdol 1 of the Food Research Institute, University of Wisconsin, Madison, Wisconsin, USA. We mixed one milligram of freeze-dried Staphylococcus aureus species into one milliliter of brain heart infusion (Brai η Heart Infusion, referred to as ΒΗΙ) broth (from Deutsch, Michigan, USA-this paper is used in Η countries Standard (CNS) A4 specifications (210 > &297;) (Please read the precautions on the back before filling in this page) Outfit · Printed by the Ministry of Economic Affairs, Bureau of Standards, A Industrial and Consumer Cooperatives 5. Description of invention (14 ) Obtained from Difco Laboratories in Lishi), transfer the above mixture to a test tube containing five milliliters of BHI broth, mix thoroughly again, and incubate at 37 ° C for 24 hours before use to prepare a golden yellow Staphylococcus suspension. Afterwards, add the biological and culture base to the sterile centrifuge tube, spin in a refrigerated centrifuge at 2,000 rpm for nine minutes, and pour out the supernatant to make Jiu re-floating in phosphoric acid. Washed salt water ((PH4.0). This process is repeated five times for 10 minutes of washing. Ph4.0 solution is inoculated without transferring nutrients, and prevents bacteria from being exposed to vine salt when exposed to PH4.0 solution. Massengil 丨 and Summer's Eve lavage products performed this procedure as described above. Place one hundred milliliters of BHI fat (also obtained from Difco Laboratories) into each of ten 3.8 cm x 20 cm culture tubes. Reiser et al. Cellulose dialysis bags were prepared and sterilized in the reported manner. The dialysis-free dialysis bag (limited to a molecular weight of 8.000) was sufficient to provide 5.20 X 10 cfu / ml of Staphylococcus aureus at the beginning of the test. The golden yellow "staphylococcus suspension is inoculated. The test solution is prepared by adding solid glyceryl monolaurate to a commercially available lavage solution (Massengill and summer's Eve) and heating to 60 degrees Celsius. Lavage The content of glyceryl monolaurate in the liquid is 0.1, 1.0, and 1.¾ by weight. These solutions are cooled while stirring, and then added to contain 1.0 g Λ 6 13 6 by weight (please first Read the precautions on the back and then fill out this page) Binding-Binding · Thread. The size of this paper uses Chinese National Standard (CNS) A 4 specifications (210x297 gong) Λ 6 Β6 V. Description of invention (M Staphylococcus aureus has only Inoculation of dialysis bag. Separately add one gram of non-collateral distilled water to the dialysis bag inoculated with Staphylococcus aureus without adding any additional additives, this is called a control inoculum. Then each dialysis bag is inserted into the In the culture tube, and allow it to harden. I used two control inoculums, each of which was a serving. Therefore, in this experiment, ten culture tubes were used, and four contained control materials (two with Massengill vinegar and water lavage fluid). , Two pieces without), and six cultured meal tubes containing glyceryl monolaurate added to a commercially available lavage solution, the concentration of which is 0.1 mass to produce glyceryl monolaurate W / W Massengill lavage solution , With 1.0¾ glyceryl monolaurate Massengill lavage fluid with ester tf / W, and Massengill lavage fluid with 10¾ glyceryl monolaurate W / W. After a 24-hour incubation period, determine the cell concentration and TSST-1 degree of the culture tube. This sample The results are shown in Table 1. (Please read the precautions on the back before filling in this page) Outfit-Printed by the Ministry of Economic Affairs + Central Standards Bureau Employee Consumer Cooperative Co., Ltd. 17 This paper standard uses the Chinese National Standard (CNS) A4 specifications (210x297 public waste) 5. Description of the invention (16 Table Λ 6 1) 6 The effect of glyceryl monolaurate added to Massengill lavage on the formation of TSST-1 and the growth of Staphylococcus aureus ?) # After / i The color of the most FU yellow C gold bacteria 10 X / C

球度升 萄濃_ 色最C 黃之S 金 SLO TSST-1 之最後量h (毫徹克) 僅有接種物 91.20 9.96 6,309.80 Masseno i I 1 灌洗液 0.16 7.21 6,512.52 Masseno i Π灌洗液 (0. IS:甘油基一月 桂酸酯) 2.25 8.35 2,161.60 Masseno Π 1灌洗液 (1.0¾:甘油基一月 桂酸酯) 0.71 6.85 31.80 Masseno Π 1灌洗液 (10¾甘油基一月 桂酸酯) 0.22 7 .35 35.78 (請先閱讀背面之注意事項再填寫本頁) 裝. 經濟部屮央櫺準局貝工消费合作社印製 a以10為底之對數所示之活金黃色葡萄球菌細胞數。 b Reiser等人在應用及環境撤生物學,.1982年12月,1349-13 55頁報告之ELISA法所確定。 c燹份樣本之平均測定。 -18 - 本紙張尺度逍用中a國家標準(CNS)甲4規格(210x297公茇) i-i ούύ ο 66 ΛΒ 經濟部屮央標準局β工消费合作社印製 1 7 五、發明説明() 表1中所示之數據證明在0. UW/W甘油基一月桂酸 酯濃度,TSST-1減少66¾,而在1.0¾ W/W甘油基一月桂 酸酯,則見減少95¾。在10S; W/W甘油基一月桂酸酯濃度 ,TSST-1生成之出現減少99¾。在細胞暴露於含有0.1¾ 甘油基一月桂酸酯之Massengill灌洗液時,見到其中活 細胞計數由僅有對照組市售配方中之對數濃度7.21增 加至8. 35。對照而言,具有U W/W甘油基一月桂酸酯 之Masse ngi 1 1灌洗,液産生對數濃度6.85(減少4.9¾),而 具有10¾ W/W甘油基一月桂酸酯之Massengill灌洗液再 産生對數濃度由對照組中所見之7.21增加至7.35。所採 用之方法不阻止活性成份移動越渦摻析袋。但甚至由此 種移動之觀點而言,仍然見有作用。 奮例2 吾人也曾於存在具有及無甘油基一月桂酸酯之 Summer^Eve灌洗液時評量金黃色«萄球菌之增長,以及 其所引起之TSST-1産生。Summer’s Eve灌洗液為維吉尼 亞州Lynchburg市C.B. Fleet Co. Inc.所製造,並且在 美國可在市上寅到。在幾種灌洗液産品以商品名稱 Summer’s Eve發售,但在此實例中所試驗之産品含有淨 化水、醋及苯酸。含有SUmneriS Eve灌洗液及不冏濃度 甘油基一月桂酸酯之溶液如實例1中所述予以加熱,以 使活性成份溶解。在此實例中包括含有量為0.1, 1.0及 -19 - 本紙張尺度边用中國國家標準(CNS)甲4規格(210父297公货) (請先閱讀背面之注意事項再塡寫本頁) 裝· 訂* Λ 6 Β6 五、發明説明(13 10»; W/W之甘油基一月桂酸酯濃度之溶液。如實例1中所述 以至 並加 液 溶 備 製Sphericality increase vine concentration _ color most C yellow S gold SLO TSST-1 final volume h (milligram) only inoculum 91.20 9.96 6,309.80 Masseno i I 1 lavage 0.16 7.21 6,512.52 Masseno i Π lavage ( 0. IS: glyceryl monolaurate) 2.25 8.35 2,161.60 Masseno Π 1 lavage fluid (1.0¾: glyceryl monolaurate) 0.71 6.85 31.80 Masseno Π 1 lavage fluid (10¾ glyceryl monolaurate) 0.22 7.35 35.78 (please read the precautions on the back before filling in this page). Pack. Printed by the Ministry of Economic Affairs, Bureau of Economic Development, Beigong Consumer Cooperatives, a. The number of live Staphylococcus aureus cells indicated by the logarithm of 10. b Reiser et al. withdrew biology in application and environment, determined in December 1982, 1349-13 page 55 by the ELISA method. c Average determination of samples. -18-This paper is used in a national standard (CNS) Grade 4 (210x297 gong) ii ούύ ο 66 ΛΒ Printed by the β-Consumer Cooperative of the Bureau of Standards, Ministry of Economic Affairs 1 7 V. Description of invention () Table 1 The data shown in the figure demonstrates that at a concentration of 0. UW / W glyceryl monolaurate, TSST-1 decreases by 66¾, while at 1.0¾ W / W glyceryl monolaurate, a reduction of 95¾ is seen. At 10S; W / W glyceryl monolaurate concentration, the occurrence of TSST-1 decreased by 99¾. When the cells were exposed to Massengill lavage fluid containing 0.1¾ glyceryl monolaurate, the viable cell count was increased from 7.21 to 8.35 in the logarithmic concentration in the commercially available formulation of the control group only. In contrast, Massengi 1 1 lavage with UW / W glyceryl monolaurate produced a logarithmic concentration of 6.85 (reduced by 4.9¾), while Massengill lavage with 10¾ W / W glyceryl monolaurate The logarithmic regeneration concentration increased from 7.21 to 7.35 seen in the control group. The method used does not prevent the active ingredient from moving beyond the vortex dosing bag. But even from this point of view of movement, it still works. Example 2 I have also evaluated the growth of Staphylococcus aureus and the production of TSST-1 caused by the presence of Summer ^ Eve lavage fluid with and without glyceryl monolaurate. Summer ’s Eve lavage fluid is manufactured by C.B. Fleet Co. Inc. of Lynchburg, Virginia, and is available in the United States. Several lavage fluid products are sold under the trade name Summer ’s Eve, but the products tested in this example contain purified water, vinegar, and benzoic acid. The solution containing the SumneriS Eve lavage fluid and the unconcentrated glyceryl monolaurate was heated as described in Example 1 to dissolve the active ingredient. In this example, the content is 0.1, 1.0 and -19-this paper scale is used in China National Standard (CNS) A4 specifications (210 father 297 public goods) (please read the precautions on the back before writing this page) Binding · Order * Λ 6 Β6 V. Description of the invention (13 10 »; W / W glyceryl monolaurate concentration solution. Prepared as described in Example 1 and added with liquid solution

表 酯用 於酸作 告 桂之 報月長 果一增 結基菌 驗油球 試甘萄 。2之# 量 液色 評表洗黃 以灌金 予 e及 量EV成 樣 球度ΐ 萄濃夭 I 8 ® # 後/1 色最FU 黃之ε 金菌10 X /IV 本Epiester is used for acid report. Gui Zhi reports moon growth, fruit growth, and growth of bacteria. 2 ## Amount of liquid color Evaluation table Wash yellow to fill with gold to give e and amount EV to form a sample sphericity l vine concentration Yao I 8 ® # back / 1 color FU yellow ε gold bacteria 10 X / IV

球度升 萄濃_ 葡後1 色最C 黃之g 金菌LO TSST-1 之最後量 (毫撤克) 僅有接種物 91.20 9.96 6,309.80 Summer Ts Eva 灌洗液 0.021 6.34 670.94 Summer Ts Eva 灌洗液 (〇. u甘油基一月 桂酸酯) 0.005 5.74 27.87 Masseno Π 1灌洗液 (1. 03:甘油基一月 桂酸酯) 0.006 5.83 4.60 Summex^s Eva灌洗液 (10¾甘油基一月 0.12 7.08 4.00 桂酸酯) a以10為底之對數所示之活金黃色葡萄球菌細胞數。 b Reiser等人在懕用及環境微生物學,1982年12月,1349-1355頁報告之ELIS A法所確定。 c雙份樣本之平均測定。 (請先閲讀背面之注意事項再填寫本頁) 經濟部+央櫺準局A工消费合作社印製 本紙張尺度逍用中國國家標準(CNS)甲4規格(210x297公釐) -20 - _136_ _136_ 經濟部屮央橾準局貝工消費合作社印製 A6 五、發明説明(19) 表2中所列之结果示活細胞計數由對數濃度9.96顯 箸減低至存在該市售灌洗液時之6.34(減少3650, TSST-1形成也由6,309.8 0顯箸減低至670.94(減低89¾) 。活細胞濃度之減低,除了市售配方中之醋酸外,最可 能為存在苯酸(一種已知之殺菌剤)。表2中所列之數據 顯示,與僅含有Summer’s Eve灌洗液之對照组所産生者 比較,TSST-1形成在0.U甘油基一月桂酸酯之濃度時減 低至少96S!之水準,存在1.0及10¾甘油基一月桂酸酯 W/W時,減低99ί!。 與對照組比較,存在0.U W/W甘油基一月桂酸酯 産生對數濃度5.74(減少9¾)活細胞。存在1.0¾ W/W甘 油基一月桂酸酯時,對數濃度為5.83(減少8S;)。對照而 言,Summers Eve灌洗液中之10¾ W/V甘油基一月桂酸 酯溶液産生對數濃度7.08(增加11JO。 啻例3 在此實例中,吾人曾於蒸餾水中存在濃度0.1, 1.0及1(U之甘油基一月桂酸酯懸浮體時評量金黃色葡萄 球菌之增長及其所致之TSST-1産生。除了在試驗中未採 用市售産品外,溶液俱如實例1中所述以1. 0克數量予 以評量。结果列示於表3。 -21 - 本紙張尺度逍用中困國家標準(CNS)甲4規格(210x297公放) (請先閲讀背面之注意事項再填寫本頁) 裝- 線- Λ 6 136 五、發明説明(20) 表 3 水中之甘油基一月桂酸酯懸浮體 對TSST-1形成及金黃色葡萄球菌增長之作用 樣 本 金黃色葡萄球 金黃色葡萄球 TSST-1 菌之最後濃度 菌之最後濃度Λ之最後量1^ (xlO CFU/毫升)(Log CFφ½升)(毫撤克) 接種水 91.20 9.96 6,309.80 (對照組) 基酯中 油酸水 甘桂在 X 11 月· 基酯中 油酸水 甘桂在 月° (請先閱讀背面之注意事項再填寫本頁) 基酯中 油酸水 甘桂在 月0¾ 裝- 訂 經濟部+央標準局员工消t合作社印製 a以10為底之對數所示之活金黃色葡萄球薗細胞數。 b Reiser等人在應用及環境微生物學,1982年12月, 1349-1355頁報告之ELIS A法所確定。 c雙份樣本之平均測定。 -22 - 本紙張尺度边用中国國家標準(CNS)甲4規格(210x297公货) 經濟部中央櫺準局貝工消费合作社印製 Γ〇'ύύ^(:: 五、發明説明(21) 表3中所提出之數據顯示在懸浮於水中之甘油基一 月桂酸酯濃度在瀑度為0. IX tf/W甘油基一月桂酸酯及 超過時,TSST-1形成顯箸減低(99.9V)。另外,在0.U W/W甘油基一月桂酸酷濃度,毒素形成減少一千倍也在 金黃色蕕萄球薗活細胞數見有對應之減少99.6¾。在增 加甘油基一月桂酸酯之濃度時,抗徹生物作用較主要為 在1.0¾水準。在10¾ W/W甘油基一月桂酸酯,抗微生物 作用減少,這可能歸因於所試驗之化合物之不可溶解性 。TSST-1形成之減低自0.S:至10¾甘油基一月桂酸酯並無 顯著改變,而在活細胞數則見有顯箸改變。 音俐4 吾人曾於存在無吸收性避孕産品,Today Sponge, 具有及無甘油基一月桂酸酯時進行此實例,以評量金黃 色葡萄球@之增長及其所致之TSST-1産生。Today Sponge為小卜®Whitehall Laboratories Inc. 所製造。據其說明today Sponge為在一種聚氨基甲酸酯 泡沫海綿中含有Nonoxyno丨-9、苯酸、檸樣酸二氫納、 焦亞硫酸納、山梨酸及水。該海綿平均重為7.0克。 水中之甘油基一月桂酸酯溶液予以加熱,直到甘油 基一月桂酸酯溶解,然後並形成丸狀至1.0克量之 today Sponge,以産生依據Today Sponge之重量為〇·1, 1.0及lOM/W甘油基一月桂酸酯。1.0克樣本予以插入已 • - 23 - Λ 6 Β6 (請先閲讀背面之注意事項再填寫本頁) - -裝- 訂_ 本紙張尺度逍用中國困家樣準(CNS)甲4規格(210><297公釐) 五、發明説明(22) Λ 6η 6 接種之滲析袋内,其内含有濃度在開始時為5.20 χ 10 cfu/毫升之産生TSST-1之金黃色葡萄球菌。試驗结果報 告於表4。 表 4 水中之甘油基一月桂酸酯懸浮體 對TSST-1形成及金黃色葡萄球菌增長之作用 球度Ϊ 色最FU 黃之C 金菌10 X /IV 本 金黃色蕕萄球 TSST-1 菌之最後濃度Λ之最後量17 (Log 0?_升)(毫微克)Sphericality increase vine concentration _ the last color of the first color of the golden yellow gold bacterium LO TSST-1 the final amount (milligrams) only inoculum 91.20 9.96 6,309.80 Summer Ts Eva lavage 0.021 6.34 670.94 Summer Ts Eva lavage Liquid (〇. U glyceryl monolaurate) 0.005 5.74 27.87 Masseno Π 1 lavage fluid (1.03: glyceryl monolaurate) 0.006 5.83 4.60 Summex ^ s Eva lavage fluid (10 ¾ glyceryl January 0.12 7.08 4.00 cinnamate) a The number of live Staphylococcus aureus cells shown in logarithm to the base 10. b Reiser et al. Applied and Environmental Microbiology, December 1982, determined by the ELIS A method reported on pages 1349-1355. c Average determination of duplicate samples. (Please read the precautions on the back and then fill out this page) The Ministry of Economic Affairs + Central Bureau of Industry and Commerce A Industrial and Consumer Cooperatives printed this paper. The Chinese Standard (CNS) Grade 4 specifications (210x297 mm) are used -20-_136_ _136_ A6 printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs 5. Description of the invention (19) The results listed in Table 2 show that the viable cell count was significantly reduced from a log concentration of 9.96 to 6.34 when the commercially available lavage fluid was present (Reduced 3650, TSST-1 formation was also reduced from 6,309.8 0 to 670.94 (reduced 89¾). The reduction in the concentration of living cells, in addition to the acetic acid in the commercially available formula, is most likely the presence of benzoic acid (a known bactericidal agent) The data listed in Table 2 shows that, compared with the control group containing only Summer's Eve lavage fluid, TSST-1 formed at a concentration of 0. U glyceryl monolaurate reduced the level of at least 96S !, In the presence of 1.0 and 10¾ glyceryl monolaurate W / W, a reduction of 99μ! Compared with the control group, the presence of 0.UW / W glyceryl monolaurate produces a logarithmic concentration of 5.74 (decrease 9¾) live cells. There is 1.0¾ W / W glyceryl monolaurate, the logarithmic concentration is 5.83 (minus 8S;). For comparison, the 10¾ W / V glyceryl monolaurate solution in the Summers Eve lavage solution produced a logarithmic concentration of 7.08 (increased by 11JO. Example 3 In this example, we had a concentration of 0.1 in distilled water , 1.0 and 1 (U's glyceryl monolaurate suspension was used to evaluate the growth of Staphylococcus aureus and the resulting TSST-1 production. The solution was the same as in Example 1 except that no commercial products were used in the test. The above is evaluated by the quantity of 1.0 g. The results are shown in Table 3. -21-This paper scale is used in the national standard (CNS) A 4 specifications (210x297 public release) (please read the precautions on the back (Fill in this page again) Pack-Line-Λ 6 136 V. Description of the invention (20) Table 3 Effect of glyceryl monolaurate suspension in water on TSST-1 formation and S. aureus growth sample S. aureus gold The final concentration of the staphylococcus aureus TSST-1 bacteria The final amount of the final concentration of bacteria 1 ^ (xlO CFU / ml) (Log CFφ½ liter) (milligrams) inoculation water 91.20 9.96 6,309.80 (control group) oleic acid water in the base ester Gan Gui in X November (Please read the precautions on the back and then fill out this page) The oleic acid water laurel in the base ester is installed on the month 0¾-Ordered by the Ministry of Economic Affairs + Central Standards Bureau Staff Consumer Cooperatives to print a living gold shown in logarithm to the base 10 Number of yellow staphylococcus cells. B Reiser et al., Determined by ELIS A method reported in December 1982, pages 1349-1355. c Average determination of duplicate samples. -22-This paper uses the Chinese National Standard (CNS) A4 specifications (210x297 public goods) printed by the Ministry of Economic Affairs, Central Bureau of Economic and Social Development, Beigong Consumer Cooperative Printed Γ〇'ύύ ^ (:: V. Invention Description (21) Table The data presented in 3 show that when the concentration of glyceryl monolaurate suspended in water is 0. IX tf / W glyceryl monolaurate and above, TSST-1 formation is significantly reduced (99.9V) In addition, at a concentration of 0.UW / W glyceryl monolaurate, the toxin formation is reduced by a factor of 1,000 and there is a corresponding reduction of 99.6¾ in the number of viable cells of golden yellow grape bulbs. In increasing glyceryl monolaurate At the concentration, the anti-biological effect is mainly at 1.0¾ level. At 10¾ W / W glyceryl monolaurate, the anti-microbial effect is reduced, which may be due to the insolubility of the tested compounds. TSST-1 The reduction of the formation from 0.S: to 10¾ glyceryl monolaurate did not change significantly, and the number of viable cells showed significant changes. Yin Li 4 I once had non-absorbable contraceptive products, Today Sponge, with And without glyceryl monolaurate to carry out this example to evaluate golden yellow grapes @ 之 Growth and the resulting TSST-1. Today Sponge is manufactured by Kobu® Whitehall Laboratories Inc. According to its description, today Sponge contains Nonoxyno 丨 -9 and benzoic acid in a polyurethane foam sponge , Sodium dihydrogen citrate, sodium metabisulfite, sorbic acid and water. The average weight of the sponge is 7.0 grams. The glyceryl monolaurate solution in the water is heated until the glyceryl monolaurate is dissolved and then formed Pill to 1.0g of today Sponge to produce a weight of 0.11, 1.0 and lOM / W glyceryl monolaurate according to Today Sponge. 1.0g sample is inserted •-23-Λ 6 Β6 (please first Read the precautions on the back and then fill out this page)--Installation- Order _ This paper scale is easy to use Chinese sleepy standard (CNS) A 4 specifications (210 > < 297mm) Fifth, the invention description (22) Λ 6η 6 The inoculated dialysis bag contains TSST-1 producing Staphylococcus aureus with a concentration of 5.20 χ 10 cfu / ml at the beginning. The test results are reported in Table 4. Table 4 Glyceryl monolaurate suspension in water Effects of TS2 on the formation of TSST-1 and the growth of Staphylococcus aureus Sphericality Ϊ color the most FU yellow C golden bacteria 10 X / IV this golden yellow staphylococcus TSST-1 the final concentration of the final amount Λ 17 (Log 0? _L) (nanograms)

Today Sponge (對照組) 5.66 8.75 12,635.21 Today Sponge (0 . 1甘油基 一月桂酸酯) 4.60 8.66 2,185.88 Today Sponge (1 . (U甘油基 一月桂酸酯) 4.46 8.65 799.99 Today Sponge (1.0¾甘油基 一月桂酸酯) 0.13 7.13 3.29 a以10為底之對數所示之活金黃色葡萄球菌細胞數。 (請先閲讀背面之注意事項再填寫本頁) - 裝- -線- 經濟部屮央標準局A工消#合作社印製 b Reiser等人在應用及環境微生物學,1982年12月, 1349-1355頁報告之ELISA法所確定。 c雙份樣本之平均測定。 -24 - 本紙張尺度逍用中困國家標準(CKS)甲4規格(210x297公垃) 經濟部屮央梂準局Α工消t合作社印製 Λ 6 13 6 五、發明説明2(3 ) 表4中所報告之結果顯示在0.1¾ W/W甘油基一月 桂酸酯,TSST-1形成減低至少82¾之水準,存在1.0及 10¾ W/W甘油基一月桂酸酯時,分別見有減低93¾及 99.9%。 關於細胞生存力,與對照組比較,存在0.1¾ W/W甘 油基一月桂酸酯産生對數濃度δ. 66 (減少1.0¾)。存在 1.0¾ W/W甘油基一月桂酸酯時,對數濃度為8.65(減 1.U),在10¾ V/W甘油基一月桂酸酯時,具有較高之抗 徹生物作用,導致活細胞減少18¾。 奮例5 由於市售灌洗液常衩濫用作為避孕劑,吾人曾著手實 驗甘油基一月桂酸酯以評量殺精子作用。吾人使用 Sander-Craner試驗(採用人類精液)評量甘油基一月桂 酸酯之殺精子作用。該化合物傜在鹽水中以100毫克/毫 升之濃度配製而成。將一毫升此種溶液與0.2毫升人類 精液快速混合。準備一懸滴此種混合物,並在距混合開 始20秒以内以顯徹鏡檢査精子活動能力。在此最高應用 濃度,精子活動能力持缅超過三分鍾,指示缺少對精子 活動能力之作用。 此等實例證明甘油基一月桂酸酯對於金黃色葡萄球 菌所産生之TSST-1毒素偽一種有效之毒素抑制劑c再者 ,該化合物在本發明市售成份所使用之濃度實際不抑制 -25 - 本紙張尺度逍用中國國家標準(CNS)甲4規格(210x297公;li:) (請先閱讀背面之注意事項再塡寫本頁)Today Sponge (control group) 5.66 8.75 12,635.21 Today Sponge (0.1 glyceryl monolaurate) 4.60 8.66 2,185.88 Today Sponge (1. (U glyceryl monolaurate) 4.46 8.65 799.99 Today Sponge (1.0¾ glyceryl mono Laurate) 0.13 7.13 3.29 a The number of live Staphylococcus aureus cells is shown as a logarithm of 10. (Please read the precautions on the back before filling in this page)-Installation--Line-Ministry of Economic Affairs Bureau of Standards Printed by A Gong Xiao # Cooperative Society b Reiser et al. Applied and Environmental Microbiology, December 1982, determined by the ELISA method reported on pages 1349-1355. C Average determination of duplicate samples. Printed by the National Standard (CKS) Grade 4 (210x297 public wastes), printed by the Quongqiang Bureau of the Ministry of Economic Affairs, A Gongxiaot Cooperative Society Λ 6 13 6 V. Description of the Invention 2 (3) The results reported in Table 4 are shown in 0.1¾ W / W glyceryl monolaurate, TSST-1 formed a reduction level of at least 82¾, and in the presence of 1.0 and 10¾ W / W glyceryl monolaurate, there was a reduction of 93¾ and 99.9%, respectively. Regarding cell viability , Compared with the control group, there is 0.1¾ W / W glyceryl monolaurel The acid ester produces a logarithmic concentration of δ. 66 (reduction of 1.0¾). In the presence of 1.0¾ W / W glyceryl monolaurate, the logarithmic concentration is 8.65 (minus 1.U), at 10¾ V / W glyceryl monolaurate At that time, it has a high resistance to biological penetration, resulting in a reduction of 18¾ living cells. Fen Case 5 Because commercially available lavage fluid is often abused as a contraceptive, I have experimented with glyceryl monolaurate to evaluate the spermicidal effect. We used the Sander-Craner test (using human semen) to evaluate the spermicidal effect of glyceryl monolaurate. The compound was prepared at a concentration of 100 mg / ml in saline. One ml of this solution was mixed with 0.2 ml Human semen is mixed quickly. Prepare a hanging drop of this mixture, and check the sperm motility within 20 seconds from the start of mixing. The highest application concentration, sperm motility is maintained for more than three minutes, indicating the lack of sperm activity These examples demonstrate that glyceryl monolaurate is a potent toxin inhibitor for the TSST-1 toxin produced by Staphylococcus aureus. The compound is a commercially available ingredient of the present invention. The concentration used does not actually inhibit -25-The size of this paper uses the Chinese National Standard (CNS) A4 specifications (210x297 g; li :) (Please read the precautions on the back before writing this page)

Λ 6 η 6 五、發明説明( 細胞增長。而且,甘油基一月桂酸酯不抑制精子活動能力 0 奮例6 在明尼蘇達大學Patrick schlievert博士所進行之 此項實驗中,甘油基一月桂酸酯曾以不同潘度加至50毫 一·. .....——- . --------- 心浸液肉湯然後將此等溶液接種1. ο X 1 〇 CFU/ 、、.、_____________________________________-〆 毫升A屬鏈球菌種C203,或一種已知之産生TSST-1之金 黃色葡萄球菌MN8。含有A屬鏈球菌C203之樣本於存在 7% C02時予以在攝氏37。培育1 2小時而不搖動,俾減少有 機體暴露於氧。除了搖動(以每分鐘200轉之速率)及在 標準培育器外,含有MN8之樣本予以類似接種。此項實 驗之結果摘要示於表5。 (請先閱讀背面之注意事項再塡寫本頁) t 丁 象 經濟部屮央標準局貝工消費合作社印製 本紙張尺度边用中國困家標準(CNS)甲4規格(210X297公没) ϋ' Λ 6 η 6 五、發明説明g6 ) 表 5 甘油基一月桂酸酯對於a靥鐽球菌及金黃色μ 萄球S5MN8之毒素産生及細胞活動能力之作用 甘油基1 SPE型 月桂酸酯 CPU A B TSST-1 揉本 毫克八〇〇 __;- °3 C20 ο ^Ι^Ό^Ο25·50·75·0·00· °-°-aaaL111251 0808080808080706 11111111 xxxxxxxx 1 5 2 3 2 Λ ο, 3·3·3·3·3·24300000 SS^N.D.NX>.N.D.NJ).NX>.NX).NO.N1).NX>. 33.00.75盟品喆:^ (請先閲讀背面之注意事項再填寫本頁) 裝- 訂 MN8 經濟部屮央標準局兵工消費合作社印製 0 8.4 X 10y 0.05 9.0 x 109 0.1 9.4 χ 109 0.25 6.2 χ 109 0.5 1.8 χ ΙΟ10 .75 9.7 χ ΙΟ9 1.0 2.1 χ ΙΟ10 1.25 7.0 χ ΙΟ9 1.5 1.4 χ ΙΟ10 1.75 1·1 χ ΙΟ10 2.0 4.0 χ ΙΟ5 2.25 2.0 χ ΙΟ3 2.5 2.3 χ ΙΟ4 5.0 2.1 χ ΙΟ4 10.0 2.9 χ ΙΟ4 48 48 48 12 NX>. N.D. N.D. N.D. N.D. NJD. N.D. N.D. N.D. N.D. N.D. 線. -27 - 本紙張尺度逍用中國國家標準(CNS)甲4規格(210x297公;Ιέ) 經濟部中央標準局β工消t合作社印製 Λ 6 13 6 五、發明説明Ρ) 啻例7 在Patrick sehlievert博士所進行之此實例中,曾 對分別表示SPEA, SPEB或SPEC之A屬鐽球菌種,以及B、 F及G屬鐽球菌種就甘油基一月桂酸酯對外毒素產生之作用 予以評置。使用實例6中所述之方法使徹生物暴露於腦心 浸液肉湯中之不同濃度甘油基一月桂酸酯。所使用者分 別為産生SPE A之菌種594,産生SPEB之菌種86-858及産 生SPEC毒素之菌種T18P。毒素産生偽藉Western免疫塗 抹法歷時96小時予以測定。此項實驗確定甘油基一月桂 酸酯對SPEA、SPEB以及SPEC毒素産生之作用,其結果列 7F於表6。 金黃色葡萄球菌種MH8也暴露於甘油基一月桂酸酯 。金黃色葡萄球菌種MN8所産生之TSST-1之量曾予以測 定。此試驗之結果列示於表7。 也由菌種594, 86-858及T19P所産生之鐽球菌溶素 0及S以及B屬鏈球菌溶血素,F屬鐽球薗溶血素及G羼鏈 球菌溶血素,曾以0.U綿羊紅血球及0.01 4S! 2-颞基乙 醇作為還原劑在磷缓衝溶液(PBS)中之0.75¾瓊脂耱( 4. 5毫升/載片)所進行之溶解予以測定。PBS由0.005克 分子磷酸納與0.15克分子HaCl (pH 7.0)所組成。將 20 ul無細胞培養物加至載Η上所打之凹部24小時後所 引起之溶血現象用以測定溶血素産生。除了使用0 , 1S: -28 - 本紙張尺度边用中國國家標準(CNS)甲4規格(210x297公发) (請先閲讀背面之注意事項再塡寫本頁) f 裝< Λ 6 13 6 五、發明説明(27) 三酪脂清除作為標準外,脂肪酵素以與溶血素相同之方 式予以澜定。 減低鏈球菌溶素0及S之結果也列示於表6。此等實 驗之結果證明甘油基一月桂酸酯分別對表8,9及10中 B, F及G屬鐽球菌所致毒素産生之作用。數據顯示有甘 油基一月桂酸酯存在時,A, B, F及G颺銻球菌所産生之 毒素及/或溶血素之量顯箸減少。 (請先閲讀背面之注意事項再填寫本頁) f 裝· 經濟部中央標準局3工消费合作社印製 -29 本紙張尺度通用中困國家標準(CNS)甲4規格(210x297公¢) Λ 6 13 6 五、發明説明ί8 ) 表 6 甘油基一月桂酸酯對A屬鏈球菌之作用 細菌£甘油基—月桂酸酯對數CFU/ = #少 (毫徹克/毫升)毫升 (笔徹克/毫升)资皿系 594 (SPEA) 0 8.6 32 7.0 25 8J 03 4.0 10.0 S3 03 0.0 20.0 6.0 0.0 0.0 86-858 (SP£B) 0 8.0 0.8 4.0 2.5 7.7 0·0 2.0 10.0 7.7 0.0 0.0 20.0 5.8 0.0 0.0 T18P (SPEC) 0 7.9 0.4 8.0 2J 7.9 0.0 8.0 10.0 6.1 0.0 0.0 a接種物大小在10與10 CFU/毫升之間。 b包括以公厘計溶解直徑所實測之鐽球薗溶素0及S。 (請先閱讀背面之注意事項再填寫本頁) 經濟部屮央標準局β工消t合作社印製 -30 - 本紙張尺度逍用中國國家標準(CNS)甲4規格(210x297公度) 五、發明説明(巧) 66 Λβ 經濟部+央標準局员工消费合作社印製 昍娄fgooNH I涵泜©«却赋啪寐避鐙埋叫1蝴葚ill " L 撇 卜 9 9 2 «〇 X oo 七 Ώ 2 jn tn 〇 r-i 〇 n O m o H ? ? 00 〇 m 3: ·-» r> o -ζ^ «4 jo 2 □ o cs o r*» 〇 o o s . H $ Q o 葩τ 世涔 3: 谅馬|w JQ «s 2 o o o «0 n 〇 Ov H «s o o o m X σ\ o o o · 00 •J o >〇 cs mmm s <n «η >d «0 T- o o o o ft s: o o o o CN tN «N| mwm 5 •0 tn 00 •S β、 1 fc Jro -ppr mi - < 二 f wi 〇 8 8 § ίπ ας ^ # 31- 。-1£ϊ/ωοΙ/ο·ιψ4<^®^ro (宋 W/ 轵耘 w) I-1SS1 ·1 Ρ (請先閱讀背面之注意事項再塡寫本頁) 穿· 鳑· ,本紙張尺度逍用中國國家標準(CNS)甲4規格(210x297公;1J:) £: Λ 6 Π 6 五、發明説明(30) 表 δ 甘油某一月梓酴酷對R«鍊琺鍤夕作用 甘油期一月桂酸 (毫微克/毫升) m 間 畺 8小時 對教細朐/臺并 2 4小時 溶血素胞/毫升溶血素_ 0 8.7 2 8.5 2 2 . 5 8.1 0 8.4 0 10.0 <4.0 0 <3.0 0 接種物大小2 . 0 X 105 /毫升 (請先閱讀背面之注意事項再塡寫本頁) 裝. 線- 經濟部屮央標準局見工消费合作社印製 32 - 本紙張尺度逍用中國國家標準(CNS)甲4規格(210x297公货) Λ 6 Β 6 經濟部屮央標準局员工消費合作社印製 五、發明説明(3| ) 表 9 甘油某一月株酴酯對FB銻琺舖夕作用 甘油期一月桂酸 (毫徹克/毫升) m 問 畺 8小時 對勘細朐/臺并溶rfn袤 24小時 對數細胞/蕞并溶血素 0 8.3 7 8.3 7 2.5 8.5 0 8.3 0 10.0 <10^ 0 <1 〇3 0 接種物大小2 . 0 X 1〇5/毫升 -33 - (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度逍用中國國家標準(CNS)甲4規格(210x297公釐) Λ 6 13 6 的认!?: 五、發明説明(32·) 表 10 _甘油基一月样酸酷對(}靨_球舖之作用_ _時間 最_ 甘油期一月桂酸 8小時 24小時 (毫徹克/毫升)對數细朐/裏并溶而袤 對數細朐/臺并溶rfn袤 10 10 v3 接種物大小2. 0 X 1(//毫升 (請先閱讀背面之注意事項再填寫本頁) 裝. 訂- 線. 經濟部中央標準局员工消費合作社印製 -34 - 本紙張尺度逍用中國國家標準(CNS)甲4規格(210x297公釐) __136_ Λ 6 五、發明説明(33) 奮例8 在Patrick schlievert博士所進行之此項實驗中, 曾試圖誘使鍵球菌種C203及金黃色葡萄球菌種MN8在含 有甘油基一月桂酸酯之板上生長。在瓊脂板上塗覆 5 X 106 CFU時,菌種C203之最低甘油基一月桂酸醏抑 制濃度為1毫克/100毫升。2毫克/100毫升板便無生長 。在塗覆7 X 10y CFU時,菌種MN8之最低甘油基一月桂 酸酯抑制濃度為5毫克/100毫升。7.5毫克/100毫升板 便無生長。此項實驗曾平均每週試作兩次,歷時六個月 。數據顯示在有抑制水準之甘油基一月桂酸酯時,不可 能有費種生長。 (請先閲讀背面之注意事項再填寫本頁) 裝· -線- 經濟部屮央櫺準局员工消费合作社印製 -35 - 本紙張尺度逍用中国國家標準CCNS)甲4規格(210x297公龙)Λ 6 η 6 V. Description of the invention (Cell growth. Moreover, glyceryl monolaurate does not inhibit sperm motility. Example 6 In this experiment conducted by Dr. Patrick Schlievert of the University of Minnesota, glyceryl monolaurate had Add to 50 milliliters with different pan degrees........------------------------------------------------------------------------------------------------Be s ., _____________________________________-〆 ml of genus A streptococcus species C203, or a known type of Staphylococcus aureus MN8 that produces TSST-1. Samples containing genus A streptococcus C203 in the presence of 7% C02 will be at 37 degrees Celsius. Cultivation 1 2 Hours without shaking to reduce the exposure of the organism to oxygen. Except for shaking (at a rate of 200 revolutions per minute) and in a standard incubator, samples containing MN8 were similarly inoculated. The summary of the results of this experiment is shown in Table 5. ( Please read the precautions on the back before writing this page) t Dingxiang Printed this paper by the Beigong Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. The paper scales are based on China ’s Standards (CNS) Grade 4 (210X297). Λ 6 η 6 5. Description of invention g6) Table 5 The effect of glyceryl monolaurate on the production of toxins and cell viability of agaricus and aureus S5MN8 glyceryl 1 SPE type laurate CPU AB TSST-1 rubbing mg 800 ____;- ° 3 C20 ο ^ Ι ^ Ό ^ Ο25 · 50 · 75 · 0 · 00 · °-° -aaaL111251 0808080808080706 11111111 xxxxxxxx 1 5 2 3 2 Λ ο, 3 · 3 · 3 · 3 · 3 · 24300000 SS ^ NDNX > .NDNJ) .NX > .NX) .NO.N1) .NX >. 33.00.75 Mengpin Zhe: ^ (Please read the precautions on the back before filling in this page) Binding-Set MN8 Ministry of Economics Standard Printed by Bureau Ordnance Consumer Cooperatives 0 8.4 X 10y 0.05 9.0 x 109 0.1 9.4 χ 109 0.25 6.2 χ 109 0.5 1.8 χ ΙΟ10 .75 9.7 χ ΙΟ9 1.0 2.1 χ ΙΟ10 1.25 7.0 χ ΙΟ9 1.5 1.4 χ ΙΟ10 1.75 1 · 1 χ ΙΟ10 2.0 4.0 χ ΙΟ5 2.25 2.0 χ ΙΟ3 2.5 2.3 χ ΙΟ4 5.0 2.1 χ ΙΟ4 10.0 2.9 χ ΙΟ4 48 48 48 12 NX >. NDNDNDND NJD. NDNDNDNDND line. -27-This paper scale uses the Chinese National Standard (CNS) A4 specifications (210x297 g; Ιέ) Printed by β Gongxiaot Cooperative of Central Bureau of Standards, Ministry of Economic Affairs Λ 6 13 6 V. Description of the invention (P) Example 7 In this example conducted by Dr. Patrick sehlievert, glyceryl monolauric acid was given to the species of Rhizococcus spp. Which represents SPEA, SPEB or SPEC, and the species of R. sphaericus B, F and G, respectively The effect of esters on exotoxin production is evaluated. The method described in Example 6 was used to expose the organism to different concentrations of glyceryl monolaurate in the brain heart infusion broth. The users used were SPE A producing strain 594, SPEB producing strain 86-858 and SPEC toxin producing strain T18P. The toxin production was measured by Western immunosmear for 96 hours. This experiment determined the effect of glyceryl monolaurate on the production of SPEA, SPEB and SPEC toxins. The results are shown in Table 6 in Table 7F. Staphylococcus aureus species MH8 was also exposed to glyceryl monolaurate. The amount of TSST-1 produced by Staphylococcus aureus MN8 has been measured. The results of this test are shown in Table 7. Also produced by strains 594, 86-858 and T19P, sclerolysin 0 and S and B belong to streptococcal hemolysin, F belongs to staphylococci hemolysin and G 羼 Streptococcus hemolysin, once used 0.U sheep The dissolution of erythrocytes and 0.01 4S! 2-temporal ethanol as a reducing agent in 0.75¾ agar agar (4.5 ml / slide) in phosphorus buffer solution (PBS) was determined. PBS consists of 0.005 moles of sodium phosphate and 0.15 moles of HaCl (pH 7.0). The hemolysis phenomenon caused by adding 20 ul of cell-free culture to the recessed portion on the carrier 24 hours later was used to measure hemolysin production. In addition to the use of 0, 1S: -28-This paper scale uses the Chinese National Standard (CNS) A 4 specifications (210x297 public) (please read the precautions on the back before writing this page) f install < Λ 6 13 6 V. Description of the invention (27) Except for the removal of tributyrate as a standard, lipase is fixed in the same way as hemolysin. Table 6 also shows the results of the reduction of streptozotocin 0 and S. The results of these experiments demonstrate the effect of glyceryl monolaurate on the production of toxins caused by B. F and G in Tables 8, 9 and 10 respectively. The data shows that in the presence of glyceryl monolaurate, the amount of toxin and / or hemolysin produced by A, B, F and G anticocci is significantly reduced. (Please read the precautions on the back before filling in this page) f Printed by the Central Bureau of Standards of the Ministry of Economic Affairs, printed by the Industrial and Consumer Cooperatives-29 This paper standard is the National Standard (CNS) A 4 specifications (210x297) ¢ 6 13 6 V. Description of the invention ί8) Table 6 The effect of glyceryl monolaurate on Streptococcus spp. Bacteria. Glyceryl-laurate logarithm CFU / = #less (milligram / ml) ml (pencil / Ml) 594 (SPEA) 0 8.6 32 7.0 25 8J 03 4.0 10.0 S3 03 0.0 20.0 6.0 0.0 0.0 86-858 (SP £ B) 0 8.0 0.8 4.0 2.5 7.7 0 · 0 2.0 10.0 7.7 0.0 0.0 20.0 5.8 0.0 0.0 T18P (SPEC) 0 7.9 0.4 8.0 2J 7.9 0.0 8.0 10.0 6.1 0.0 0.0 a The inoculum size is between 10 and 10 CFU / ml. b Including the measurement of the dissolved diameter 0 and S in the measured diameter in millimeters. (Please read the precautions on the back before filling in this page) Printed by β Gongxiaot Cooperative Society, Bureau of Standards, Ministry of Economic Affairs -30-This paper scale uses the Chinese National Standard (CNS) Grade 4 specifications (210x297 degrees). Description of the invention (Qiao) 66 Λβ Printed by the Ministry of Economy + Central Bureau of Standards and Staff Employee Consumer Cooperatives 昍 fgooNH I Hanlu © «but Fu Fu sleep avoid stirrup buried call 1 葚 葚 ill " L 卜卜 9 9 2« 〇X oo Seven Ώ 2 jn tn 〇ri 〇n O mo H?? 00 〇m 3: ·-»r > o -ζ ^« 4 jo 2 □ o cs or * »〇oos. H $ Q o 葩 τ 世 涔 3 : Forgive horse | w JQ «s 2 ooo« 0 n 〇Ov H «sooom X σ \ ooo · 00 • J o > 〇cs mmm s < n« η > d «0 T- oooo ft s: oooo CN tN «N | mwm 5 • 0 tn 00 • S β, 1 fc Jro -ppr mi-< two f wi 〇8 8 § ίπ ας ^ # 31-. -1 £ ϊ / ωοΙ / ο · ιψ4 < ^ ® ^ ro (Song W / 轵 耘 w) I-1SS1 · 1 Ρ (please read the precautions on the back before writing this page) Wear · 鳑 ·, this paper The standard uses Chinese National Standards (CNS) Grade 4 specifications (210x297 g; 1J :) £: Λ 6 Π 6 V. Description of invention (30) Table δ Glycerol Glycerol a certain month on the role of R «chain enamel glycerin Monthly lauric acid (nanograms / ml) m 8 hours of interpersonal teaching cell / set and 24 hours of hemolysin cells / ml hemolysin_ 0 8.7 2 8.5 2 2. 5 8.1 0 8.4 0 10.0 < 4.0 0 < 3.0 0 Inoculum size 2. 0 X 105 / ml (please read the precautions on the back before writing this page) Packing. Line-Printed by the Ministry of Economic Affairs, Bureau of Standards, and Seen at the Consumer Cooperative Society 32-This paper size Printed with China National Standards (CNS) A4 specifications (210x297 public goods) Λ 6 Β 6 Employee Consumer Cooperative of the Bureau of Standards, Ministry of Economic Affairs V. Invention description (3 |) The effect of enamel in the glycerin phase is monolauric acid (milligram / ml). M 8 min. 8 hours to reconcile the cell / set and dissolve rfn. 24 hours logarithmic cells / sp. Hemolysin 0 8.3 7 8.3 7 2.5 8.5 0 8.3 0 10.0 < 10 ^ 0 < 1 〇3 0 Inoculum size 2. 0 X 1〇5 / ml-33-(Please read the precautions on the back before filling this page) Use the Chinese National Standard (CNS) A 4 specifications (210x297 mm) Λ 6 13 6 recognition!?: Fifth, the invention description (32 ·) Table 10 _Glyceryl January-like acid cool pair (} 靥 _ 球 铺 之Role _ _ time most _ glycerin period one lauric acid 8 hours 24 hours (milligrams / ml) logarithmic fines / li and dissolved and valerian logarithmic fines / set and dissolved rfn 褤 10 10 v3 inoculum size 2. 0 X 1 (// ml (please read the precautions on the back before filling in this page). Packing. Thread. Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. -34-This paper standard uses Chinese National Standard (CNS) A4 Specifications (210x297 mm) __136_ Λ 6 V. Description of the invention (33) Example 8 In this experiment conducted by Dr. Patrick Schlievert, attempts were made to induce the key bacterium C203 and Staphylococcus aureus MN8 to contain glyceryl groups It is grown on the board of monolaurate. When 5 X 106 CFU is coated on the agar plate, the lowest glyceryl monolaurate of strain C203 is inhibited. The preparation concentration is 1 mg / 100 ml. The 2 mg / 100 ml plate will not grow. When coating 7 X 10y CFU, the minimum inhibitory concentration of glyceryl monolaurate of strain MN8 was 5 mg / 100 ml. The 7.5 mg / 100 ml plate will not grow. This experiment was conducted on average twice a week for six months. The data shows that when there is an inhibitory level of glyceryl monolaurate, no costly growth is possible. (Please read the precautions on the back and then fill out this page) Installation · -Line-Printed by the Employee Consumer Cooperative of the Central Bureau of Economics of the Ministry of Economic Affairs -35-This paper standard uses the Chinese National Standard CCNS) A 4 specifications (210x297 male dragon )

五、發明説明() Λ 6 Π 6 專利申請案第80 108379號 ROC Patent Appln. Ho. 80 108379 補充之實例中文本一附件㈠ Supplemental Examples in Chinese - Enel. I (民國81年6月(6日修正並送呈) (Amended & Submitted on June (^.1992) g例1 使用上述待測止血垄.製備各含有o.i %、 ι·〇 %及 10% (重量tb)上述Lauricidin混合物之止血塞,以未 經處理_的止血塞之重量為基準。將此Lauricidin混合物 塗¥於待制止血塞上,根據本申請案中前述關於製備本 發明止血塞之一般程序進行。將含有匕31-11“ in之止血 塞裂成兩份。然後將La^iricidin處理過之止血塞,根據 止血塞囊方法.進行測試,此方法偽由Reise「等人報告於 臨床徹生物學期刊,第25卷,1987年8月,第1450-1452 頁,其掲示内容併於本文供參考。將得自美國, i/iscons in, Madison, Vine y〇ns;n 大學,食品研究所, Merlin Be「gdoll博士,呈已凍乾形式之金黃色®萄球 箇種FRI-1169,採用於本試驗中。一種金黃色蒱萄球菌 懸浮液係以下述方法製成.,撤底混合一毫克已凍乾之金 黃色涵萄球®種至一毫克腦心灌注液(BHI)培養基(片 自 Difco 實驗室,Detroit. Michigan,美國)中,將 混合物鞞移至一支含有五毫克B IU培養基之試管中,再 一次撤底混合.,於使用前.在37Ό下培育24小時。V. Description of Invention () Λ 6 Π 6 Patent Application No. 80 108379 ROC Patent Appln. Ho. 80 108379 Supplemental Examples in Chinese-Annex I (Supplemental Examples in Chinese-Enel. I (June 81, June 6 (Amended & Submitted on June (^ .1992) g Example 1 The above mentioned hemostatic ridges to be tested were used. Prepare hemostatic plugs each containing oi%, ι · 〇% and 10% (weight tb) of the above-mentioned Lauricidin mixture, Based on the weight of the untreated haemostatic plug. Apply this Lauricidin mixture to the haemostatic plug to be prepared according to the general procedure for preparing the haemostatic plug of the present invention as described above in this application. It will contain dagger 31-11 " The hemostatic plug in is split into two parts. Then, the hemostatic plug treated by La ^ iricidin is tested according to the hemostatic plug method. This method is reported by Reise "et al. in the Journal of Clinical Biology, Volume 25, 1987 August 2014, pp. 1450-1452, the contents of which are shown and are included in this article for reference. It will be obtained from the United States, i / iscons in, Madison, Vine y〇ns; n University, Food Research Institute, Merlin Be, Dr. Gdoll, presented Golden Yellow® in lyophilized form Staphylococcus aureus FRI-1169, used in this experiment. A suspension of Staphylococcus aureus was prepared by the following method. One milligram of freeze-dried Staphylococcus aureus® was mixed with 1 mg of brain Heart perfusion solution (BHI) medium (tablets from Difco Laboratories, Detroit. Michigan, USA), the mixture is transferred to a test tube containing five milligrams of B IU medium, and the bottom is mixed again. Before use. Incubate for 24 hours at 37Ό.

將1 0 0毫升腦心灌注液(B丨1 I )瑱脂(亦得自D丨f c 〇宵 駿室.’Detroit , Michigan,美國~)放入十支3.8公分X 本紙尺度边用中Η困家標準(CNS) 規格(210x297公;!I:) (請先閲請背而之注意事項再墙寫本頁) 裝< 線. 經濟部屮央標準局Α工消讣合作杜印¾ 81. 4. 10,000張(H) 五、發明説明() Λ 6 η 6 20公分培養試管之毎一支中。製成谢維素囊,並 Reiser等人所報告之方法消毒。以上述金贸色葡 懸浮液接種此無閣谢維素囊,其毋足以在開始此 時,於其中提供lx 10s CFU/毫升。 將毎一値經過L a u r i c i d i η處理過之待測止血基 含有金黃色葡萄球 入含有B 瓊脂之 件: ' 於一對照組( 接種之囊(其中無 養管之每一屆中。 止血塞(意即以上 未含 Laruicidin) BHI S脂之培養管 培養管,四支含有 未使用止血塞), 菌之無菌戡維素囊中,然後將 培養試管中。使用兩組對照物 稱為…接種物對照組”)_中,將 止血塞)置於兩値含有BHI琪 於第二對照組中.將兩個未經 述方法裂成之止血塞,但在異 置於谢維素S中,再將其置於 中。因此,在此項試驗中係使 上述對照洛(兩支使用止血塞 而其他則含有上述Lauricidir 以 項試驗 .插入 各囊插 ,各兩 一個已 脂之培 處理之 丙醇中 含有 用+支 :甬支 處理過 (請先閲讀背而之注意事項孙填寫本頁) 裝· 訂· 線- 經濟部屮央梂準/!00:工消费合作杜印製 份I-時 兩FR小 c 各@0中 -球ί 1 塞萄時表 血 I® 始於 止色開示 測黃驗傜 待金試 , 之 於度 ,蒺 T之 素後 毒時 群小 候24 m育 克培 ^ Ttt-.p 7 骞37 與於 69及 2 本紙張尺度边用中a B家樣毕(CNS) T4規格(2丨0x297公龙) 81. 4·]0,000張(H)Place 100 mL of brain-heart perfusion solution (B 丨 1 I) fat (also available from D 丨 fc 〇 夜 骏 室 .'Detroit, Michigan, USA ~) into ten pieces of 3.8 cm X paper size for medium use. CNS Standard (210x297; I!) (Please read the notes on the back and write this page on the wall) Install & Line. The Ministry of Economic Affairs, Bureau of Standards, Alpha Engineering Cooperative Du Du ¾ 81. 4. 10,000 sheets (H) V. Description of the invention () Λ 6 η 6 20 cm in each test tube. It is made into Xieweisu capsule and sterilized by the method reported by Reiser et al. Inoculation of this non-German vesuvin capsule with the above-mentioned gold trade color Portuguese suspension is not sufficient to provide lx 10s CFU / ml in it at the beginning. Place each test hemostatic base treated with Lauricidi η containing golden grape spheres into a piece containing B agar: 'In a control group (inoculated sacs (where there is no maintenance tube. Hemostatic plug ( This means that the above culture tubes do not contain Laruicidin) BHI S lipids, four tubes contain unused hemostatic plugs), bacteria in sterile sterilized capsules, and then the culture test tubes. The two groups of controls are called inoculum In the control group ") _, place the hemostatic plug) in the second control group containing BHI Qi in the second control group. Split the two hemostatic plugs into the Xieweisu S before they are placed in Xieweisu S Therefore, in this test, the above-mentioned control Luo (two use hemostatic plugs and the other contains the above-mentioned Lauricidir for the test. Insert into each capsule, each of which contains propofol treated with fat. Use + support: Yong support has been processed (please read the precautions to be filled out by Sun before filling out this page) Binding · Order · Line-Ministry of Economic Affairs, Bingyangzhun /! 00: Industrial and Consumer Cooperation Du Printed I-Time Two FR Small c each @ 0 中-球 ί 1 Serve the table blood I® starts from stop color The yellow test is for the gold test, and for the test, for the degree, the venom of the trichosanthin is 24 m yokepei ^ Ttt-.p 7 骞 37 and yu 69 and 2 paper size in the middle of a B home Sample Bi (CNS) T4 specification (2 丨 0x297 male dragon) 81.4 ·] 0,000 sheets (H)

Jat 05^0 A 6η 6 五、發明説明() 表 1 经1^11「丨£:;£)丨11處理過之止血塞對於由金黃色 蕕萄球国所生成之TSST-1及其生長之作用 試樣 金黃色《 萄球菌之· 最初頃度 TSST-l 之最初 濃度a) .金黃色蒱 萄球菌之 最後焉度 金黃色蕕 萄球®之 最後谤度b) TSST-1 之最後 猥度a) (CFU/毫升) (毫徹克 (CFD/毫升) (/毫升) (毫克/ 無止血塞 (10θ ) 1.0 /毫升) HD . (1〇θ ) • 100 10.0 毫升) 50 (對照物) 未處理之 1.0 HD ,.100 10.0 31 止血塞 (對照物) 止血塞 1.0 ND 794 10.9 15 w/0. 1% La ur i c i d 止血塞· in 1.0 HD 158 10.2 0.09 v/1. ΟΧ Laur i c i d ί η 止血塞 1.0 HD 316 10.5 0.08 (請先閲請背而之注意事項再填寫本頁} 裝< 訂· 線. r|! η y) JL i. J·、 L I: i · 11 3. w/10.03: ·Jat 05 ^ 0 A 6η 6 V. Description of the invention () Table 1 The hemostatic stopper treated with 1 ^ 11 "丨 £:; £) 丨 11 For the TSST-1 produced by the golden yellow grape country and its growth The effect of the sample is golden "The initial concentration of Staphylococcus aureus TSST-l a). The final salience of Staphylococcus aureus the final slurredness of Golden Staphylococcus aureus® b) The final stagnation of TSST-1 Degree a) (CFU / ml) (Cochroch (CFD / ml) (/ ml) (mg / without tampon (10θ) 1.0 / ml) HD. (1θθ) • 100 10.0 ml) 50 (control ) Untreated 1.0 HD, .100 10.0 31 Hemostatic plug (control) Hemostatic plug 1.0 ND 794 10.9 15 w / 0.1% La ur icid Hemostatic plug in 1.0 HD 158 10.2 0.09 v / 1. ΟΧ Laur icid ί η Hemostatic plug 1.0 HD 316 10.5 0.08 (please read the precautions before filling in this page) Pack < Order · line. r |! η y) JL i. J ·, LI: i · 11 3. w /10.03: ·

Laur i c i d i η HD =未測得。Re ise「等人之EL ISA方法之偵測掻限為0.5毫拥Γ克/ 毫升。 a) =按Reise「等人於應用舆環境撤生物學,1982年12月,第1349 - 1 355頁中所報告之ELISA方法測定.其掲示内容併於本文 供參考。 b) =以底10之log值表示_。 所有上述數據均為燹Μ試樣之平均測定值。 本紙張尺度边用中Η國家標毕(CNS)Ή規格(210x297公;«:) 81. 4. 10,000» H) ^0550^ Λ (5 __ Β 6_ 五、發明説明() 表1中之數據顯示金黃色葡萄球茵,於含有o.ixu/w) Laurie i."d in之止血塞存在下,偽tb當其暴露於未含 L aYr ί c i (Π η之對照止血塞時.,産生减少5 1 %之毒性休克徵 候群毒素-1(了5 51'-1),而不管以下之事實,意即於 Lauricidin處理過之止血塞存在下,存活的金黃色葡萄 球菌细胞之實際數目並無降低。此數據進一步顯示金黃Laur i c i d i η HD = not measured. Re ise "The detection limit of the EL ISA method by others is 0.5 milligrams Γg / ml. A) = Press Reise" Wait for the withdrawal of biology in the applied public environment, December 1982, pages 1349-1355 The ELISA method reported in the test. Its content is shown here and for reference. B) = Log value expressed at the bottom 10_. All the above data are the average measured value of the sample. The paper is used in the middle of the scale. National Standards (CNS) Ή specification (210x297 g; «:) 81. 4. 10,000» H) ^ 0550 ^ Λ (5 __ Β 6_ V. Description of invention () The data in Table 1 shows that the staphylococcus aureus, In the presence of a hemostatic plug containing o.ixu / w) Laurie i. &Quot; d in, pseudo-tb when exposed to a control hemostatic plug that does not contain LaYr ί ci (Π η., Produces a toxicity reduction of 51% Shock syndrome group toxin-1 (5 51'-1), regardless of the fact that the actual number of surviving Staphylococcus aureus cells does not decrease in the presence of Lauricin-treated tampon. This data is further Show golden

I 色葡萄球菌於含有 l.〇X(w/w)與 10.0X(w/w) Lauricidin 之止血塞存在下,與相同數目金黃色®萄球閨细菌於未 含Laurie丨din之對照止血塞'存在下相比較,會産生减少I. Staphylococcus aureus in the presence of a hemostatic plug containing 1.0X (w / w) and 10.0X (w / w) Lauricidin, with the same number of golden yellow® staphylococcus bacteria in a control hemostatic plug without Laurie 丨 din 'Compared under the existence, there will be a reduction

I 99%之TSST-1,又一次不管以下事實,意即於含有 Laruicidin之止血塞存在下,於存活的金黃色涵萄球菌 細胞之數目上未降低。此數據顯示,當金黃色»萄球菌 细胞皋露於含有不同程度Lauricidin之止血塞時,雖然 存活的细胞數目並未减少.但由該细胞産生之TSST-1實 (請先閲請背而之注意事項再場寫本頁) 裝- 線. 經濟部屮央梂準/(0CI:工消赀合作杜印製 理與 ·細休 的於降 處0¾之茵性 潮在箸 π 1 言球羞 來存 _ di以換萄之 經常,會 CI在。¾生 月通, 1如} 色産 於由-1 au例中黃胞S^ST L ί況金細 血 ,TS 1*除倩的該 止於之 0.消之活由 的在生 以上塞存绖 過處産 在質血低制 理之闰 如S止降抑 處利球 例或之箸箸in有萄 過顯顯id其IRI 低中理未實 '1C.色 降況處並確 。,^用黄 著情inin其-lLa使金 顯之1(]1(1但素信内何 則塞1C1C,毐咸眩任 ,•血 u U 目群 —之之 量止LaLa數候此中中 數之%然之 m 因女道 際過10雖胞克 婦陰 81. 4. 10,000張(H) 本紙张尺度边用中S Η家樣準(CNS) f 4規枯(2】0x297公釐) Λ 6 Π 6 五、發明説明( 低。此外,於預備研究中.偽使用存在於陰道中之主要 撤生物(意即唣酸乳捍 a nl π t 0 h a P i 1 1 II s ar irioo h i 1 u s ) )進行,發現該撤生物在與含有l.OXU/w) Lauricidin 之實例1止血塞接《時,不會有不利影逛。 g例?. 進行第二値實驗,以評估在使用不同量之Laruicidin t 處理的市售止血塞存在下,金黃色《萄球菌細胞之生長 及由其産生之TSST-1。於本實例2之實驗中傜採用,在 公開市埸上購得之TaBpaXt &月經用止血塞(正規尺寸 ,産品號碼8L015Z)。此等止血塞偽良美國紐約Lake Success之Tanbrands公司所製造。Tanpax*止血塞含有 (請先閲讀背而之注意事項再填寫本頁) 經濟部屮央榀準而扎工消费合作社印製 細據 基含用照測 回根 為未-使對 。 取 。%«以物及试 條塞10重丨照塞測 一 血及之除對血行 及止¾塞切為止進 、.離 D 血已作的件 層切 1 止澠.過條 _蓋规、的細燥理與 s'细 Ϊ 理中乾處序 物回0'.處其箸in程 鍇取有經丨._接id之 縈之含未塞 ,10告 炫塞份以血理Ur報 1 血兩,止處La中 。 、止備塞' ί 醇绖 1 咿 層將製血ax丙的例 2 芯,,止ΠΡ異燥實表 核前序之Ta之乾據於 收試程.111.膣10已根告 吸測般id兩id將,報 花於 1JC將1C後塞果 棉。述Ur。^然血结 一澠上La準La。止試 本紙5fc尺度边用中困國家標準(CNS)fM規格(210x297公;«:) 81. 4. 10,000張(H) Λ 6 Π 6 五、發明説明() 表 2I 99% of TSST-1, once again irrespective of the fact that in the presence of a hemostatic plug containing Laruicidin, the number of viable Staphylococcus aureus cells did not decrease. This data shows that when aureus »Staphylococcus aureus cells are exposed to hemostatic plugs containing varying degrees of Lauricidin, although the number of surviving cells has not decreased. However, the TSST-1 produced by the cells is real (please read it first. Matters needing attention to write this page again) Outfit-line. Ministry of Economic Affairs 屮 央 梂 准 / (0CI: Cooperation between the industrial consumer and the Du Yin system and · Xiuxi at the drop-off point 0¾ The instinct is at the 相 π 1 Come to save _ di in order to exchange grapes often, CI will be there. ¾ Shengyuetong, 1} The color is produced by -1 au in the case of yellow cells S ^ ST L ί condition gold fine blood, TS 1 * except Qian ’s It ends at 0. The cause of the elimination is due to the existence of stagnation in the life above the birth. The leap is low in the quality of the blood. The leukard, such as S, the drop in the ball, or the chopsticks in the wine, the IRI is low. Zhongli is not real '1C. The color drop situation is confirmed. ^ Use yellow to express love inin its -lLa to make Jin Xian's 1 () 1 (1 but Su Xin within the letter is 1C1C u U The number of groups-the limit of the LaLa number is the middle of the number, but the m is due to the female crossing the age of 10 although the cell is female. 81. 4. 10,000 sheets (H) The size of the paper is used in the S family. Sample standard (CNS) f 4 gauge (2) 0x297 mm) Λ 6 Π 6 1. Description of the invention (low. In addition, in preliminary studies. Pseudo-use of the main withdrawal organisms present in the vagina (i.e., yoghurt defend a nl π t 0 ha P i 1 1 II s ar irioo hi 1 us)) It was found that when the withdrawal creature was connected with the example 1 hemostatic plug containing l.OXU / w) Lauricidin, there would be no adverse effects. G cases ?. A second experiment was conducted to evaluate the use of different amounts of Laruicidin t In the presence of the treated commercial hemostatic plug, the growth of Staphylococcus aureus cells and the TSST-1 produced by it. It was adopted in the experiment of this Example 2 and was purchased on the public market for TaBpaXt & menstrual bleeding Plug (regular size, product number 8L015Z). These tampon are manufactured by Tanbrands of Lake Success, New York, USA. Tanpax * tampon contains (please read the precautions before filling out this page) Ministry of Economic Affairs The standard printed by the Zhagong Consumer Cooperative Association is based on the use of photometry to return to the root. It is correct. Take.% «Materials and test strips, 10 weights, test the blood and remove the blood and stop the blood. Cut forward, cut off the pieces that have been made by D blood, and stop cutting. Regulations, fine dryness and s 'fine dryness in the order of the dry place back to 0'. At the place where the chao in Cheng Kai has a sutra. Ur report 1 blood two, stop at La., Stop the stopper 'ί 绖 绖 1 The layer 2 will make the blood ax C example 2 core, and stop the dry basis of the ΠΡ different dryness table before the test is based on the acceptance test Cheng.111. 膣 10 has already announced that the two IDs will be the same as that of the suction test. Scription Ur. ^ Ran blood knot La quasi-La. Stop the test The 5fc scale of the paper is used in the national standard (CNS) fM specification (210x297 g; «:) 81. 4. 10,000 sheets (H) Λ 6 Π 6 V. Description of invention () Table 2

Lauricidin處理過的TAMPAX止血塞(産品 < 號碼8L025Z)對於由金黃色蒱萄球菌( FRI-1169).生成的TSST-1之作用 金黃色蒱萄 金黃色蒱萄The effect of Lauricidin-treated TAMPAX hemostatic plug (product < No. 8L025Z) on TSST-1 produced by Staphylococcus aureus (FRI-1169). Golden yellow grapes Golden yellow grapes

I 球ίϊί細胞之 球a细胞之 TSST-1之最 試 樣 最後濃度 最後猥度b) 後瘵度a) (CFU/毫升) (/毫升) (毫克/毫升) (108 ) 1 Γ. 7 2 27.50 10.30 3.70 10.40 1.05 .13 8.33 0.19 OXLauricidin 5,248 止血塞(對照物) O.IXLauricidin 199 於止血塞上 l.OXLauricidin 251 於止血垄上 lO.OXLauricidin 2 經濟部屮央標準局a工消"合作社印製 於止血塞上 e r等人)所測得。 a )=由 EL IS A方法(R"e i s b )=以底1 0之1 ο ε值表示。 所有试搽之測定,均於3 7 Ό下培育2 4小時後進行。 所有上述数姊均為兩份试疣之平均測定值。 81. 4.〗0,000張(Η) (請先閲請背而之注意事項再塥寫本頁) 本紙張尺度逍用中a Η家標毕(CNS) Ή規格(210Χ.25Π公;《:) Λ 6 _Π6_ 五、發明説明() (請先閲讀背而之注意事項#塡寫本頁) 表2中之數據顯示金黃色«萄球SS,在使用不同量之 Lauricidin處理過之Tampax'*牌止血塞存在下·與當其 暴转於未杳Lanricidin之對照止血塞時比較.偽産生較 少TSST-1,其在毒素産生上降低之程度係與Lauricidin 在止血塞中之量有關。以0.1重fi%Lauricidin處理之 Tanpax*止血塞,與對照物tb較,係造成所産生的I ball spheres of a cell TSTS-1 of a cell the final concentration of the final sample of the final concentration b) the posterior degree a) (CFU / ml) (/ ml) (mg / ml) (108) 1 Γ. 7 2 27.50 10.30 3.70 10.40 1.05 .13 8.33 0.19 OXLauricidin 5,248 Hemostatic plug (control) O.IXLauricidin 199 On the hemostatic plug l.OXLauricidin 251 On the hemostatic ridge lO.OXLauricidin 2 Ministry of Economic Affairs, Bureau of Standards, Industrial and Commercial Cooperative Print Measured on the tampon, er et al.). a) = by the EL IS A method (R " e i s b) = expressed in terms of base 1 0 to 1 ε. All tests were performed after 24 hours of incubation at 37 ° C. All the above figures are the average measured values of two test warts. 81. 4.〗 0,000 sheets (Η) (please read the precautions first and then write this page) The standard of this paper is easy to use a Η 家 标 毕 (CNS) Ή specification (210Χ.25Π 公; ": ) Λ 6 _Π6_ V. Description of invention () (please read the back-end notes # 塡 write this page) The data in Table 2 shows the golden yellow «Grape SS, using different amounts of Lauricidin treated Tampax '* The presence of a brand hemostatic plug was compared with when it was violently transferred to the control hemostatic plug of Lanricidin. The pseudo-production of less TSST-1, the degree of reduction in toxin production is related to the amount of Lauricidin in the hemostatic plug. Tanpax * tampon treated with 0.1% fi% Lauricidin, compared with the control tb, caused

I TSST-1上之86%降低,而以1 %及10% (重量比)86% of I TSST-1 is reduced, and by 1% and 10% (weight ratio)

Laur丨cidin處理之Tanpax* ik血塞,偽各別造成96%與 99%降低。使用Tanpax*牌止血塞之结果,亦頴示在金 / 黃色葡萄球®细胞缌數上之降低;此項作用係依 Lauricidin在止血塞中之猥度而定。於24小時培育期结 束時,金黃色葡萄球®細胞於對照-止血塞存在下之對數 濃度為11.72;金黃色》萄球閎细胞於含有0.1%The Tanpax * ik thrombus treated by Laur 丨 cidin caused a 96% and 99% reduction respectively. The results of using the Tanpax * brand hemostatic plug also showed a decrease in the gold / yellow grape ball® cell count; this effect depends on the degree of Lauricidin's hemostatic plug. At the end of the 24-hour incubation period, the log concentration of golden staphylococcus aureus® cells in the presence of the control-hemostatic plug was 11.72;

Lau「ic丨din之止血塞存在下,其封,數濃度為10.30 (减 少12%);金黃色涵萄球箇细胞於含有1.〇 %In the presence of Lau "ic 丨 din's hemostatic plug, the number of seals is 10.30 (12% reduction); golden yellow staphylococcal cells contain 1.0%

Lau「丨cidin之止血塞存在下,其對數濃度為10.40 (減 少11%);及金黃色蒱萄球S5·細胞於含有!〇%Lau「icidin 之止血塞存在下,其對數猥度為8.33 (减少29%)。 經濟部屮央榀準而辽工消仲合作社印製 進行第三屆筲驗,_以評估在使用不同费.之L a u「i c i d i η 處理過之市锘止血莪存在下,'"金员色貼萄球®細胞之生 長及由其産生之TSST-1。於本實例3之筲驗中採用在公 開市場上購得之P丨a y t e X *牌月經用止血垄(正規尺寸. -7 - 81. 4. 10,000張(H) 本紙張尺度逍用中國困家楳準(CNS) 1M規格(210x297公釐) Λ 6 Π 6 五、發明説明() 産品號碼3496P)。此等止血塞係由美國Del aware, Dover ,囪際Playtex公司製造。Playtex*止血塞由全 炫紫·潘維·製成,並有一取回细澠但無覆g·雜物。於測試 前,將止血塞取回细澠切離止血塞。根據上述一般程序 ,製備兩份含有0.1%、1.0%及10%Lau「icidin之經處 理的止血塞,以未經處理的止血塞重量為基準。使用兩 傾未經任何Lauricidin處理之Playtex*止血塞(其中細 澠已切除)作為對照物。然後根據實例1中所述之程序 與筷件,測試已乾燥之绖L,a u'r i c i d ί η處理過之止血塞及 未经處理之對照物。其試驗结果報告於表3中。 (請先閲讀背而之注意事項再填寫本頁) ί 裝- 訂· 線. 經濟部中央#準/ioa工消费合作杜印Μ 8 本紙張尺度边用中困Η家標毕(CNS) Τ4規格(210X297公没) 81. 4. ]0,000張(Η) 五、發明説明( Λ 6 Η 6 表 3 Lauricidin處理過的PLAYTEX止血塞(産品 號、8L025Z)對於由金黃色®萄球間( FRI-1169)生成的TSST-1之作用 試 樣 金黃色蒱萄 球®细胞之 最後猥度 金黃色茹萄 球®细胞之 TSST-1之最 最後濃度b) 後蒺度a) (請先閲讀背而之注意事項再填窍本頁) (CFU/毫升) (/毫升) (1〇θ ) OXLauricidin 3,3 8 8 1 1.-5 3 止血塞(對照物) 0. l^Lauricidin 2 13 10.33 於止血塞上 l.O^Lauricidin 131 10.12 (毫克/毫升) 10.86 .69 .38 經濟部屮央標準局厍工消作合作杜印製 之i«1揲 上Γ1上IS10之數 0au塞EL底搽述 血 $ 血由以试上 止.0止 = || 有有 於10於8)6)所所 法 方 1定均 進 後. 時 。 小值 24定 茛测 培均 下平 人P 之 等 。37搽 er示於试 .is表係份 Reia均兩 9 本紙張尺度逍用中困Η家標準(CNS) Ή規格(210X297公:¢) |§ 測 所 81. 4. 10,000張(H) ^055Cd Afi Λ ο __IV6_ 五、發明説明() I · , I 報告於表3中之數據,顯示绖由金黃色葡萄球®所産 ! · -I 生之 TSST-1 量,於使用 0 . 1 :C、 1 . 0¾ 及 1 0 . 0¾ La u r i c i d i η .處ϋ的Playtex*止血塞存在下,當與未含Lauricidin 之對照止血塞存在下所産生之TSST-1蛋比較時,偽各別 降低75%、96%及97%。另一方面,與對照物數值l:b較 ,於'24小時培育.期结束時,使用0.1%、1.0%及10.0% Lauricidin處理過之Playtex*止血塞,會诰成10%、 12 %及26%較少之金黃色葡萄球ϊϊί細胞。 宵例4 ," 進行第四值實驗,以評估在使用不同量Lauricidin處 理過的另一種品牌之月绖用止血塞存在下,金黃色葡萄 球®之生長及由其産生之TSST-1。於本實例4之實驗中 ,係採用1980年9月以前在公開市場上購得之Rely*牌 月经用止血塞(正規尺寸,産品號碼2 060 LC01A )。此 (請先閲讀背而之注意事項再填寫本頁) 經濟部中央標準;ft工消贽合作社印驭 泡製前-處用回程 發所轼序經使取之 * 酯維測程之。其述 er5g谢於般1 η準f 所 ct於酯 。一id基箜中 ΓΟ散聚绳述1C為血 1 P 分鈷細上urfi 止例 i丨有纺回柹Lalni 筲 at含由取根 % 之ly撺 nn塞在之 。10埜^根 ci血裹用垄及血之後 in止包常血¾.:止理然 e ί 偽有止 0的岛 。 o.yl其具離 1 理Iη物 hiRe-其切、處id照 0 此素。鈕 % 绖1C對 國。維中细 1,未Ur為 美诰谢物回 ο 以La作 由製基锘取有,何丨 係·司甲造之含塞任除 塞公羧锘塞刨血绖切 血le之非血兩止未已 止nb中之止備的個澠 等Ga體成將製理兩細 本紙5良尺度边用中a Η家榣毕(CNS) T4規格(210x297公及) 81. 4. 10,000張(Η) Λ 6 Π 6 五、發明説明() 序與條件,測試已乾燥之經Lau「icidin處理之止血塞及 未經處理之對照止血塞。其试驗结果報告於表4中。 (請先閲讀背而之注意事項#塡寫本頁) 裝· 線< 經濟部屮央栉準局民工消费合作社印驭 11 1 81. 4. 10,000張(H) 本紙張尺度边用中S國家楳毕(CNS) TM規格(210x297公龙) 五、發明説明( Λ 6 Π 6 表 4 Lauricidin處理過的RELY止血塞(産品號 碼2060LC01A)對於由金黃色涵萄^菌( FRI-1169)生成的TSST-1之作用 試 樣 .金黃色《5萄 球菌細胞之 最後蒺度 金黃色葡萄 球崮細胞之 TSST-1之最 最後猥度b ) 後猥度a ) (請先閲請背而之注意本項孙堝寫本頁) (毫克/毫升) 經 濟 部 央 準 工 消 合 杜 印 (CFU/毫升) (/毫升)_ (1〇8 ) OXLauricidin 12,303 12.09 止血塞(對照物) 0.1S:Lauricidin 2.818 11.45 於止血塞上 l.OXLauricidin 1,995 11.30 1. 於止血塞上 10.03;Lauricidin 1,096 1 1.04 0 . 於止血垄上 a )=由E L I S Λ方法(R e i s e r等人)所测得。 b)=以底10之log值表示。 所有試揉之浏定,均於37Ό下培育24小時後進行。 所有上述數捣均為兩份试揉之平均測定值。 6 4.32 6.92 54 09 裝· 訂 線· 12 本紙張尺度逍用中困Η家標毕(CNS)<f 4規格(2丨0X297公;《:) 81. 4. 10,000張'(H) A 6 116 五、發明説明() 報告於表4中之數據,顯示由金黃色龆萄球jg所産生 之 T S S T - 1 Μ .在使用 0 . 1 %、 1 . 0 % 及 1 0 . 〇 % L a u r i C ί d i η 處理過之.kely*止血塞存在下,當與未含[auricidin之 對照止血塞存在下所産生之TSST-1量比較時,偽各別降 低8 9 %、9 7 %及9 9 %。然而,於2 4小時培育期结k時, 在對照止血塞夸在下之金黃色葡萄球閣細胞结獏度(以Lau "丨 cidin's hemostatic plug has a logarithmic concentration of 10.40 (a reduction of 11%); and the golden yellow globulus S5 · cells contain! 〇% Lau" icidin's hemostatic plug, its logarithmic degree is 8.33 (Decrease by 29%). The Ministry of Economic Affairs has approved it and printed it by the Liaogong Xiaozhong Cooperative for the third session, to evaluate the use of L au "icidi η treated cities with different fees. Hemostatic presence , '&Quot; Golden color paste grape® cell growth and TSST-1 produced by it. In the test of Example 3, the P 丨 ayte X * brand menstrual hemostatic ridge (available on the open market) was used ( Regular size. -7-81. 4. 10,000 sheets (H) The size of this paper is easy to use China Sleepless Standard (CNS) 1M specification (210x297 mm) Λ 6 Π 6 V. Description of invention () Product number 3496P). These hemostatic plugs are made by Del aware, Dover, Playtex, Inc. of the United States. Playtex * hemostatic plugs are made of Quan Xuanzi Panwei, and have a retrieved fine but not covered with g. Debris. Before testing , Retrieve the hemostatic plug and cut off the hemostatic plug. According to the above general procedure, prepare two portions containing 0.1%, 1.0% and 10% Lau "icid The treated hemostatic plug in is based on the weight of the untreated hemostatic plug. Use a two-pile Playtex * hemostatic plug without any Lauricidin treatment (where the fine pill has been excised) as a control. Then follow the instructions in Example 1 The procedure and chopsticks, test the dried tampon L, a u'r icid ί η treated tampon and untreated control. The test results are reported in Table 3. (Please read the notes first Please fill in this page for details) ί Installation-Order · Line. The Ministry of Economic Affairs Central # quasi / ioa industrial and consumer cooperation Du Yin Μ 8 This paper standard is used in the middle of the trouble Η home standard Bi (CNS) Τ4 specifications (210X297 public) 81. 4.] 0,000 sheets (Η) V. Description of the invention (Λ 6 Η 6 Table 3 Lauricidin-treated PLAYTEX tampon (product number, 8L025Z) For TSST-1 produced by Golden Yellow® Grape Ball Room (FRI-1169) The effect of the sample is the final concentration of the golden yellow spheres® cells. The final concentration of TSST-1 in the golden yellow spheres® cells b) After the concentration a) (please read the precautions before filling in this book (Page) (CFU / ml) (/ ml) (1〇θ) OXLauricidin 3,3 8 8 1 1.-5 3 tampon ( Photographs) 0. l ^ Lauricidin 2 13 10.33 On the tampon lO ^ Lauricidin 131 10.12 (mg / ml) 10.86 .69 .38 The Ministry of Economic Affairs, Bureau of Standards, Work and Cooperation, Du Printing, i «1 揲 上The number of IS10 on Γ1 is 0au, and the EL bottom is filled with blood. The blood is stopped by the test. 0 stop = || there are 10 to 8) 6) the French side 1 is set to enter the time. A small value of 24 determines the average value of Pingjun Ping, etc. 37 搽 er is shown in the test. Is the list of parts Reia are both 9 copies of the paper standard xiao family standard (CNS) Ή specifications (210X297 public: ¢) | § test 81. 4. 10,000 sheets (H) ^ 055Cd Afi Λ ο __IV6_ V. Description of the invention () I ·, I The data reported in Table 3 shows that the 绖 is produced by Golden Grape Ball®! · -I The amount of TSST-1 produced, when using 0.1: C , 1.0 ¾ and 1 0. 0¾ La uricidi η. Playtex * hemostatic plug at ϋ, when compared with TSST-1 eggs produced in the presence of a control tampon without Lauricidin, the pseudo-individual reduction is 75% , 96% and 97%. On the other hand, compared with the control value of l: b, at the end of the '24 -hour incubation period, the Playtex * hemostatic plugs treated with 0.1%, 1.0% and 10.0% Lauricidin will become 10%, 12% and 26% less golden yellow grape spheres. Example 4 "A fourth value experiment was conducted to evaluate the growth of Golden Staphylococcus aureus® and TSST-1 produced by it in the presence of another brand of Lubricant Hemostatic Plug treated with different amounts of Lauricidin. In the experiment of Example 4, the Rely * brand tampon for menstruation (regular size, product number 2 060 LC01A) purchased on the open market before September 1980 was used. This (please read the precautions before filling out this page) Central Standards of the Ministry of Economic Affairs; FT Gong Xiao Zhi Cooperative Society Yin Yu Before the brewing-use the return trip The order taken by the hair salon * Ester dimension measurement. Its description er5g thanks to the general 1 η quasi-f ct in the ester. In an id base, ΓΟ scattered poly rope 1C is blood 1 P sub-cobalt fine upper urfi only examples i 丨 Lalni 犲 with spinning back contains at least lys nn from roots. 10 wild ^ root ci blood wrapped with ridges and blood after stopping the normal blood ¾ .: Zhi Liran e ί pseudo-stop 0 island. o.yl It has a separation of 1 η I hi things-its cut, location id according to 0 this element. Button% 1C to the country. Wei Zhongxi 1, Ur is a beautiful confession. It is based on La as a base, and the non-blood is made by the scorpion. Two unfinished pieces of nb, such as a single piece of Ga, will be processed into two fine papers of 5 good-size edges and used in a 漢 家 榣 毕 (CNS) T4 specification (210x297 g) 81. 4. 10,000 sheets (Η) Λ 6 Π 6 V. Description of the invention () Sequence and conditions, test the dried icidin-treated tampon and untreated control tampon. The test results are reported in Table 4. (Please First read the back and the matters needing attention # 塡 write this page) 装 · 线 < The Ministry of Economic Affairs, Pyongyang quasi-bureau, Migrant Workers and Consumers Cooperatives Co., Ltd. Yin Yu 11 1 81. 4. 10,000 sheets (H) This paper is used in S countries. Bi (CNS) TM specification (210x297 male dragon) V. Description of the invention (Λ 6 Π 6 Table 4 Lauricidin-treated RELY hemostatic plug (product number 2060LC01A) For the TSST generated by Staphylococcus aureus (FRI-1169) -1 effect sample. Golden yellow "5 The last degree of Staphylococcus aureus cells The last degree of TSST-1 of golden staphylococcus aureus cells b) After the degree of a) (Please Please pay attention to this item. Sun Guo wrote this page) (mg / ml) Central Ministry of Economic Affairs, Duxin (CFU / ml) (/ ml) _ (1〇8) OXLauricidin 12,303 12.09 Hemostatic plug (control Substance) 0.1S: Lauricidin 2.818 11.45 on the hemostatic plug l.OXLauricidin 1,995 11.30 1. on the hemostatic plug 10.03; Lauricidin 1,096 1 1.04 0. On the hemostatic ridge a) = measured by ELIS Λ method (R eiser et al.) Obtained. B) = Log value expressed as the bottom 10. All test kneading is performed after incubation for 24 hours at 37 °. All the above numbers are the average measured value of two test kneading. 6 4.32 6.92 54 09 Binding · Stranding · 12 Paper-scale, easy-to-use, trapped, and HF home standard (CNS) < f 4 specifications (2 丨 0X297; ":) 81. 4. 10,000 sheets' (H) A 6 116 V. Invention Explanation () The data reported in Table 4 shows the TSST-1 Μ produced by the golden yellow jg. In use 0.1%, 1.0% and 10.0% Lauri C ί di η Treated. In the presence of kely * hemostatic plug, when compared with the amount of TSST-1 produced in the presence of a control hemostatic plug without [auricidin, Pseudo-respectively decreased by 8 9%, 97% and 99%. However, at the end of the 24-hour incubation period, at the control hemostatic plug, the degree of the golden staphylococcus cell tapir (under the

I 底10之對數值表示)偽為12. 09,而於使用0.1%、Ι.οχ 及10% Lauricidin處理過’之Rely*止血塞存在下,金黃 色涵萄球菌细胞缌蒺度(叫底10之對數值表示),係各 別為 11.45 (低 5.3%) 、 11.20(低 7.4%)及 11.04( 低 7 · 8% ) 0 宮例F5 - 進行第五值實驗,以評估在使用不同量Lauricidin處 理過的市售止血塞存在下,.金黃色韶萄球菌細胞之生長 及由其産生之TSST-1。於本實例5之實驗中,採用在公 開市場上購得之o.b·、牌月經用止血塞(正規尺寸,産 品號碼0 6 9 4 T)。此等止血塞偽由美國HJ, Milltown. (請先閲讀背而之注意事項#填窍本頁) 裝· 訂_ 線. 經濟部屮央榀準而A工消费合作社印31 棉於前Sr止 與。中 之 b 縈片文 垄 〇 炫闲本 % 血之 有蓋柹10止理 含S根及的處 垄外 。%處|0 血奋垄 ο 绖id 止具血 1未1C ί 未止、以Ur bmf^ll%.La_ ο 澠切''0.垄何13 此細ffll有血任 -。回細含止經 銷取ig份的末 分括取兩理艏 司包之備處兩 公其垄裂經用 物。血序之使 1¾物止程1η。 81合將般id準 on摻前一ics rs之試之Ur為 pe花测述La员 本紙尺度边用中困國家標準(CNS) TM規格(210x297公釐) 81. 4.】0,000張(Η) Λ 6 Π 6 五、發明説明() 血塞(其中细《I已切除)作為對照物。然後根據實例1 中所述之'程序與條件,測試已乾燥的經Lauricidin處理 過‘之止ώΓ塞及未經處理的對照止血塞。其測試結未報告 於表5中。 (請先閲讀背而之注意事項#填寫本頁) 經濟部屮央標準局cf:工消作合作社印製I The logarithmic value of bottom 10) is assumed to be 12. 09, and in the presence of Rely * hemostatic plugs treated with 0.1%, Ι.οχ and 10% Lauricidin, the degree of staphylococcus aureus cells (called bottom 10 logarithmic values), which are 11.45 (low 5.3%), 11.20 (low 7.4%) and 11.04 (low 7.8%) 0 Fang Gong F5-conduct the fifth value experiment to evaluate the use of different amounts In the presence of commercially available hemostatic plugs treated with Lauricidin, the growth of S. aureus cells and the TSST-1 produced by them. In the experiment of this example 5, the o.b., brand menstrual tampon (available in regular size, product number 0 6 9 4 T) purchased on the public market was used. These hemostatic plugs are from the United States HJ, Milltown. (Please read the back of the precautions # fill in this page) to install · order _ line. The Ministry of Economic Affairs is accurate and the A Industrial Consumer Cooperatives printed 31 cotton in the former Sr versus. In the b bract ridge ridge 〇 Xuan Xian% of the blood of the cover cover 10 only reason containing S root and beyond the ridge. % 处 | 0 血 奋 岭 ο 绖 id only has blood 1 but 1C ί unstopped, with Ur bmf ^ ll% .La_ ο 渑 切 '' 0. 龍 何 13 This fine ffll has blood-. Back to the detailed content of the end of the distribution of ig copies, including the preparation of two sets of the company's package two ridges and cracks. The blood sequence makes 1¾ things stop 1η. 81. The general ID quasi-on is mixed with the previous ics rs. The test for Ur is a pe flower. La member's paper scale is used in the national standard (CNS) TM specification (210x297 mm). 4.1.4 0,000 sheets (Η ) Λ 6 Π 6 V. Description of the invention () Blood plug (where the detail "I has been excised) is used as a control. Then, according to the procedures and conditions described in Example 1, the dried Lauricidin-treated stopper and untreated control hemostatic plug were tested. The test results are not reported in Table 5. (Please read the back-end notes first # fill in this page) cf: by the Central Bureau of Standards of the Ministry of Economic Affairs: Printed by the Gongxiaozuo Cooperative

本紙尺度边用中國困家標準(CHS)ΤΜ規格(21ΠΧ297公¢) 81. 4. 10,000張(H) L055G4 Λ 6 Π 6 五、發明説明() 表 5 La\jricidin處理過的o.b.*止血塞(産品 -· 號碼0 6 9 4 T )對於由金黃色S萄球窗( FRIM169)生成的TSST-1之作用 金黃色蒱萄 金黃色S萄 球菌细胞之 球菌细胞之 TSST-1之最 試 樣 最後湊度 最後濃度b) 後猥度a) (請先閲讀背而之注意事項典填寫本頁) (CFU/毫升) (/毫升) (毫克/毫升) (1〇θ ) OSiLaur ic id in 3,3 8 8 1 1 , 53 止血塞(對照物) 0. l%Lauricidin 15 8 10.20 於止血塞上 l.OXLauricidin 316 10.50 於止血塞上 13.46 3.26 0.28 裝· 訂_ 線. U a 經濟部屮央櫺準局总工消费合作社印虹 之測拽 上IS10之數 gEL底樣述 血由以试上 止 II II 有有 於a)b)所所 法 方 1C定均 測 所 \1/ 人 等 Γ e 進 後 〇 時值 小定 24測 育均 培平 下之 〇 P .樣 V 3 试 is表於份 Re值均兩 0 - 為 5 11 -7 本紙張尺度边用中a國家標準(CNS) Ή規格(210x29/公;¢) 81. 4. 10,000張(H) Λ 6 _[V6_ 五、發明説明() 呈現於表5中之數據,顯示在含有0.1%、 1.0%及10 % (重fi比)Lauricidin之o.b.*止血塞存在下,由金 黃¥蒱萄球菌所産生之TSST-1量•當與未含Lauricidin 之對照o.b.*止血塞存在下所産生之TSST-1量比較時, 係各別降低75%、98%及98%。於對照止血塞存在下, 金黃色《萄球闺细胞缌濃度(以底1〇之l〇s值表示)傑 為11.53。於使用0.1%、 1.0%及10% (重量比)The size of the paper is based on the Chinese Standard for Sleepy Family (CHS) TM specifications (21ΠΧ297 公 ¢) 81. 4. 10,000 sheets (H) L055G4 Λ 6 Π 6 V. Description of the invention () Table 5 La * jricidin treated ob * hemostatic plug (Product- · No. 0 6 9 4 T) The most effective sample of TSST-1 for the effect of TSST-1 produced by the golden yellow spheroid window (FRIM169) The final concentration b) The final concentration a) (Please read the precautionary code and fill in this page first) (CFU / ml) (/ ml) (mg / ml) (1〇θ) OSiLaur ic id in 3 , 3 8 8 1 1, 53 Hemostatic plug (control) 0. l% Lauricidin 15 8 10.20 On the hemostatic plug l.OXLauricidin 316 10.50 On the hemostatic plug 13.46 3.26 0.28 Installation · Order_ line. U a The Hong Kong Bureau of Industry and Engineering ’s Consumer Cooperative ’s Yinhong ’s test draws the number of IS10 gEL samples described by the test. II II is available in a) b) the French 1C average test institute \ 1 / person etc. Γ e. After the advance, the hour value is small and the 24 test is under the same level. The sample V 3 test is shown in the copy. The Re values are both 2 0-5 11 -7. a National Standard (CNS) Ή specification (210x29 / male; ¢) 81. 4. 10,000 sheets (H) Λ 6 _ [V6_ V. Description of invention () The data presented in Table 5 shows that it contains 0.1%, 1.0 % And 10% (weight-fi ratio) the amount of TSST-1 produced by Staphylococcus aureus in the presence of ob * hemostatic plug of Lauricidin • When compared with the control ob * hemostatic plug without Lauricidin, the TSST- When comparing one quantity, the system reduces 75%, 98% and 98% respectively. In the presence of a control hemostatic plug, the golden yellow "concentration of the bovine cell (expressed at the bottom 10 to 10)) is 11.53. Used in 0.1%, 1.0% and 10% (weight ratio)

Lauricidin處理過之O.B.*止血塞存在下,金黃色涵萄 球®绾濃度(以底1 〇之丨〇 ?值表示),係各別為1 〇 . 2 0 (低 11%) 、10.50(低 8. 9%)及 9.98(低 13%)。 宮例6 進行第六值實驗,以評估在不同量Lauricidin處理過 之市售止血塞存在下,金黃色葡萄球®细胞之生長及由 其産生之TSST-1。於本實例6之實驗中,係採用在公開 市場上賭得之Kotex* Security*牌月經用止血塞(正規 尺寸,産品號碼5C0907C)。此等止血塞係由美國, Visconsin, Neenah, KiubeKly-Clark 公司銷售。其含 (請先閲讀背而之注意事項#填寫本頁) 裝- 訂_ 線· 經濟部屮央標準局^工消奸合作杜印製 -前序止未it 规试程的傾ί 細測般理兩轾 回於 I 處用血 取 。述經使止 用 Μ 上之 常覆拽in_it 有物根id基Ur 具鍩 。.10為以 ,诰垄urfis 物銷血Larrxi. _ 合非止..¾之te16 -1 之成t;J及血之 縈裂澠 % 止理 炫雒細 α 的處 %戡回.1 理Iη 40烯取彡、處id 與丙之1?经1C 花聚塞 ο 未Ur 棉由血有以La % 經止含,何 60以將俯垄任 有並-製血經 本紙張尺度边用中困國家楳毕(CNS)TM規格(210x297公;《:) 81. 4. 10,000張(H) 205 ⑽ Λ6 _Π6_ 五、發明説明() 中细斑已切除)作為對照物。然後,根據實例1中所述 之程序與條件,測試已乾燥之经Lauricidin處理過之止 血塞及未經處理之對照止血塞。試驗结果報告於表6中。 (請先閲讀背而之注意事項#填寫本頁) 裝- 訂· -線. 經濟部屮央搮準而译工消赀合作杜印3i 本紙尺度边用中a Η家榀準(CNS)甲4規格(2丨0X297公;«:) 81. 4. 10,000張'(Η) Λ 6 _____Π_6_ 五、發明説明() 表 6In the presence of Lauricidin-treated OB * hemostatic plugs, the concentration of golden yellow staphylococcus aureus® (expressed as a base value of 10%) is 10% (low 11%) and 10.50 (low 8. 9%) and 9.98 (low 13%). Palace Example 6 A sixth value experiment was conducted to evaluate the growth of the Staphylococcus aureus® cells and the TSST-1 produced therefrom in the presence of different amounts of Lauricidin-treated commercially available tampon. In the experiment of Example 6, the Kotex * Security * brand menstrual tampon used in the open market (regular size, product number 5C0907C) was used. These hemostatic plugs are sold by the United States, Visconsin, Neenah, KiubeKly-Clark. It contains (please read the back and attention matters # fill in this page) to install-order _ line · Ministry of Economic Affairs Bureau of Central Standards ^ work elimination cooperation cooperation du printing-the pre-order is not yet the test of the program. The general reason is to take blood at I. The Scriptures only use the usual overrides on Μ in_it to have a root and a base of Ur. .10 is to believe that the urfis are sold to Larrxi. _ 合 非 止 .. ¾ of te16 -1 is completed; J and the blood rupture % stop only the place where Xuan Luo fine α is returned. Iη 40 ene take 彡, place id and C of 1? Jing 1C flower poly plug ο not Ur cotton by blood with La% only, He 60 to put any ridges and-blood making this paper scale side in use CNS TM specifications (210x297); ":) 81. 4. 10,000 (H) 205 ⑽ Λ6 _Π6_ V. Description of invention (fine spots have been removed) as a control. Then, according to the procedures and conditions described in Example 1, the dried hemostatic plugs treated with Lauricidin and the untreated control tampon were tested. The test results are reported in Table 6. (Please read the back and the precautions # fill in this page first) Binding-Order ·-Line. The Ministry of Economic Affairs is accurate and the translator works to cooperate with Du Yin 3i. This paper is used in the standard a Η 家 槀 准 (CNS) A 4 Specifications (2 丨 0X297 public; «:) 81. 4. 10,000 sheets of '(Η) Λ 6 _____ Π_6_ V. Description of invention () Table 6

Lauricidin處理過的 KOTEX SECURITY止血塞 ‘ (産品號碼5 C 0 9 0 7 C )對於由金黃色蒱萄球 菌(FRI-1169)生成的TSST-1之作用 金黃色《萄 金黃色砀萄 球闓细胞之 球菌细胞之 TSST-1之最 試樣 最後蒺度 最後濃度b) 後濃度a) (CFU/毫升) (/毫升) (毫克/毫升) (1〇θ ) 11.-2 3 10.19 0%Lauricidin 1,698 止血塞(哿照物) 10.29 4.90 10.63 〇.〇9 10.63 0.05 0. 1%1, auricidin 19 4 於止血塞上 l.OJ^Lauricidin 4 2 6 於止血塞上 經濟部屮央榀準而11工消"合作杜印製 lO.OKLauricidin 426 於止血垄上 a )=由E L I S A方法(R e i s e「等人)所测彳导。 b)=以底10之log值表不。 所有试揉之測定,均於3 7它下培育2 4小時後進行。 所有上述數捣均為兩份试搽之平均测定值。 -18 - 81. 4. 10,000張(Η) (請先閱讀背而之注意事項再填寫本頁) 本紙张尺度逍用中國困家標準(CNS) Ή規格(210x297公;《:) 0 ^ l~ Λ 6 _;_IV6_ 五、發明説明() 呈現於表6中之數據,顯示在含有0.1%、 1.0%及1〇 % (重量比)Lauricidin之Kotex*止血塞存在下,由金 黃爸訇萄砝β所産生之TSST-1量,當與未含Lauricidin 之對照Kotex*止血塞存在下,於相同賁驗條件下産生之 TSST-1量比較時,傜各別降低52%、99%及99%。於含 有 0.1%、1.0% 及 10% (重量比)Lauricidin 之 Kotex* t 止血塞存在下,金黃色涵萄球菌细胞之缌嬝度(以底10 之丨0 g值表示),偽各別為1 〇 · 2 9 (低9 4 % ) , 1 0 · 6 3 ( 低 60%)及 10.63(低 60%)+'。 由前述寅例1-6可明瞭,許多個止血塞,其中之一由 本發明人裂成(實例1),其他為市購而得(實例2、 3、 5及6)且其中之一已市售但僦及由市塲配銷處取 經濟部屮央標準而^工消仲合作社印奴 回(實例4).以上均已使用木同程度之Lauricidin處 理,該Laurie i din為一種市售之混合物.其中含有93重 量%單月桂酸甘油酯與3.5重蛋%二月桂酸甘油酯。於 表1-6中報告之數拽顯示,依Lauricidin在止血塞中之 含量而定I當與未含有Laurie· idin之對照止血塞存在下 ,於相同實驗條件下,由金黃色ϋ萄球闻所産生之TSST -1量lib較時,前者之金黃色涵萄球闻偽産生顯箸較少之 TSST-1 ,或換言之,披泖制而不含産生大员TSST-1。 皙例7 於本宵例7中使用筲例I中所用紐型之待测止血轾。 根柹本文前述之一般程序.製備含有〇 . 1 %、 〇 · 5 %及 -19 - 81. 4, ]0,000張(Η) (請先閲誚背而之注意事項再填窩本頁) 本紙張尺度边用中國Η家樣準(CNS) T4規格(210X297公龙) Λ 6 B 6 ^〇550i 五、發明説明() 1 . 0 % L a u r i c i d ί η之待測止血塞(以未經處理的待測止 血塞之蜇量為基準),並根據實例1中所述之止血塞囊 方法進行'測試。然而,於本實例7中,止血塞囊傜在將 Lauricidin處理過的止血箜插入其中之前.接種不同阂 種之金黃色《萄球菌。所測試之各別金黃色蕕萄球菌種 ,係標明於表了中。於開始實驗時,金黃色葡萄球菌之 蒺度為1Χ10Θ CFU/毫升。於本實例7中所使用的會産 生TSST-1之金黃色》萄球菌種FRI-1169,偽得自美國, Wisconsin, Madison, Wigo0nsin 大學,食品研究所, He「丨ίπ Be「sdoll博士。命名為1169W之會産生TSST-1 之金黃色《5萄球菌種,偽得自美國纽約州紐約市, Cornell K 校,Fred Quimby, V.-H. D.博士。第三種 金黃色®萄球菌種(特別是FRI-1169之一種亞屬)係單 離自由母崮種並命名為TSS單離物。此TSS單離物可以 凍乾狀態獲得,得自美國.Mew Jersey, Hill town,値 人産物公司,S. K. B「own-Sk「〇bot博士。第四種會産 生T S S T - 1之金黃色涵萄球菌種’,命名為Η η 8 ,偽得自美 國,Minnesota, Hinneapol is-st. Paul, HI innesota 大學,Patrick Sch I ie「vert丨!? 士。第五種會産生TSST -1之金员色涵萄球閑.種,命名為1 1 8 7 ,偽捋自英國, Leeds, Leeds 大學,Keith T. Holland 丨!9 士。於本齊 例中測试之所有金资色韶萄球免嵇。可捋自上述之個人 按筲例1中所述製備各梗闰楹之懸浮ίϊί .並於插入止 -20 - t紙張尺度边用中ΗΒ家標準(CNS)T<i規ΙΜ210Χ297公;¢) (請先閲讀背而之注意事項再填寫本頁) 裝< 線· 經濟部屮央標準局ft工消费合作杜印5i 81. 4. 10,000張(H) A 6 Π 6 L055G1 五、發明説明() 血塞之前,將其用以接種囊袋,然後根據實例1中所述 之止血塞囊方法進行測試。使用兩側未含任何Laur丨cidin 之待測止血塞作為對照物。試驗结果報告於表7中。 示於表7中之结果,顯示生成的TSST-1偽随箸 L a u r i c丨d ί η猥度之增^而降低。此偽在全部五種所測試 之菌種中見及。由試驗结果所得之结論是,在實例1-6 中所發現之Lau「icidin效果,對於任何特定的會産生 | TSST-1之金黃色葡萄球菌種Μ未具專一性。 (請先閲讀背而之注意事項#项寫本頁) 經濟部屮央標準杓貝工消"合作社印奴 1Χ 2 81. 4. 10,000張(Η) 本紙5fc尺度逍用中S Η家標準(CNS) Τ4規怙(210X297公放) 五、發明説明( Λ 6 Π 6 經 郎 屮 'k \$ X. η [\· lv Ψ :土f, Ά 表 7 L a r u i c i ..¾萄球菌 din處理過的止血塞對於各種金黃色 種之生長及由其産生的TSST-1之作用 産生TSST-1 LAUR IC ID IN 所産生的TSST-1 之®種 之蒺度a ) 之缌最b ) (96 ) (撤克) 1 1 69 V 無 56.54 (Quimby® 種 ) 0 . 1 17.54 0.5 0.35 1 ,0 J 0.07 FR I - 1 1 69 無 48.75 (B e r g d 〇 1 1 髮 種) 0.1 5.06 0 . 5 0.04 1.0 ' 0.03 TSS單_物 無 53.04 (F R .1 - 1 1 6 9 之 亞茵 種) 0.1 2.25 0.5 1.27 1 . 0 0.48 Η η 8 無 66.30 (Schlievert留種 ) 0 . 1 0.66 0.5 0.12 1.0 0.05 1187 — 無 46.80 (fl ο 丨丨 a n d 種) 0.1 6.63 0.5 0.92 1.0 0.58 22 - 本紙尺度边用中國因家榣毕(CNS) T4規格(2]0X297公;《:) 81. 4. 10,000張\H) (請先閲讀背而之注意事項再填寫本頁) ( 裝- 線· 205504 Λ 6 Π 6 五、發明説明() a) =以未经處理的止血塞之重量為基準。 b) =於37¾下培育24小時後,毎一止血塞中之TSST-1绾 fi 〇 *· · 所有試樣均使用ELISA方法(Reiser等人),測試所 産生之TSST-1缌量。 實例8 於本實1例8‘中,測試含有各種脂肪酸酯之止血塞.以 _定其對於金黃色蒱萄球閡.(FRI-1169)之生長及由其産 生TSST-1之作用。於本實例8中使用實例1中所用的待 _止血塞種類。所有待測’止血塞重為2.6克。將0.65克 各種待測脂肪酸酯溶於9 9 . 3 5克試藥级異丙醇中。將四 克各脂肪酸酯溶液塗敷於各兩値待測止血塞之外表面上 ,以提供含有〗重量%酯或酯混合物之經處理的止血塞 ,以未經處理的待測止血塞之重S為基準。於70¾下, 藉蒸發移除醇,然後根據實例1中所述之止血塞囊方法 ,測試經處理之止血塞。下列為绖評估的脂肪酸酯之清 (請先閲讀背而之注意事項再填寫本頁) 裝. 訂 線. 經濟部屮央榣準局诼工消仰合作杜印製 含含物ST此 為為合9 。 酸酸混36油 辛癸此约甘 β 0 0 0 1¾ 61酸酸酯由 油肪肪酸自 甘脂脂辛¾ 酸和和%co 癸跑筢贵 ο 與之之gl約 .酯子子 3 及 油原.原3868 甘硪5K约酸 酸痼傾有癸 辛 810,含¾ 單有有中S 1 ΊΛ 號 塞 : 血 單止 81. 4. 10,000張'(H) 本紙尺度逍用中a Η家榣毕(CNS) T4規格(210X297公釐) L ㈣ L.' Λ 6 ____ 五、發明説明() 混合物之其餘部份含有少量此兩種脂肪 之二酯與三酯。 止-血塞编號2 - 90-95 %純度之單月桂酸甘油酯,並含 有0.2 %自由態甘油及少量二酯與三酯 。月桂酸為含有12値碩原子之飽和脂肪 止血塞&號3 - 90-95 %純度之單肉登蔻酸甘油酯,並 含有约& . 2 %自由態甘油及少量二醋與 三酯。肉S·寇酸為含有14個碩原子之跑 j 和脂肪酸。 止血塞编號4 - 90-95 %純度之單棕撊酸甘油酯,並含 有0.2 %自由態甘油及少量二酯與三酯 。棕润酸為含有1 6傾明原子之筢和脂肪 酸。 止血塞编號5 - 90-95 %純度之單硬脂酸甘油酯,並含 有0.2 %自由態甘油及少量二酯與三酯 。硬脂酸為会有1 8値硝原子之跑和脂肪 酸。 經濟部屮央梂準:工消奸合作社印rt,,4 止血塞编號6 - 9 0 - 9 5 %純度之眾油酸讨油酯,並含有 〇 · 2 _ %自由態甘油及少Μ二酯與三酯。 油酸為含有〗8IS明原子及一個雙扭之未 跑和脂肪酸。 於本筲例8中.偽使用兩個未經岛理之止血轾作為對 81. 4. 10,000張(H) (請先閲讀背而之注意事項抖蜞寫本頁) 本紙5良尺度边用中a國家樣準(CNS)T4規格(210X297公龙) Λ 6 _Π6_ 五、發明説明() 照物。 試驗結果示於表8中。此數據顯示當與未經處理的對 照止血塞存在下所産生之TSST-1量比較時·,於使用不同 脂肪酸酯處理過的止血塞存在下,由金黃色«5萄球菌種 FRI-1169所産生之TSST-1量,有顯箸降低。所産生的 TSST-1量之降低範圍,為约90%至99%,而在含有單硬 脂酸甘油酯的止血塞之情況中,觀察到TSST-1生産之60 %降低,其雖然並未如使用含有其他酯類的止血塞所獲 得者一樣高,但仍然是十分大量的,故被認為是很顯箸 / 。於存活的金黃色®萄球閨細胞之數目上,未觀察到相 應之降低樣式。但應注意的是,在24小時培育期结束時 ,在經處理的止血塞上之存活的金-黃色蒱萄球菌細胞. 比在未以醋處理的止血塞上存存活者少。 (請先閲讀背而之注意事項孙塡寫本頁) 裝- 訂_ 線· 經濟部屮央榀準局A工消作合作社印3i 5 2 本紙張尺度边用中B B家样毕(CNS)>F4規格(210X29/公;«:) 81. 4.〗0,000張(H) 五、發明説明() I 丨 Isss Λ 6 Η 6 b Z · 09 £, 68 『96 T , 66 6·Β6 (%) 昍亡?:I-lSSi 州liM-ffl^:略刼-N(69u Iocitt-)®货洄泯卸瓶啪运葙瘅啪与龆菊扭03K· 000 (ε^绍?: I-1SS1 £^制^ (q赵鸹 兹啶?: s泜 们!·卜τThe effect of Lauricidin-treated KOTEX SECURITY hemostatic plug (product number 5 C 0 9 0 7 C) on TSST-1 produced by S. aureus (FRI-1169) golden yellow The final concentration of TSST-1 of the most samples of cocci cells b) The final concentration a) (CFU / ml) (/ ml) (mg / ml) (10θ) 11.-2 3 10.19 0% Lauricidin 1,698 Hemostatic plug (must take photos) 10.29 4.90 10.63 〇.〇9 10.63 0.05 0. 1% 1, auricidin 19 4 on the tampon l. OJ ^ Lauricidin 4 2 6 on the tampon, the Ministry of Economic Affairs, the central government, and 11 Gongxiao " Cooperative Du Printed by lO.OKLauricidin 426 on the hemostatic ridge a) = Guided by the ELISA method (Reeise "et al.). B) = Log value at the bottom 10 indicates no. The measurement is carried out after 24 hours of incubation under 37 ° C. All the above numbers are the average measurement value of two trials. -18-81. 4. 10,000 sheets (Η) (please read the notes first Please fill in this page again for details) This paper standard uses the Chinese Standard for the Poor Family (CNS) Ή specification (210x297 g; ":") 0 ^ l ~ Λ 6 _; _IV6_ V. Explicit description () The data presented in Table 6 shows the TSST-1 produced by the golden betaine weight β in the presence of Kotex * tampon containing 0.1%, 1.0% and 10% (weight ratio) Lauricidin When compared with the amount of TSST-1 produced under the same test conditions in the presence of the control Kotex * hemostatic plug without Lauricidin, Tong decreased by 52%, 99% and 99% respectively. Containing 0.1% and 1.0 % And 10% (weight ratio) the degree of staphylococcus aureus cells in the presence of the Kotex * t haemostatic plug of Lauricidin (expressed at the bottom 10 to 丨 0 g value), the pseudo-individual is 1 〇 · 2 9 ( Low 9 4%), 1 0 6 3 (low 60%) and 10.63 (low 60%) + '. As can be seen from the foregoing examples 1-6, there are many hemostatic plugs, one of which is split by the inventor ( Example 1), the other is commercially available (Examples 2, 3, 5 and 6) and one of them is commercially available but it is obtained by the municipal distribution office to obtain the standard of the Ministry of Economy and ^ Gongxiaozhong Cooperative Indies Back (Example 4). The above have been treated with the same level of Lauricidin treatment, the Laurie i din is a commercially available mixture. It contains 93% by weight of glyceryl monolaurate and 3.5% of eggs. Glyceryl laurate. The numbers reported in Tables 1-6 show that, depending on the content of Lauricidin in the hemostatic plug, when in the presence of a control hemostatic plug that does not contain Laurie · idin, under the same experimental conditions, the golden yellow The amount of lib produced by TSST -1 is relatively high, and the former golden yellow spherule produces false TSTS-1, or in other words, it is prepared without the production of TSST-1. Example 7 In this evening example 7, the button type hemostasis used in the example I was used. Based on the general procedure described above in this article. Preparation contains 0.1%, 0.5% and -19-81.4,] 0,000 sheets (Η) (please read the precautions before filling in this page) This The paper standard uses the Chinese Η home sample standard (CNS) T4 specification (210X297 male dragon) Λ 6 B 6 ^ 〇550i 5. Description of the invention () 1.0% L auricid ί η Hemostatic plug to be tested (untreated The amount of the hemostatic plug to be tested is the benchmark), and the test is performed according to the hemostatic plug method described in Example 1. However, in this Example 7, hemostatic cysts were inoculated with different types of Staphylococcus aureus before insertion of Lauricidin-treated hemostasis. The various Staphylococcus aureus species tested are indicated in the table. At the beginning of the experiment, the staphylococcus aureus had a thorax of 1 × 10Θ CFU / ml. The Staphylococcus aureus species FRI-1169 used in this Example 7 that produces TSST-1 is pseudo-derived from the United States, Wisconsin, Madison, WigoOnsin University, Food Research Institute, Dr. He "丨 ίπ Be" Sdoll. It is 1169W that produces TSST-1 golden "5 Staphylococcus species, pseudo-derived from Dr. Fred Quimby, V.-HD, Cornell K School, New York City, New York, USA. The third Golden Staphylococcus species (special It is a subgenus of FRI-1169). It is a single free mother species and is named TSS single ion. This TSS single ion can be obtained in a lyophilized state and obtained from the United States. Mew Jersey, Hill town, Luren Products Company, Dr. SK B "own-Sk" 〇bot. The fourth species will produce TSST-1 Staphylococcus aureus species, named Η η 8, from the United States, Minnesota, Hinneapol is-st. Paul, HI innesota University, Patrick Sch I ie "vert 丨!?". The fifth species will produce TSST -1, a gold member. It is named 1 1 8 7 and is fake from the United Kingdom, Leeds, Leeds University, Keith T. Holland 丨! 9 persons. All gold-colored balls tested in this example are exempt. Can be taken from the above The individual prepared the suspension of each of the stems and stems as described in Example 1 and used the Chinese Standard (CNS) T &I; i Regulations ΙΜ210Χ297 Gong; ¢) (Please read first Contrary to the precautions, please fill out this page) Install &Line; Line · Ministry of Economic Affairs, Bureau of Standards, FT, Industry and Consumer Cooperation Duin 5i 81. 4. 10,000 sheets (H) A 6 Π 6 L055G1 V. Description of invention () Blood plug Before, it was used to inoculate the bladder, and then tested according to the hemostatic bladder method described in Example 1. The hemostatic plug to be tested that did not contain any Lauricidin on both sides was used as a control. The test results are reported in Table 7. The results shown in Table 7 show that the generated TSST-1 pseudo-decrease with the increase of the 相 Lauric 丨 d η 犥 度. This pseudo-see is seen in all five strains tested. From the test results The conclusion is that the Lau "icidin effect found in Examples 1-6 is not specific for any specific | TSST-1 Staphylococcus aureus species. (Please read the notes beforehand #Item write this page) The Ministry of Economic Affairs, the central standard 汓 贝 工 消 " Cooperative Inno 1x 2 81. 4. 10,000 sheets Η) The 5fc scale of the paper is used in the S Η family standard (CNS) Τ4 regulations (210X297 public release) 5. Description of the invention (Λ 6 Π 6 Jing Lang 屮 'k \ $ X. η [\ · lv Ψ: soil f , Ά Table 7 L aruici .. ¾ Staphylococcus din treated hemostatic plug for the growth of various golden yellow species and the effect of TSST-1 produced by it produces TSST-1 LAUR IC ID IN produced by TSST-1 ® Species of a) 缌 最 b) (96) (withdrawal) 1 1 69 V None 56.54 (Quimby® species) 0. 1 17.54 0.5 0.35 1, 0 J 0.07 FR I-1 1 69 None 48.75 (B ergd 〇1 1 germination) 0.1 5.06 0.5 .5 0.04 1.0 '0.03 TSS single substance no 53.04 (FR .1-1 1 6 9 subspecies) 0.1 2.25 0.5 1.27 1.0 0.48 Η η 8 no 66.30 ( Schlievert (reserved species) 0. 1 0.66 0.5 0.12 1.0 0.05 1187 — None 46.80 (fl ο 丨 丨 and species) 0.1 6.63 0.5 0.92 1.0 0.58 22-This paper size is used in China (CNS) T4 specifications (2) 0X297 Public; ":) 81. 4. 10,000 sheets \ H) (Please read the notes before filling in this page) (Pack-Line · 205 504 Λ 6 Π 6 5. Description of the invention () a) = Based on the weight of the untreated tampon. b) = After 24 hours of incubation at 37¾, TSST-1 紾 fi 〇 in each tampon * * All samples were tested by ELISA (Reiser et al.), and the amount of TSST-1 produced was tested. Example 8 In Example 8 'of this study, a tampon containing various fatty acid esters was tested to determine its effect on the growth of Golden Yellow Grape Ball (FRI-1169) and the production of TSST-1 from it. In this Example 8, the type of tampon used in Example 1 was used. All the hemostatic plugs to be tested weighed 2.6 grams. Dissolve 0.65 g of various fatty acid esters to be tested in 99.35 g of reagent grade isopropanol. Four grams of each fatty acid ester solution was applied to the outer surface of each of the two hemostatic plugs to be tested to provide a treated hemostatic plug containing a 5% by weight ester or ester mixture, and an untreated hemostatic plug to be tested The weight S is the benchmark. Under 70¾, the alcohol was removed by evaporation, and then the treated hemostatic plug was tested according to the hemostatic plug method described in Example 1. The following is a clear list of fatty acid esters evaluated (please read the precautions before filling out this page). Packing. Line. The Ministry of Economic Affairs, the Ministry of Economic Affairs, the Central Bureau of Industry and Commerce, the cooperation and the printing of the content of ST. This is It is 9 in total. Acid-acid mix 36 oil octene decanoglycan β 0 0 0 1 ¾ 61 acid ester from oil fatty acid from glycerin octanoic acid and% co decorated gui ο with its gl about. Ester 3 And the original oil. The original 3868 Gan 硪 5K about acid and acid dip with decene 810, containing ¾ single with a medium S 1 ΊΛ plug: blood single stop 81. 4. 10,000 sheets' (H) The paper size is easy to use a Η Family Bibi (CNS) T4 specification (210X297 mm) L ㈣ L. 'Λ 6 ____ 5. Description of the invention () The rest of the mixture contains a small amount of diesters and triesters of these two fats. Hemostasis No. 2-90-95% purity glyceryl monolaurate, and contains 0.2% free glycerol and a small amount of diesters and triesters. Lauric acid is a saturated fat hemostatic plug & No. 3-90-95% pure glyceryl myristate containing 12% of atoms, and contains about 2% free glycerin and a small amount of diacetate and triester . Meat S · kolic acid is a fatty acid containing 14 mega atoms. Hemostatic plug No. 4-90-95% pure glycerol monopalmitate, containing 0.2% free glycerin and a small amount of diesters and triesters. Palmitic acid is a fatty acid containing 16 atoms of bright atoms. Hemostatic plug number 5-90-95% pure glyceryl monostearate, and contains 0.2% free glycerol and a small amount of diesters and triesters. Stearic acid is a fatty acid with a run of 18 to nitrate atoms. The Ministry of Economic Affairs's quasi-preparation: Gongxiaoyao cooperatives printed rt ,, 4 tampon No. 6-9 0-95% purity oleic acid oleic acid esters, and contains 〇. 2 _% free state glycerol and less M Diesters and triesters. Oleic acid is an unrun and fatty acid containing 8IS bright atoms and a double twist. In Example 8 of this book. Pseudo-use of two unmanageable hemostasis is used as a pair 81. 4. 10,000 sheets (H) (please read the precautions first and write this page) This paper is used for 5 good standards China National Standard (CNS) T4 specifications (210X297 male dragon) Λ 6 _Π6_ V. Description of invention () According to the object. The test results are shown in Table 8. This data shows that when compared to the amount of TSST-1 produced in the presence of an untreated control hemostatic plug, in the presence of a hemostatic plug treated with different fatty acid esters, the golden yellow «5 Staphylococcus species FRI-1169 The amount of TSST-1 produced was significantly reduced. The reduction in the amount of TSST-1 produced ranged from about 90% to 99%, and in the case of a tampon containing glyceryl monostearate, a 60% reduction in TSST-1 production was observed, although it did not They are as high as those obtained with hemostatic plugs containing other esters, but they are still very large, so they are considered very obvious. No corresponding reduction pattern was observed in the number of surviving golden yellow vine cells. However, it should be noted that at the end of the 24-hour incubation period, there were fewer surviving S. aureus cells on the treated hemostatic plugs than on untreated hemostatic plugs. (Please read the notes beforehand to write this page) Sun Yat-Sen _ Line · Line · Ministry of Economic Affairs, Central Bureau of Economic and Social Development, A Gongxiao Zuo Cooperative Cooperative Printed 3i 5 2 This paper is used in the BB home sample (CNS) > F4 specification (210X29 / male; «:) 81. 4.〗 0,000 sheets (H) V. Description of invention () I 丨 Isss Λ 6 Η 6 b Z · 09 £, 68『 96 T, 66 6 · Β6 (%) Fallen? : I-lSSi State liM-ffl ^: 爼 刼 -N (69u Iocitt-) ® goods 泄 泯 Unloading the bottle, shipping, shipping, and chrysanthemum twist 03K · 000 (ε ^ 绍?: I-1SS1 £ ^ system ^ (q 趹 鸹 兹 idine ?: s 泜 倜 人! · 卜 τ

To ε··1· ^L s ST (請先閲讀背而之注意事項洱填寫本頁) ro0I H S.9 m0T Μ®0·9 g〇T x ^·Τ-®οτ Μ s-ς 90T Ms··1" 9〇T Μ 0B·10 5〇I Η ΟΣη(4i w \) (太焐 \fu3) s*m fB - InIs TB 9L rs9 ·6 經濟部屮央標準而貝工消作合作杜印製 UDsssffil^T·" In尨明砌岧匄 V芻甥拗岧qr ε尨琎糊勻:JT Ί装3糊岧匄 陛葙 。-^^&-/>2卜::1$^^邳鬲擗踣 . 。:Ι}Μ0 ιβοι 铤2 。惻 ί®( Υ 紗」=ί s )^^v S 113^( π 裝. 線. 6 2 本紙張尺度边用中困困家樣率(CNS)T4規格(210x297公;a:) 81. 4. 10,000張(Η) 五、發明説明( 9 例 葚 例 實 於 告 報 中 驗 實 本 於 用 使 A 6η 6 油 甘 酸 桂 月 單 之 中 -绖 司合 公混 in此 d 1C者 "出 指 自所 得早 俱稍 ,文 物本 合如 混正 之 0 酯in 油id 甘1C 酸Ur 桂La 月為 二標 酯商 厂 a 二耳 ¾種 量兩 重自 5 得 3 偽 與 , 酯物 油合 甘混 酸酯 桂油 月甘 單之 ¾酸 量桂 重月 3 9 0 有醋 含油, 現甘 發酸 析桂 分月 源 來 他To ε ·· 1 · ^ L s ST (Please read the precautions first and fill in this page) ro0I H S.9 m0T Μ®0 · 9 g〇T x ^ · Τ-®οτ Μ s-ς 90T Ms · 1 " 9〇T Μ 0B · 10 5〇I Η Σ (4i w \) (太 焐 \ fu3) s * m fB-InIs TB 9L rs9 Du Yin made UDsssffil ^ T · " In 峨 明 勧 匧 匄 V 甥 拗 岧 qr ε 尨 琎 Mixed evenly: JT Ί installed 3 pastes. -^^ &-/ > 2 Bu :: 1 $ ^^ 邳 鬲 踗 踣.. : Ι} Μ0 ιβοι collar 2.恻 ί® (Υ 織 ”= ί s) ^^ v S 113 ^ (π loaded. Thread. 6 2 This paper scale is used in the middle-sleepy home sample rate (CNS) T4 specification (210x297 g; a :) 81. 4. 10,000 sheets (Η) V. Description of the invention (9 cases are verified in the report and verified in the use of A 6η 6 oleic acid laurel laurels-绖 司 合 公 混 在 此 d 1C 者 " The index comes from the income, and the cultural relics are as good as 0 ester in oil id glycine 1C acid Ur Gui La month for the second standard ester factory a two ears ¾ amount of two from 5 get 3 pseudo and, ester oil The mixed acid ester of osmanthus osmanthus osmanthus oil with the acid content of laurel laurel laurel 3 9 0 with vinegar and oil, now the vinegar is separated from the laurel vinegar to source from him

ο ο V ο w C e S H s 1 e 國 κ美為 自檩 得商 係·, , 司一公之學 物化 合 η 混pa I e 種 t 此s e S Γ e 物 合 混 此 一一 α ¾e fink 重He 7 3 自 及得 酯係 油. 甘種 酸一 桂另 月之 單物 % 合 量混 重種 50此 有。 含酯 現油 發甘 析酸 分桂 绖月 量述 重上 6 3 9 用 有使 含 0 其酯 現油 發甘 並酸 -桂 2 月 L1二 0-得 9測 1S未 U η 0 no酯 Ho油 為甘 稱酸 名桂 , 月 司單 下 份 兩 備0 ,塞 血 .止 rfy_J 待 同 相 之 用 所 .中 1 例 莨 .. 及塞 序血 程止 般述 % i % ο δ* ο 1基 1 及為及% s % 5 15 • s o ir o 、血 、 %% ΊΑ 1 1i o :¾ o 有待有 含之含 Ht Hv DC5 理另 各處各 中,經中 塞未塞 血以血 止,止 U a 混 酯 ο C S S e (請先閲-ift背而之注意事項*廣寫本頁) 經濟部屮央標準局A工消仰合作社印3i 準 基 為S 1 蜇及 塞¾ 血5 止ο0 寺 &lt;n 之 ο 理有 處含 经別 未各 以中 物血 合止 % ¾ ο η 及 準 , 為血 虽止 Hr之 血理 止處 測} 待酯 之何 理任 處含 经未 沬中 以其 /IV 物酵 合丙 混異 12以 -L用 90採 兩 備0 法 方 。 ( J flTr 箜9 血表 止於 之示 述未 前结 中试 文測 木 0 0 试 根測 。並 物樣 照试 對有 為所 作份 7 2 本紙張尺度边用中國困家樣準(CNS) Ή規格(2丨0x297公;«:) 81. 4. 10,000張(Η) 五、發明説明( ^τ13辁I-isss (%) Β6ςεο ο V ο w C e SH s 1 e The country κ is a self-purchased business system,,, Si Yigong's academic compound η mix pa I e kind t this se S Γ e substance mix this one α ¾e fink Heavy He 7 3 is obtained from ester oils. Glycolic acid-Gui Guiyue's single compound% combined mixed weight is 50%. The amount of glycerin-containing acid in ester-containing crude oil was increased to 6 3 9. The amount of glyceric acid in the oil-containing ester was 0-February L1 di 0-to-9. 1S was not U η 0 no ester. Ho oil is a famous name for sweet and sour, and it is prepared for two copies of 0 in the month. The blood is blocked. Stop rfy_J for the same phase. In 1 case .. and the general description of stop sequence blood flow stop% i% ο δ * ο 1 base, 1 and 1% and% s% 5 15 • so ir o 、 blood, %% ΊΑ 1 1i o: ¾ o to be included Ht Hv DC5 to be treated separately in each place, after being blocked, the blood is not blocked. Stop, stop U a mixed ester ο CSS e (please read -ift's notes on the back of this page * write this page) The Ministry of Economic Affairs Standards Bureau A Gongxiao Yang Cooperative Society printed 3i standard for S 1 sting and blood ¾ blood 5 Zhi ο0 Temple <n of ο There is no reason to contain the classics, each of which has a hemostatic percentage of ¾ ο η and quasi, for the blood although the Hr ’s hemorrhagic stop is measured} What is the reason for the ester to be contained In the raw material, its / IV substance is fermented with a mixture of 12 and -L and 90 is used to prepare two preparation methods. (J flTr 箜 9 The description of the blood table ends at the end of the test. The test paper is 0 0 and the root test. And the sample is copied to the promising copy. 7 2 The paper scale is based on the Chinese standard (CNS) ) Ή specification (2 丨 0x297 g; «:) 81. 4. 10,000 sheets (Η) V. Description of invention (^ τ13 辁 I-isss (%) Β6ςε

66 灯6 CS 66 66 96 ® m 涵 ·Ν \Μ 一 S3: ^ 啪 m 运制 ①葙 κ m 赵 « 峨 ίπ 胡 轾 Η 坻·叾κς Ζ 紐7 u 2 . Cz- 姊 — 擗 WSSl e胡制踣 ^6*69 职砌) 0「τ 〇9 · Em 3·^ 6ε·0 ε6,ε 6'^ 9Τ ·,〇 9Ε ·〇 (請先閱讀背而之注意事項孙填寫本頁) I t- fe ¢. s·/. (朱啉\) 卜01 M B,e ^w\ Π d3) 裝· Ζ9· L °τ · s s-z. IT·/. 们1·^ ες·Α_ου 訂- 線- 經濟部屮央櫺準::Γ段工消介合作杜印驭 % 0·^ ^ 0 0 · 0 * 一 6紙張尺度边用中a Η家標毕(CNS) Ή規格(2丨0χ·2!)Μ;!〇 hoTHW^〇 卜οτ Μ 9τ '^ς ·〇 9〇Τ Ms _ Τ Τ . 066 灯 6 CS 66 66 96 ® m Han · Ν \ Μ 1S3: ^ pm operation system ① 葙 κ m Zhao «Είπ 胡 轾 Η 坻 尾 κς AZ New 7 u 2. Cz- sister — 擗 WSSl e Hu Zhiyu ^ 6 * 69 vocational building) 0 「τ 〇9 · Em 3 · ^ 6ε · 0 ε6, ε 6 '^ 9Τ ·, 〇9Ε · 〇 (please read the precautions Sun filled in this page first) I t- fe ¢. S · /. (Zhuoline \) BU 01 MB, e ^ w \ Π d3) Pack · Z9 · L ° τ · s sz. IT · /. We 1 · ^ ες · Α_ου order- Line-Ministry of Economic Affairs, Central Standards :: Γ Duan Gongxiaoji cooperation Du Yinyu% 0 · ^ ^ 0 0 · 0 * A 6 paper scale edge used in a Η home standard Bi (CNS) Ή specifications (2 丨 0χ · 2!) Μ ;! 〇hoTHW ^ 〇 卜 οτ Μ 9τ '^ ς · 〇9〇Τ Ms _ Τ Τ. 0

£〇τ Μ「ε 卜〇τ Μ「X 卜〇Τ H「T ο,τ 们_ ο τ ,〇 卜〇1:«寸芡门 0*^卜οτ Μ 91‘ ς·〇 B〇T M s·Τ Τ · Ο£ 〇τ Μ "ε 卜 〇τ Μ" X 卜 〇Τ H "T ο, τ men _ ο τ, 〇 卜 〇1:« inch 芡 门 0 * ^ 卜 οτ Μ 91 'ς · 〇B〇TM s · Τ Τ · Ο

避S扛 涵型吹w oussaM 婼型叹擗 * U-Hp τυ·Μ:Ι η ρ q; ζια-06 S 1; nuioco2 81. 4. ]0,000ft (Η) A 6 _Π6_ 五、發明説明()Avoid S carrying culvert type blowing w oussaM 婼 型 嘗 * U-Hp τυ · Μ: Ι η ρ q; ζια-06 S 1; nuioco2 81. 4.] 0,000ft (Η) A 6 _Π6_ V. Description of invention ( )

Kessco*含有50重量%單月桂酸甘油酯。Kessco * contains 50% by weight of glyceryl monolaurate.

LaU「icidin*含有93重量%單月桂酸甘油酯。LaU "icidin * contains 93% by weight of glyceryl monolaurate.

Hon6Su]s 90-L12含有96重蛋%單月桂酸甘油酯。 a )以E L 1 S A方法(R e i s e r等人)測得。 b )底1 0之丨o g值。 所有測定均於3 7它下2 4小時後進行。 所有上述數據均為兩份試樣之平.均測定值。 由表9中所示之試驗數據可知,對於止血塞中酯混合 物之任何所予猥度(意即,添加量為0.1%、0.5%或 j 1.0 %),於所述測試條件下産生乏TSST-1量,係與單 月桂酸甘油酯在酯混合物中之猥度成反tb。因此,例如 若酯混合物在待測止血塞中之量保持固定在0.5 %添加 量程度,則最後TSST-1量偽由33.6 0.徹克,此時酯混合 物中含有50重量%單月桂酸甘油酯(意卽 KesscoO , 衰减至3. 39撤克,此時酯混合物中含有93重量% GHL ( 意即Lau「icidinO ,而速0.36谢克,此時酯混合物中 (請先閲讀背而之注意事項孙蜞寫本頁) -裝· 訂- 線· 。種降有症未 } 三似含之之 12此類其-1油 -L之現 iSTa· 90丨fiffiTS自 ibb,油制生 1S屋上甘抑衍 ouIr费酸於艏 ηοί-l桂對 一 HO%ST月-有 即 o T 單 } 含 -氪1 後出基其29 ί 與最指羥 ί I 酯¾之果應酯 油 1 生结&gt; 反油 甘 ο 産示未甘 。 酸用所所之的效 桂使在中油桂有 月中 ,9 甘 月更 單垄時表自二 } ¾血物 α生比玆 96止合用衍偽羥 有在混作傾,睡 含若酯低兩生反 經濟部屮央榣準局译工消赀合作社印製 本紙尺度边用中SH家標毕(CNS)T4規怙(210x297公;tf) 81. 4. 10,000張'(Η) Λ 6 Β6Hon6Su] s 90-L12 contains 96% egg glycerol monolaurate. a) Measured by E L 1 S A method (R e i s e r et al.). b) Bottom 10 g value. All measurements were carried out after 24 hours at 37 hours. All the above data are the average of two samples. All the measured values. From the test data shown in Table 9, it can be seen that for any given degree of ester mixture in the tampon (that is, the added amount is 0.1%, 0.5% or j 1.0%), a lack of TSST occurs under the test conditions The amount of -1 is inverse tb with the turbidity of glyceryl monolaurate in the ester mixture. Therefore, for example, if the amount of the ester mixture in the hemostatic plug to be measured is kept fixed at the level of 0.5% addition, the final TSST-1 amount is pseudo 33.6 0. Chuck, and the ester mixture contains 50% by weight of glycerol monolaurate Ester (Italian KesscoO, decay to 3.39 gram, at this time the ester mixture contains 93% by weight GHL (meaning Lau "icidinO, and the speed is 0.36 gram, at this time in the ester mixture (please read the back attention first Matters Sun Yao wrote this page) -Installed · Ordered-Line ·. The kind of declining disease is not} 12 of the three likes and its kind of -1 oil -L is present iSTa · 90 丨 fiffiTS from ibb, oil-made raw 1S roof Gan Yiyan ouIr Fei acid in the bow ηοί-l Gui on a HO% ST month-there is that o T single} Contains-Krypton 1 after the base of its 29 ί and most referred to hydroxy ί I ester ¾ of the fruit should be ester oil 1 Result &gt; Reverse oil Gan ο production shows that it is not sweet. The effect of the acid used in the Chinese oil Gui has a month, 9 Gan Yue more single ridge table from the second} Pseudo-hydroxyl is mixed in, mixed with sleep and low in esters. Anti-Ministry of Economics, Biyang Bureau of Economics, Translator Consumers Cooperative, printed this paper. The paper is used in the SHS standard (CNS) T4 regulation (210x297 tf) 81. 4. 10,000 sheets' (Η) Λ 6 Β6

❾❾W 五、發明説明() (請先閲讀背而之注意事項典填寫本頁) g例1 0 :單月桂酸甘油酯浸滾的止血塞之體内活性 按下述裂成待測止血塞。使用Avtex炫縈(100¾) «SH 2 5 ί 7三單尼作為待測戡維。將此繼維洗淨,以除去T w e e η 20,並留下呈未面飾狀,或塗以單月桂酸甘油酯 (Henkel Mononuls L-90)(後文稱為&quot;GHL&quot;)。此物質 中單月桂酸含貴之分析測定值為96.0%, 2.0% 1-3二 f 酯及2.0% 未確定之物質。按下述塗佈此缒維。將75磅 炫縈绡維裝填於固定槽中.此槽中焴谋水(共120加侖 )。將氨(HH3 ) (29.4¾ ν,/ν)加入固定槽中之水内。再 將此糸统加熱至2 0 0 Τ,歴經30分铵。然後以熱水( 150 Τ)洗辟繼維三次,確定洗滌水中有無任何殘留泡 沫,此泡沫傜證明Tween 20存在然後以冷水(60Τ)洗 滌錐維。 經Τϊζ:部屮央標準局ΕΪ:工消价合作社印奴 將此逍維轉移至一離心機中,趁熱旋鞞5分鐘.以移 除過fi水。此75磅重之炫縈最初傜含有54磅重之水。然 後以手打開此炫縈,並放回固定槽。將兩塊限制板置於 雜雒上,以降低抿伴,作用及虔泡沬産生降至最低。添加 熱水(10-200T),接箸添加四份5磅GML試疣,各溶 於五加侖1 7 0 T 水中。將此条統加壓並加熱至1 9 0下, 再循環30分镜。在使糸統排乾後,將谢緋取至之離心機 並旋鞞5分铵。此時.留下52磅水(70%)。诞維外部之 溫度為160 T,然而浓維内部之溫度為175-180 T。將 潮濕谢維踅於帶狀烘箱中.將其加熱至約2 5 0 - 2 6 0 1F。 -30 - 81. 4. 10,000張(H) 本紙尺度逍用中SB家標準(CNS)TM規格(210x297公;«:) Λ !|! 卜 •抽 &gt; f? ί1-/;; 作 杜 印 f ^ 五、發明説明( 此熱處理會使炫 及未經表面處理 梳i,以形成可 在纗雒已經洗 帶以製造2. 30克 並固定在一壓縮 於0.62英吋外徑 並密封。對照止 則命名為(X )。 2 . 75英时長及3 . 向,對長度而言 段集結或撕碎而 滾钆並覆蓋。對 Enka雙組份锘物 援g物為塗有2. 物。使用手動熨 Mountain工業公 長度。將此細绳 端為5/8英时, 细澠,以測试各 缩(邊對遴,然 秒铵。壓縮後, (0 · 6 2英时外徑 紫绡維一 之纖維, 供使用之 淨或塗佈 止血塞。 起皺器中. 之塗液器 血塞標示 按下述製 0英吋寬 為機器方 得玨布重 於對照坯 (2 . 7 5 &quot; X 4% EHL 斗,將覆 司之8/5 穿過各坯 然後繞成 坯布~之錨 後端對端 立即將止 )。拉引 步打開及 蓮行經過 纖雒帶, 、乾燥及 將此戡雒 五秒鐘。 上。將血 為(y ), 成it血塞 之區段, 向,對莧 2.28克。— 布而言, 4 . 7 5 &quot; ) 〇 溶液之0 . 蓋物本身 白色炫縈 布之一端 圈。於谤 定強度。 ).再固 血垄置於 之細诹並 -31 - Λ 6 Π 6 乾燥。然後將已塗佈 R a n d 〇成網機,接著 由其製成止血塞。 梳理後.使用此炫縈 以兩方向方式壓縮, 壓缩後,將止血塞置 塞包在賽璐玢紙中, 而GHL-塗佈之止血塞 :藉切割此炫縈成 以製_成坯布。繼維取 度而言為横向。將區 然後將炫縈區段以手 其覆蓋物為0.25盅斯 對EML坯布而言.其 25盅斯Enka雙組份鍇 熱封。將得自B 1 u e 細®,切成1 3 . 0英吋 ,距離貫穿單元之一 成图後,互相接此 將此玨布以兩方向脫 定於脫縮起皴器中5 R e g g i e三接頭塗掖器 未打结。將止血塞包 (請先閲讀背而之注意事項再堝寫本頁) 本紙張尺度边用中Η困家《毕(CNS) 規格(210x297公没) 81. 4. 10,000張'(H) 五、發明説明( Λ 6 Π 6❾❾W Fifth, the description of the invention () (please read the precautionary code and fill in this page first) g Example 1 0: In vivo activity of the hemostatic stopper immersed in glyceryl monolaurate Split into the hemostatic stopper to be tested as described below. Use Avtex Xuanyue (100¾) «SH 2 5 ί 7 Sandani as the dimension to be tested. This secondary dimension was washed to remove T w e e η 20 and left unfinished, or coated with glyceryl monolaurate (Henkel Mononuls L-90) (hereinafter referred to as &quot; GHL &quot;). The analytical value of the content of monolauric acid in this substance is 96.0%, 2.0% 1-3 dif ester and 2.0% unidentified substance. Apply this thread as follows. Load 75 pounds of glaring stalks into a fixed tank. This tank contains water (120 gallons in total). Add ammonia (HH3) (29.4¾ ν, / ν) to the water in the fixed tank. Then heat the system to 200 Τ, after 30 minutes of ammonium. Then wash it with hot water (150 Τ) three times to determine whether there is any residual foam in the wash water. This foam proves that Tween 20 exists and then wash the cone with cold water (60 Τ). After Τϊζ: Ministry of Standards Bureau EΪ: Industrial Consumer Price Cooperative Innu, transfer this Xiaowei to a centrifuge and spin it for 5 minutes while hot to remove the fi water. This 75-pound Xuanyu initially contained 54 pounds of water. Then open the dazzle with your hand and put it back into the fixing slot. Place two restricting plates on the miscellaneous halves to reduce the spurting partner, and the effect and the generation of pimples are minimized. Add hot water (10-200T), then add four 5 lb GML test warts to the pan, each dissolved in five gallons of 1 70 T water. The system was pressurized and heated to 190 ° C, and the 30 minute mirror was recycled. After draining the system, take Xie Fei to the centrifuge and spin it for 5 minutes. At this point, 52 pounds of water (70%) is left. The temperature outside the birthday is 160 T, but the temperature inside the rich dimension is 175-180 T. Place the moist Xiewei in a belt oven. Heat it to about 2 5 0-2 6 0 1F. -30-81. 4. 10,000 sheets (H) SB home standard (CNS) TM specifications (210x297 g; «:) Λ! |! 卜 • Draw &gt; f? Ί1- / ;; Zuo Du印 f ^ V. Description of the invention (This heat treatment will cause the dazzle and comb without surface treatment to form 2.30 grams which can be washed in 盗 雒 to manufacture 2.30 grams and fixed at a compression of 0.62 inches in outer diameter and sealed. The control is named as (X). 2.75 English hours and 3. Directions, the length is gathered or shredded to cover the gadolinium and covered. For the Enka two-component sintering aid, it is coated with 2. Use manual ironing Mountain industrial length. The end of this string is 5/8 inch, thinly rolled, to test each shrink (side to side, then second ammonium. After compression, (0.62 inch outside The fiber of the diameter of the purple silk is used for the net or coated hemostatic plug. In the wrinkle. The blood plug of the applicator is marked as follows. The width of the machine is 0 inches. The machine is made. The cloth is heavier than the control blank (2 . 7 5 &quot; X 4% EHL bucket, pass 8/5 of the cover through each blank and then wind into the gray cloth ~ the opposite end of the anchor's back end will stop immediately.) The pull step is opened and the lotus line passes through the fiber belt, , Drying and will This 曡 雒 for five seconds. Up. The blood is (y), it is the segment of the blood clot, facing, 2.28 grams to the amaranth. — For the cloth, 4. 7 5 &quot;) 〇 The solution 0. The cover itself One end circle of the white dazzling cloth. Yu Dingding strength.). Re-fix the blood ridge and put it into a thin frame and dry it -31-Λ 6 Π 6. Then apply the R and 〇 web forming machine, and then make it After combing. Use this dazzle to compress it in two directions, after compression, put the tamper to be wrapped in cellophane paper, and GHL-coated hemostatic plug: by cutting this dazzle to make _ Into a grey cloth. It is horizontal in terms of dimension. The area is then covered with a 0.25 cup of Xuanyu section. For EML gray cloth, its 25 cup of Enka two-component heat seal. From B 1 ue Fine®, cut into 13.0 inches, after a picture of one of the through units is connected, connect this to the cloth in two directions and fix it to the 5 R eggie three joint coating The gripper is not knotted. Pack the hemostatic plug (please read the precautions first and then write this page). This paper is used in the "CNS" specification (210x297 ) 81. 4. 10,000 sheets' (H) V. invention is described (Λ 6 Π 6

經濟部中央#準而ft工消赀合作杜印M 在白色塞璐玢套苘中並封合。 分析已壓缩之止血塞,以測定GML在止血.塞谢維上之 濃GML在所測試的止血塞上之平均濃度為2.38%。 與未绖表面整理的止血塞比較,此GHL止血塞之體外 衝擊作用,係使用用以評估金黃色餐i萄球®生成T S S T - 1 之Holland振遨燒杯法與Reiser止血塞囊法進行評估。 此等方法已描述於上文實例1_與7中。GML (2.38¾ w/w) 塗佈的止血塞之衝筚作用,其測定結果示於表10與11中 。表10顯示,當使用下述振邊燒杯法評估此止血塞時, 發現在TSST-1生成上有大於99.9%降@ :將具有三個葉 片之兩升燒杯,在熱壓鍋中消毒,其中含有500毫升 D ί f c 〇腦心注液培養基。消毒殺鲒後,將五毫升經過2 4 小時培養之金黃色g萄球®種(標明為U87),加入燒 杯中。於燒杯中添加2 5 . 0克量之待測物質,或未添加物 質(於對照燒杯中),各兩份。將所有燒杯在37t:下培 耷,並在16〇Γρπ下振盪24小時,此時進行TSST-1濃度與 金黃色涵萄球閣細胞绾數之測定。TSST-1含量係使用 E L I S A試驗測定,而绾細胞數則使用標準板計數程序進 行。 於表11中可見,使用止血垄曩方法,蘇萏GML止血箜 與未經表面整理的止血垄至金黃色妬词球闍之結果。其 中證筲TS S T - 1生成上之降低範圍,係由在培萊基中使用 血液時之8 1 . 1 % .至未使用血液時之9 5 . 9 % ,然而對於 32 - 本紙張尺度边用中11困家楳毕(CHS) T4規怙(210x297公龙) 81. 4. 10,000張'(H) (請先閲讀背而之注意事項#填寫本页) - 裝. 訂_ 線- 經濟部屮央揲準局a工消费合作杜印λ'14 Λ 6 Π 6 五、發明説明() 金黃、色涵萄球菌細胞绾數之衝擊作用,則為於血液存在 時之一點&amp;不影铤,或在未使用血液的試管中之9.1%。 ‘其功效之S内評估.傜按下述進行。將對照與GML止 血塞郵寄至Texas州San Antonio市之西南研究所,以 評估在拂拂陰道中對於由金黃色蒱萄球®生成之TSST-1 之降低作用。使用氛胺嗣HC1固定化作用,辨誔十二隻 t 雌性拂拂,及陰道檢査以獲得感染之缌脰證撺。 未經表面整理之對照止血叁,於37X:下歴經24小時, 有5毫升金黃色®萄球菌p性菌種成長於腦心灌注液培 養基中,吸收於其末端(遠離細趣之兩端)。將已預先 稱重之接種止血塞立即置入拂拂陰道中,未使用檢視鏡 ,並切除拉回用细澠。測定並記錄·其直賜溫度及間接心 臟收缩血壓。自其頭部血管採取五毫升血液试樣,並將 血清儲存於-7〇υ下,直到分析出抗-TSST-1之抗體出現 且能進行臨床化學為止。 將接種止血塞保持在陰道内十二小時。於第一膣十二 小時後,以氛胺酮H C丨使拂拂固定不動,並移除止血塞 。將此接種之止血塞置於已預先稱蜇之4盎斯塑if杯中 。一起稱重止血塞與杯子.及計算伴随箸止血塞之流脰 蛋。將此止血垄料移/至含有50毫升無1¾食鹽水(0.9 % H a C丨)之.胃袋中,並混合6 0秒浅。然後對留袋中之流脰 ,進行定贵剷定.以得知金员色ίή萄球闍細朐缌数及 T S S Τ - 1 jg度。跑细胞数測定,係使用標準板計數法進行 本紙張尺度逍用中困困家榣毕(CNS)規怙(210x29/公釐) 81. 4. 10,000». (H) (請先閲讀背而之注意事項再填窍本頁) 裝· 線. Λ 6 1J6 經濟部屮央標準局a工消1Ϊ·合作社印51 五、發明説明(),而T S S T - 1蒺度,則使用放射免疫分析法(R . I . A .)測定。 於接種止血塞之後所插入之全部止血塞,均按上述方 法运一理。ίΕ移除接種止血塞之後,所有拂拂均以對照(y) 止血塞插入陰道内,以允許額外的金黃色涵萄球®之生 長及TSST-1之産生於陰道腔内。於另外培育十二小時後 ,將動物區分成兩組,各六隻,其中六隻拂拂以對照止 I 血塞測試,另六隻以G M L塗佈之止血塞測試。4 8小時暴 露期間後,所有已插入止ώ塞之動物,均以其本身之5.0 毫升血清補充,因减少月缇流量。於所有止血塞上進行 存活的金黃色标萄球菌細胞绾數及TSST-1含量之測定。 於所有止血塞均已進行完畢及毒素與細胞計數測定均已 進行後,將四雙動物排除在本研究之外(兩隻對照動物 及兩隻GHL待浏動物)。於此等動物中,有機脖並未鞞 移至陰道腔内以引起感染,或者發現其具有tb已知已施 加至接種止血塞者更少之毒素或更少之細胞含量。表12 示出伴随著止血塞之每毫升流體中之缌毒素數據及在止 血塞上之绾毒素數據,以及其對細胞計數之衝擊作用。 所示之數據,於各測试群中.係以四隻動物為代表。 表12中所示之數摔涅筲,在帶有GHL止血塞之四隻動 物中,比僅帶有對照止血垄考,在毒素形成上有相當大 之降低。圖1 - 4表示GHL止血箜銜筚作用之數柹。雖 然在閲始時,於帶有對照止血垄的待測勖物中之毐素含 贵具有較高TSST-1含贵,但GHL止血垄使得齿素含毋顯 -34 - (請先閲讀背而之注意事項#填寫本頁) 裝&lt; 訂· 線- 本紙张尺度边用中a國家樣準(CNS) Τ4規格(210x29/公釐) 81. 4.〗0,000張(Η)The Ministry of Economic Affairs # Zhuo Er ft work consumer cooperation Du Yin M and sealed in white celluloid sleeves. The compressed hemostatic plug was analyzed to determine the average concentration of GML on the hemostatic. The average concentration of GML on the tested hemostatic plug was 2.38%. Compared with the hemostatic stopper with unfinished surface, the in vitro impact of this GHL hemostatic stopper was evaluated using the Holland vibrating beaker method and the Reiser hemostatic bladder method used to evaluate the golden yellow meal ® to produce T S S T-1. These methods have been described in Examples 1_ and 7 above. The impact of GML (2.38¾ w / w) coated hemostatic plug is shown in Tables 10 and 11. Table 10 shows that when the hemostatic plug was evaluated using the vibrating edge beaker method described below, it was found that there was a greater than 99.9% drop in TSST-1 generation @: A two-liter beaker with three blades was sterilized in an autoclave, where Contains 500 ml D ί fc 〇 Brain heart injection medium. After sterilizing the killifish, add five milliliters of Golden Yellow Grape Ball® (marked as U87) after 24 hours of cultivation and add it to the beaker. Add 25.0 grams of the substance to be tested to the beaker, or add no substance (in the control beaker), in two portions. All beakers were cultured at 37t: and shaken at 160 ° F for 24 hours. At this time, the TSST-1 concentration and the number of golden yellow cells were measured. The TSST-1 content was determined using the ELISA test, and the number of striatal cells was measured using a standard plate counting procedure. It can be seen in Table 11 that using the hemostatic ridge method, Sulian GML hemostatic ridge and the untreated surface hemostatic ridge to the golden yellow jealous word ball. Among them, the reduction range in the production of TSQ-1 is from 81.1% when using blood in Peleiki to 95.9% when not using blood, but for 32-the paper size Used in 11 sleepy homes (CHS) T4 regulations (210x297 male dragons) 81. 4. 10,000 sheets' (H) (please read the back-end notes # fill out this page)-Pack. Order_ Line-Economy The Ministry of Finance, Industry and Consumer Affairs, Du Yin λ'14 Λ 6 Π 6 V. Description of the invention () The impact of the golden and staphylococcus aureus cell count is one point in the presence of blood. Collar, or 9.1% of the test tubes that do not use blood. ‘Internal evaluation of its efficacy. 傜 proceeds as follows. The control and GML hemostatic plugs were mailed to the Southwest Research Institute in San Antonio, Texas, to evaluate the reduction effect of TSST-1 produced by Golden Globe® in the vagina. Using amine HC1 immobilization, identify twelve female whiskers, and vaginal examination to obtain an evidence of infection. The control hemostasis three without surface finishing, at 37X: After 24 hours, 5 ml of Staphylococcus aureus p sex strain grows in the brain-heart perfusion medium and is absorbed at its end (away from the ends of the fun) ). Immediately place the pre-weighed inoculation hemostatic plug into the vaginal vagina without using an inspection scope, and remove it and pull it back to use a thin lump. Measure and record the direct temperature and indirect systolic blood pressure. Five milliliters of blood samples were taken from the blood vessels of the head, and the serum was stored at -7〇υ until the analysis of anti-TSST-1 antibody appeared and clinical chemistry could be performed. Keep the vaccination tampon in the vagina for twelve hours. Twelve hours after the first fat, the amine ketone H C 丨 was used to fix the brush and the tampon was removed. Place the inoculated hemostatic plug in a 4 ounce plastic if cup that has been previously stung. Weigh the tampon and cup together. Calculate the egg that accompanies the tampon. Transfer this hemostatic material to a stomach bag containing 50 ml of saline (0.9% Ha C1), and mix for 60 seconds. Then, determine the value of the flow in the remaining bag, to determine the value of the gold member's color and the T S S Τ-1 jg degree. The number of running cells is determined by using the standard plate counting method for this paper-scale homelessness (CNS) rule (210x29 / mm) 81. 4. 10,000 ». (H) (please read on the back Note: Please fill in this page again) Install · Line. Λ 6 1J6 The Ministry of Economic Affairs, Bureau of Standards, Industry, Consumers, 1Ϊ · Cooperative Print 51 V. Description of invention (), and TSST-1 degree, use radioimmunoassay (R.I.A.) determination. All hemostatic plugs inserted after inoculation of hemostatic plugs will be handled as described above. ίΕ After removing the inoculated hemostatic plug, all whisks were inserted into the vagina as a control (y) hemostatic plug to allow the growth of additional golden yellow bulbs and the production of TSST-1 in the vaginal cavity. After another twelve hours of incubation, the animals were divided into two groups of six animals, six of which were tested with the control hemostatic plug, and the other six were tested with G M L coated hemostatic plugs. 4 After the 8-hour exposure period, all animals that have been inserted into the stopper are supplemented with their own 5.0 ml of serum, because the flow of Yue Ti is reduced. The number of viable Staphylococcus aureus cells and the content of TSST-1 were measured on all hemostatic plugs. After all hemostatic plugs have been completed and toxin and cell count measurements have been performed, four pairs of animals were excluded from the study (two control animals and two GHL animals to be visited). In these animals, the organic neck has not moved into the vaginal cavity to cause infection, or it has been found to have less toxin or less cellular content that tb is known to have been applied to the vaccinated hemostatic plug. Table 12 shows the toxin data per ml of fluid accompanying the tampon and the toxin data on the tampon, and their impact on cell count. The data shown are represented by four animals in each test group. The numbers shown in Table 12 fell nirvana. In the four animals with the GHL hemostatic plug, there was a considerable reduction in toxin formation compared with the control hemostatic test. Figures 1-4 show the number of GHL hemostatic effects. Although at the beginning of the reading, the content of sucralose in the sample with control hemostatic ridge is higher than that of TSST-1, but GHL hemostatic ridge makes the dentin content not obvious -34-(please read the back And the precautions # fill out this page) Install &Order; Line-This paper is used in the national standard (CNS) Τ4 specifications (210x29 / mm) 81. 4.〗 0,000 sheets (Η)

五、發明説明() 箸降低,超過在對照物中所察晃到者。 此數據係表示毎1〇6傾金黃色葡萄球菌細胞所産生之 缌毒素,因此使數據對膣別細胞正規化,其證實在含有 G H L ’之止血塞中之顯著降低,麽於對照止血塞。於添加 血液於60小時止血塞上之後,在對照動物中發現,與細 菌细胞有關之毒素有增加之趨勢。於對照動物中發現之 趨勢,似乎是對於細胞本耳及生長曲線之直接衝擊作用 。此種趨勢亦在帶有GHL止血塞之動物中發現。 於表13中所示之數據,顯示於伴随箸止血塞之流匾上 j 毒素之對照百分比之tb較,及在止ώ塞上所形成之缌盡 素與對照止血塞作比較。 (請先閲讀背而之注意事項#填寫本頁) 裝- 線. 經濟钩屮决標準而εί:工消合作社印Μ 5 3 本紙5fc尺度边用中SS家樣毕(CNS) Ή規格(210x29/公:«:) 81. 4. 10,000張(Η) Π 6 五、發明説明() isi±^.^ifov110H^3!^els·® A!^4HI-lssi^M^TIJrqT^^:.«)lJHD01 w 2TS Μ 02.τ (Π3。) ss?lf\!lis泜聛涵昍 5〇Ι Η U{朱搁/ = JQ) 制琺兹啭-N瓶胡effi桦 (%)V. Description of the invention () The chopsticks are lower than those found in the control. This data is representative of the toxin produced by each 106-gram Staphylococcus aureus cell, so the data is normalized to the diabetic cells, which confirms a significant reduction in hemostatic plugs containing G H L 'compared to the control hemostatic plugs. After adding blood to the hemostatic plug for 60 hours, it was found in control animals that the toxins associated with bacterial cells had an increasing trend. The trend found in control animals seems to be a direct impact on the cell's ear and growth curve. This trend is also found in animals with GHL hemostatic plugs. The data shown in Table 13 shows the comparison of the tb control percentage of j toxin on the flow plaque with the tampon, and the comparison of the detoxification factor formed on the tampon with the control tampon. (Please read the back and the precautions # fill in this page first) Pack-line. Economically determined standard and εί: printed by the industrial and commercial cooperatives Μ 5 3 This paper 5fc standard side uses the Chinese SS home sample (CNS) Ή specification (210x29 / Public: «:) 81. 4. 10,000 sheets (Η) Π 6 V. Description of invention () isi ± ^. ^ Ifov110H ^ 3! ^ Els · ® A! ^ 4HI-lssi ^ M ^ TIJrqT ^^ :. «) LJHD01 w 2TS Μ 02.τ (Π3.) Ss? Lf \! Lis 泜 聛 涵 昍 5〇Ι Η U {朱 架 / = JQ) made of Faz-N bottle Hueffi birch (%)

οτ Η 09 · 6 ποΓ-ιΜ 36 . τ Ζ6 . 66 3X〇T Σ 03·τΟΤ Μ 5·ζ I ΝΤΟτ Μ 00·Τ 5S Μ 0-OJ- I Γοοτ χ οο .ιη&gt; οτ&gt; ε6. &amp;s tr-ιοτ Σ 09 . 6CT1S Μ MCTI.rHI I -1SS1 ΤΝ!州制矻 φι 31s i . 0 ε(Ν·νο 68.99 TOO .0&gt; OJ9 ·τ ζ-ιη.τοο(踩费) 經濟部屮央標準而β工消费合作社印製 IHBis^3lg$J闼啪οτ Η 09 · 6 ποΓ-ιΜ 36. τ AZ6 .66 3X〇T Σ 03 · τΟΤ Μ 5 · ζ I ΝΤΟτ Μ 00 · Τ 5S Μ 0-OJ- I Γοοτ χ οο .ιη &gt; οτ &gt; ε6. &amp; s tr-ιοτ Σ 09. 6CT1S Μ MCTI.rHI I -1SS1 TN! State-made 緻 φι 31s i. 0 ε (Ν · νο 68.99 TOO .0 &gt; OJ9 · τ ζ-ιη.τοο (stepping fee) Ministry of Economic Affairs IHBis ^ 3lg $ J printed by the Central Standard and β Industry Consumer Cooperative

Ixca 拗萄-il 匪葙 蹉岧 砌与-^(%Βε·ζ) d.cs淫翎 砌Tp-il 陛辄 IHm«l-gqr(%00ε ·ζ) Ίκυ 6 3 。昏1臣-&lt;茛与卅?:-0:蚶_笏狴«[11筅-赳蜓&gt;/&gt;«0.1这庀啭„ (請先閲讀背而之注意事項#堝寫本頁) 裝· 線· 本紙5民尺度边用中S Η家楳準(CNS) ΤΊ規怙(210x297公;«:) 81. 4. 10,000張(Η) 五、發明説明( 艇啪£S杜 g&lt;ws胆杜 ¾^8猢翎 qU 3 SI 3 3 ¢¾¾^¾¾ ® Λ!1§胡 I-lssisli 糊与 Ψ-Nie劍 ihd . U 帐 Λ 6 Π 6 gOT M S- -Ότ Μ/,τ·τ °'0IHlos-goIM寸3·9 5012:^9^ 寸 (5。) 朱搁/nJu)Ixca 拗 貗 -il 貉 呧 貉 岧 Build and-^ (% Βε · ζ) d.cs obscenely build Tp-il 陛 辄 IHm «l-gqr (% 00ε · ζ) Ίκυ 6 3. Faint 1-&lt; Buttercup and 30? : -0: 蚶 _wat 狴 «[11 筅-譳 鳳> / &gt;« 0.1 庀 孭 …… (please read the back-to-end precautions #pot write this page) installation · line · original paper 5 people scale side In use S Η family 楳 quasi (CNS) ΤΊ regulations 怙 (210x297 public; «:) 81. 4. 10,000 sheets (Η) 5. Description of the invention (boat buckle £ S Du g &lt; ws gall Du ¾ ^ 8 猢 qU 3 SI 3 3 ¢ ¾¾ ^ ¾¾ ® Λ! 1§Hu I-lssisli paste and Ψ-Nie sword ihd. U account Λ 6 Π 6 gOT M S- -Ότ Μ /, τ · τ ° '0IHlos-goIM inch 3 · 9 5012: ^ 9 ^ inch (5.) Zhu She / nJu)

°T M ® ΟΙ ·Μ 0.9' 卜ΟΤ w 9Μ 卜OT 二: Bs Mv.l /s H 0- -S6 -« (請先閲讀背而之注意事項#堝寫本頁) 裝. S¾ I-iSSl INS ·6 ιηιη,οιη Rl-S s·^. &lt;ο0·ιη9 oo-oTr (轵耘) 線· 經濟部屮央榣準局译工消奸合作社印製 rt) IH 3}8货职!§^艇啪 IHn IHra 糊萄4d Isa 陛aft (q)fe&lt;一与涵抵职诨昍贼啪° TM ® ΟΙ · Μ 0.9 'Bu Τ w 9Μ Bu OT II: Bs Mv.l / s H 0- -S6-«(please read the back-to-be-attentive matters # Crucible to write this page) installed. S¾ I-iSSl INS · 6 ιηιη, οιη Rl-S s · ^. &Lt; ο0 · ιη9 oo-oTr (轵 耘) Line · Printed by the Ministry of Economic Affairs, Bureau of Biography, Translator and Cooperative Cooperative Society rt) IH 3} 8 cargo positions! § ^ Boat snap IHn IHra paste 4d Isa aft (q) fe &lt; Yi and Han resigned

MW 糊与匄 TKD sim 7 3 本紙張尺度边用中國Η家標準規格(210x29/公;«:) 81. 4. 10,000張(Η) 五、發明説明() ,豳铤擗9〇1/ 猢与Ψ&quot; 0 Ls·! ®6,α S9.SI S.99 S 卜.SS S.IC /.•SZ 卜 6-·° ζδ.^ε 6Ζ.0Τ (名°1 κ)«釦斛領杓 T猢岧^¾. ε·0 ε·ε •αs_6 €6 ®·0Ι ετ-τ £ ·ζ 0·寸 ε,κ 10-! 堀货诹|$^租相尹担.1551^^^坦8^0,CJI術經濟部屮央標準而Λ工消作合作社印¾. (汞彻、5。9°1 w)(^爸懈)(朱硝/2£轻辦) i —Ml W鹅一—Issl 洄货©遐却 与匄§? ?:哥豳诓e 瓶啪fiK灶 糊萄匄涅鸯笵 ~TtsyiTTQHSgrTQe.I.N 明圈 S69U) I - n —c L * - Juu 3 C 3 τκο Z6.C ^•ΔΤ 2Ζ ζ·®ε °.ss . ®-·Ι 卜τ. 9 τ·οζ ®·®-MW paste and paper TKD sim 7 3 This paper uses the Chinese standard standard (210x29 / gong; «:) 81. 4. 10,000 sheets (Η) 5. Description of the invention (), 鱳 铤 擗 9〇1 / 猢With Ψ &quot; 0 Ls ·! ®6, α S9.SI S.99 S 卜 .SS S.IC /.•SZ 卜 6- · ° ζδ. ^ Ε 6Z.0Τ (名 ° 1 κ) «buckle collar擓 T 猢 岧 ^ ¾. Ε · 0 ε · ε • αs_6 € 6 ® · 0Ι ετ-τ £ · ζ 0 · inchε, κ 10-! Hori Goods | $ ^ 租 相 尹 载 .1551 ^^^ Tan 8 ^ 0, CJI Technical Ministry of Economics and Central Standards, and ΛGongxiao as a cooperative print ¾. (Mercury, 5.9 ° 1 w) (^ father) (Zhu Ni / 2/2 lightly) i — Ml W Goose one—Issl stock © ya but with §§ ??: Gefen e bottle cracker fiK stove paste grape nirvana ~ TtsyiTTQHSgrTQe.IN Ming circle S69U) I-n —c L *-Juu 3 C 3 τκο Z6.C ^ • ΔΤ 2ζ ζ · ®ε ° .ss. ®- · Ι 卜 τ. 9 τ · οζ ® · ®-

ο τ^ L5 S9寸I &gt;ζζ卜 I Dt:10 °68 ss S56 1^5 STZ s ^st °m IL m VST KS £6 0- S IL S B'5· 幻门 .-°3 ZL· S °3寸 °门 (S、) J— SS. S0^ 8 3ο τ ^ L5 S9 inch I &gt; ζζ Bu I Dt: 10 ° 68 ss S56 1 ^ 5 STZ s ^ st ° m IL m VST KS £ 6 0- S IL S B'5 · Magic Gate.- ° 3 ZL · S ° 3 inch ° door (S,) J— SS. S0 ^ 8 3

Ίκ° TSO ΤΚ3 TSO TSO 眭·ε3 60IXS6.I轭驭降挪柜菪鋇陛萌餡莉_綃岧^w/-D-Ixg.s^^-^^M-^ •求w/nfc 80IX--苑邳zkf,賠菪裔匪菡-辄•網与彐闺迆 0 (請先閲讀背而之注意事項孙填寫本頁) 裝- 訂_ 線· 本紙張尺度边用中a Η家橒準(CNS) T4規格(210X297公龙) 81. 4. 10,000張(Η) LOGbC- Λ 6 ___HJ5 五、發明説明() 表 13 毒素形成之對照百分比 (請先閲讀背而之注意事項孙填窍本頁) 裝. 訂· 線· 經濟部屮央榀準^;β工消伢合作杜印製 9 3 止 血 塞 類型 於 伴 隨止血 塞 於 止 血塞上 所 的 流 瞪中毒 素 形 成 的缌毒 素 之 對 照百分 bb 之 對 照百分 bb t (%) ⑴ 對 照 動 物 對 照 - - 對 照 199 * 294 對 照 134 -10 2 對 照 29 40 對 照 56 77 對 照 4 1 119 待 m 動 物 對 照 - - * G HL 46 30 . 5 G HL 33 . ! 20 . 25 本紙5t尺度边用中困Η家榣準(CNS)T4規格(210X297公放) 81. 4. 10,000張(H) L05bG-i A6 l&gt; Ό 五、發明説明() 表 14 經濟部屮央榀準局d:工消&quot;合作社印奴 各種 脂肪酸酯化合 物對於生 長 *' *· 及 TSST- 1形成之 衝擊作用 金 黃色轺萄 所産生的 M T S S Τ - 1 球 菌最後猥 TSST- 1 生成上之 試 樣' 度 之對數值 之绝量 降低值 (/毫升&gt; (徹克) (%) 接種1 169 11.0 -J 15.45 —— 對照止血塞 9.60 8.566 -- 止血塞1 0 . 1 3: 9.1 7.93 7% ϋ . 5¾ 7.64 1.25 85% 1 . 0¾ 8.79 0.09 9 9 % 10¾ .8.37 0.05 99¾ 止血塞2 Ψ 0 · 1 % 8.45 0.12 99% 0 . 5% 7.40 0.01 99¾ 1 . 0% 6.13 0.01 99¾ 10¾ 7.42 0.11 99¾ (請先閲誚背而之注意事項孙構寫本頁) 本紙張尺度边用中國困家榣毕(CHS) 規怙(210x297公龙) 81. 4. 10,000張(H) :n Λ 6 Π 6 明 説 明 發 五 例 奮 以 塞 血 止 之 酯 酸 肪 旨 RH 同 不 有 含 試 中 11 例 實 本 於Ίκ ° TSO ΤΚ3 TSO TSO 眭 · ε3 60IXS6.I yoke control lowering cabinets barium moe filling _ 绡 岧 ^ w / -D-Ixg.s ^^-^^ M- ^ • Seeking w / nfc 80IX- -Yuan Pi zkf, 菪 亪 bandits- 辄 • Net and 彐 女 忤 0 (please read the notes beforehand Sun fills in this page) 装-定 _ 线 · This paper is used in the standard a Η 家 橒 准(CNS) T4 specification (210X297 male dragon) 81. 4. 10,000 sheets (Η) LOGbC- Λ 6 ___HJ5 V. Description of invention () Table 13 Control percentage of toxin formation (please read the precautions to be filled first Page) Pack. Thread · Line · The Ministry of Economic Affairs, the central government ^; β work consumer cooperation in cooperation with Du printed 9 3 type of tampon to the control of the toxin formed in the toxin formed with the tampon on the tampon Percentage of control in bb bb t (%) ⑴ Control animal control--Control 199 * 294 Control 134 -10 2 Control 29 40 Control 56 77 Control 4 1 119 Pending animal control--* G HL 46 30.5 G HL 33.! 20. 25 paper 5t scale edge Used in the middle of the family 揣 榣 (CNS) T4 specification (210X297 public release) 81. 4. 10,000 sheets (H) L05bG-i A6 l &gt; Ό V. Description of invention () Table 14: Department of Economics, Ministry of Economic Affairs, quasi-d: Gongxiao &quot; Cooperative Innu ’s various fatty acid ester compounds have an impact on growth * and the formation of TSST-1, the MTSS Τ-1 produced by the golden yellow grapes, and the final sample of TSST-1 produced on the ‘TS’-1 The absolute reduction of the logarithmic value (/ ml> (Chuck) (%) inoculation 1 169 11.0 -J 15.45-control hemostatic plug 9.60 8.566-hemostatic plug 1 0.1: 3: 9.1 7.93 7% ϋ. 5¾ 7.64 1.25 85% 1. 0¾ 8.79 0.09 9 9% 10¾ .8.37 0.05 99¾ tampon 2 Ψ 0 · 1% 8.45 0.12 99% 0. 5% 7.40 0.01 99¾ 1. 0% 6.13 0.01 99¾ 10¾ 7.42 0.11 99¾ (please (First read the back-to-back precautions Sun Gou wrote this page) This paper uses the Chinese poverty-stricken family (CHS) rules (210x297 male dragon) 81. 4. 10,000 sheets (H): n Λ 6 Π 6 Ming Explain that five cases of dyslipidemia and fatty acid RH were not included in 11 cases. To

I TXI TX

成 , 生類 ,1 c si- 其種 由之 及塞 長血 生止 之測 9)待 16的 I用 所 (F中 閨 1 球例 萄實 葡於 色 〇 黃用 金作 於之 對-1 定ST g'J-TS 有未 含以 備 , 製塞 序血 程止 般測 1 待 之之 述酯 前酸 文肪 本脂 拣% 根10 0 及 中0¾ il · 1Λ 11 例 、 實5X 本Ό 於 、 用 1 係 ο 所肪 中脂 1 何 例任 實有 據含 根未 並份 兩 準用 基使 為 〇 量試 重制 之·行 塞進 血法 止方 測囊 待塞 的血 理止 處之 绖述 表 於 告 報 果 結. 試 測 0 物棚 對¾ 作 塞 血 止 制 待 之 61。 酸中 (請先閲讀背而之注意事項#项寫本頁) 裝- 訂- 線· 經濟部屮央#準局β工消汾合作杜印3i 11 4 本紙尺度边用中S Η家楳毕(CNS) 規怙(210x297公龙) 81. 4. 10,000張(Η)Adults, raw species, 1 c si- its species and the test of the growth and death of blood plug 9) I will be used in 16 (F in the female 1 ball example, the grape color is yellow and yellow with gold for the -1 set ST g'J-TS is not included in the preparation, the blood flow of the stopcock sequence is generally measured. 1 To be described, the ester preacid, the fatty acid, the fatty acid, the root, the root 10 0 and the middle 0¾ il · 1Λ 11 cases, the actual 5X is less than 、 Use 1 system ο The fat in the fat 1 Any example is based on the fact that it contains two quasi-use bases that are not combined. The test is made by measuring the volume of the blood. The statement is summarized in the report. Test 0. The shed works to stop the blood clots at 61. Acidic (please read the back-end notes #Item to write this page) Binding-Order-Line · Ministry of Economic Affairs屮 央 #Public Bureau β 工 消 汾 Cooperation Duyin 3i 11 4 This paper scale is used in the middle S Η 楳 楳 Bi (CNS) regulations (210x297 male dragon) 81. 4. 10,000 sheets (Η)

Claims (1)

祕麵 公告本 A 7 B7 C7 D7 六、申請專利範圊 專利申請案第80 108379號 ROC Patent Appln. No. 80 108379 修正之申請專利範圍中文本一附件㈠ Amended Claims in Ch i nese-EncI . I (民國81年10月21曰修正並送呈) (Amended &amp; Submitted on October 21 ,1992) 巧修正之申請專利範圍: 1. 一種供婦女個人衛生用之液體组成物,其包含一種藥劑可 接受載體及一種選自下列類组之化合物: (a) —種多羥基脂族醇及一種含八至十八値原子之脂肪酸 之單酯頚,其中該單酯類至少有一羥基輿其腊族醇殘 留物相締合; (b) —種多羥基脂族醇及一種含八至十八傾原子之脂肪睃 之二酯類,其中該二酯類至少有一羥基與其脂族醇殘 留物相缔合;Μ及 (c) 該單酯類及二酯類之混合物, 上述化合物存在之量為當該組成物暴露於金黃色葡萄球菌 時可有效抑制該細菌產生中毒性休克戲候群病毒-1。 2. 根據申請專利範圍第1項之组成物,其中該化合物存在之 量,依據該組成物之重量,至少約為0.1 %。 3. 根據申請專利範圍第1項之組成物,其中該化合物存在之 量,依據該組成物之重量,至少約為1.0 %。 經濟部中央標準局8工消费合作社印製 (請先閱讀背面之注意事項再填寫本頁) •打:: •線. 根據申請專利範圍第1項之組成物,其中該化合物存在之 量,依據該組成物之重量,至少約為10 %。 5.根據申請專利範圍第1項之组成物,其中該脂肪酸為月桂 睃。 6·根據申請專利範圍第1項之組成物,其中該多元醇為甘油。 、本紙張尺度適用中囷國家櫺準(QjS)甲4規格(2丨0x297公货) ^ObbC ^ a7 B7 C7 ------------D7 _ 六、申請專利範圊 7. 根據申請專利範圍第1項之組成物,其中該化合物為甘油 基一月桂酸醋。 8. 根據申請專利範圍第7項之組成物,其中該甘油基一月桂 睃醋存在之量,依據該组成物之重量,至少約為0.1 %。 9. 根據申請專利範圍第7項之组成物,其中該甘油基-月桂 酸酯存在之量,依據該组成物之重量*至少約為0.5 % 1 10. 根據申請專利範圍第1項之組成物,其中該化合物包含甘 油基一月桂酸酯及甘油基二月桂酸酯之混合物。 11. 根據申請專利範圍第10項之组成物,其中該混合物存在之 量,依據該组成物之重量,至少约為0.1 %。 12. 根據申請專利範圍第11項之組成物,其中該混合物以重量 計包含至少90%甘油基一月桂酸酯。 13. 根據申請專利範圍第1〇項之组成物,其中混合物存在之量 ,依據該組成物之重量•至少約為0.1 %。 14. 稂據申請專利範圍第1項之组成物,其中該化合物包含甘 油基一辛酸酯。 15. 根據申請專利範圍第1項之組成物,其中該化合物包含甘 油基癸酸酯。 16. 根據申請專利範圍第1項之組成物,其中該化合物包含甘 油基-辛酸酯及甘油基癸酸酯之一種混合物。。 經 濟 部 央 橾 準 局 貝 工 消 費 合 作 社 印 製 (請先聞讀背面之注意事項再填寫本頁) •線· 17. 根據申請專利範圍第1項之組成物,其中該化合物包含甘 油基一肉豆蔻酸酯。 18. 根據申請專利範圍第1項之组成物,其中該化合物包含甘 油基一棕櫚酸酯。 43 - 本紙張尺度適用中國國家標準(CNS)甲4規格(210X297公釐) A 7 B7 C7 D7 經濟部中央樣準局貝工消費合作杜印製” 六、申請專利範® 19. 根據申誚專利範圍第1項之組成物,其中該化合物包含甘 油基一硬脂酸酯。 20. 根據申謓專利範圍第1項之組成物,其中該化合物包含甘 油基_油酸酯。 21. —種供婦女傾人衛生用之液體组成物,其包含一種藥劑可 接受載體及一種選自下列類組之化合物: (a) —種多羥基脂族醇及一種含八至十八個原子之脂肪酸 之單酯類,其中該單酯類至少有一羥基與其脂族醇殘 v 留物相締合; (b) —種多羥基脂族醇及一棰含八至十八値原子之脂肪酸 之二酯類,其中該二酯類至少有一羥基與其脂族醇殘 留物相締合;Μ及ί (c) 該單酯類及二g旨類之混合物, 上逑化合物存在之量為當該組成物暴露於.金黃色葡萄球菌 時可有效抑制該細菌產生腸毒素A、賎毒素B或腸毒素C。 22. 根據申請專利範圍第21項之組成物,其中該化合物存在之 量·依據該組成物之重量,至少約為0,1 %。 23. 根據申請專利範圍第21項之組成物,其中該化合物存在之 量,依據該組成物之重量,至少約為1.0 %。 24. 根據申請專利範圍第21項之組成物,其中該化合物存在之 量,依據該組成物之重量,至少约為10%。 25. 根據申請專利範圍第21項之成物,其中該脂肪酸為月桂酸。 26. 根據申請專利範圍第21項之组成物,其中該多元醇為甘油。 27. 根據申請專利範圍第21項之組成物,其中該多元醇為甘油 基一月桂酸酯。 -44 - (請先閲讀背面之注意事颉再填宵本頁} •,Λ_ •打· .線· 本紙張尺度通用中國國家標準(CNS)甲4規格(210x297公釐) A B c D /、、申請專利範園 28. 根據申請專利範圍第27項之組成物,其中該甘油基一月桂 酸酯存在之量,依據該组成物之重量,至少為0.1 %。 29. 根據申諸專利範圍第27項之組成物,其中該甘油基一月桂 酸酯存在之量,依據該组成物之重量,至少為1.0 %。 30. 根據申請專利範圍第21項之組成物,其中該化合物包含甘 油基-月桂酸酯及甘油基二月桂酸酯之混合物。 31. 根據申請專利範圍第30項之组成物*其中該化合物存在之 量*依據該組成物之重量,至少約為0.1 %。 / 32. 根據申請專利範圍第31項之組成物,其中該混合物以重量 計包含至少90%甘油基-月桂酸酯。 33. 根據申請專利範圍第31項之组成物 計包含至少95%甘油基-月桂酸酯 34. 根據申請專利範圍第31項之組成物 量,依據該組成物之重置,至少约為0.1 %。 35. 根據申謓專利範圍第34項之組成物,其中該混合物以重量 計包含至少90%甘油基-月桂酸酯。 36. 根據申請專利範圍第35項之組成物 計包含至少95%甘油基-月桂酸酯 37. 根據申請專利範圍第21項之组成物 其中該混合物以重量 其I中該混合物存在之 其中該混合物以重量 其中該化合物包含甘 (請先聞讀背面之注意事項再填荈本百} 油基一辛酸酯 經濟部中央樣準局貝工消費合作社印製 &gt; 3/.根據申請專利範圍第21項之組成物,其中該化合物包含甘 油基癸酸酯。 39.根據申請專利範圍第21項之组成物,其中該化合物包含甘 油基一辛酸酯及甘油基癸酸酯之一棰混合物。 45 - 表紙張尺度適用中國固家標準(CNS)甲4織(210x297公货) AT B7 C7 D7 六'申請專利範園 40. 根據申請專利範圍第21項之组成物,其中該化合物包含甘 油基一肉豆蔻酸醋。 41. 根據申請專利範圍第21項之組成物,其中該化合物包含甘 油基一棕摘酸酯。 42. 根據申請專利範圍第21項之組成物,其中該化合物包含甘 油基一硬脂酸酯。 43. 根據申請專利範圍第21項之组成物,其中該化合物包含甘 油基—油酸酯。 44. 一種供婦女倕人衛生用之液體组成物,其包含一種藥劑可 接受載體及一種選自下列類组之化合物: (a) —種多羥基脂族醇及一種含八至十八個原子之脂肪酸 之單酯類|其中該單酯類至少有一羥基與其脂族醇殘 留物相缔合; (b) —種多羥基脂族醇及一種含八至十八個原子之脂肪酸 之二酯類,其中該二酯類至少有一羥基與其脂族醇殘 留物相缔合;Μ及 (c) 該單酯類及二酯類之混合物, 上述化合物存在之量為當該組成物暴露於A、Β、F及G 颶鏈球菌時,可有效抑制此等細菌產生鏈球菌生熱外毒素 A、B及CM及溶血素。 經 濟 部 中 央 標 準 局 貝 工 消 费 -46 - (請先閱讀背面之注意事項再瑱窝本頁) 合 作 社 印 製 -本紙張尺度適用中國國家標準(CNS) f 4規格(210x297公釐)Secret Announcement A 7 B7 C7 D7 VI. Application for Patent Fan Ji Patent Application No. 80 108379 ROC Patent Appln. No. 80 108379 Amendment to the scope of the patent application Chinese Amendment 1 Amend Claims in Chinese-EncI. I (Amended and submitted on October 21, 1981) (Amended & Submitted on October 21, 1992) Patent application for amended & amended: 1. A liquid composition for women ’s personal hygiene, which contains a pharmaceutical acceptable carrier And a compound selected from the following groups: (a)-a polyhydroxy aliphatic alcohol and a monoester moth containing eight to eighteen atoms of fatty acids, wherein the monoester has at least one hydroxyl group and its wax alcohol residues Phase association; (b)-a polyhydroxy aliphatic alcohol and a diester containing eight to eighteen atoms of fatty acids, wherein the diester has at least one hydroxyl group associated with the residue of the aliphatic alcohol; Μ and (c) the mixture of monoesters and diesters, the above compounds are present in an amount effective to inhibit the production of toxic shock syphilis virus-1 by the bacteria when the composition is exposed to Staphylococcus aureus. 2. The composition according to item 1 of the patent application scope, wherein the amount of the compound present is at least about 0.1% based on the weight of the composition. 3. The composition according to item 1 of the patent application scope, wherein the amount of the compound present is at least about 1.0% based on the weight of the composition. Printed by the 8th Industrial and Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) The weight of the composition is at least about 10%. 5. The composition according to item 1 of the patent application scope, wherein the fatty acid is laurel. 6. The composition according to item 1 of the patent application scope, wherein the polyol is glycerin. 、 This paper scale is applicable to China National Standard (QjS) A4 specifications (2 丨 0x297 public goods) ^ ObbC ^ a7 B7 C7 ------------ D7 _ VI. Patent application Fan 7 . The composition according to item 1 of the patent application scope, wherein the compound is glyceryl monolaurate. 8. The composition according to item 7 of the patent application scope, wherein the amount of the glyceryl monolaurel vinegar present is at least about 0.1% based on the weight of the composition. 9. The composition according to item 7 of the patent application scope, wherein the amount of the glyceryl-laurate present is at least about 0.5% based on the weight of the composition 1 10. The composition according to item 1 of the patent application scope , Wherein the compound contains a mixture of glyceryl monolaurate and glyceryl dilaurate. 11. The composition according to item 10 of the patent application scope, wherein the amount of the mixture present is at least about 0.1% based on the weight of the composition. 12. The composition according to item 11 of the patent application scope, wherein the mixture contains at least 90% glyceryl monolaurate by weight. 13. The composition according to item 10 of the patent application scope, in which the amount of the mixture is based on the weight of the composition • at least about 0.1%. 14. The composition according to item 1 of the patent application scope, wherein the compound contains glyceryl monocaprylate. 15. The composition according to item 1 of the patent application scope, wherein the compound contains glyceryl caprate. 16. The composition according to item 1 of the patent application scope, wherein the compound comprises a mixture of glyceryl-caprylate and glyceryl caprate. . Printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs (please read the precautions on the back before filling in this page) • Line · 17. The composition according to item 1 of the scope of the patent application, in which the compound contains glyceryl-based meat Myristate. 18. The composition according to item 1 of the patent application scope, wherein the compound contains glyceryl monopalmitate. 43-This paper scale is applicable to the Chinese National Standard (CNS) Grade 4 (210X297 mm) A 7 B7 C7 D7 Printed by the Central Sample Bureau of the Ministry of Economic Affairs, Cooperate with Consumers of DuPont "6. Application for a patent model 19. According to the application The composition according to item 1 of the patent scope, wherein the compound contains glyceryl monostearate. 20. The composition according to item 1 of the patent scope, wherein the compound contains glyceryl oleate. A liquid composition for women's hygiene, which contains a pharmaceutical acceptable carrier and a compound selected from the following group: (a)-a polyhydroxy aliphatic alcohol and a fatty acid containing 8 to 18 atoms of fatty acids Monoesters, wherein the monoesters have at least one hydroxyl group associated with the residue of the aliphatic alcohol; (b)-a polyhydroxy aliphatic alcohol and a diester of fatty acids containing 8 to 18 atoms Where at least one hydroxyl group of the diester is associated with the residue of aliphatic alcohol; Μ and ί (c) the mixture of the monoester and the two g compounds, the amount of the upper compound is present when the composition is exposed to . Staphylococcus aureus can effectively inhibit the production of the bacteria Enterotoxin A, Cotoxin B, or Enterotoxin C. 22. The composition according to item 21 of the patent application, where the amount of the compound is present · based on the weight of the composition, at least about 0.1%. 23. According to The composition of claim 21, wherein the amount of the compound present is at least about 1.0% based on the weight of the composition. 24. The composition of claim 21, the amount of the compound present, According to the weight of the composition, at least about 10%. 25. The composition according to item 21 of the patent application, wherein the fatty acid is lauric acid. 26. The composition according to item 21 of the patent application, wherein the polyol It is glycerin. 27. The composition according to item 21 of the patent application scope, in which the polyhydric alcohol is glyceryl monolaurate. -44-(Please read the notes on the back first and then fill this page) •, Λ_ • Thread ·. Line · This paper scale is in accordance with the Chinese National Standard (CNS) A 4 specifications (210x297 mm) AB c D / 、, patent application Fan Garden 28. The composition according to item 27 of the patent application scope, in which the glyceryl group One laurate exists , Based on the weight of the composition, at least 0.1%. 29. The composition according to claim 27, wherein the amount of the glyceryl monolaurate present, based on the weight of the composition, is at least 1.0% 30. The composition according to item 21 of the patent application scope, wherein the compound comprises a mixture of glyceryl-laurate and glyceryl dilaurate. 31. The composition according to item 30 of the patent application scope * wherein the compound The amount present * is at least about 0.1% based on the weight of the composition. / 32. The composition according to item 31 of the patent application, wherein the mixture contains at least 90% glyceryl-laurate by weight. 33. The composition according to item 31 of the patent application scope contains at least 95% glyceryl-laurate 34. The composition according to item 31 of the patent application scope, based on the replacement of the composition, is at least about 0.1%. 35. The composition according to item 34 of the application scope, wherein the mixture contains at least 90% glyceryl-laurate by weight. 36. The composition according to item 35 of the patent application range contains at least 95% glyceryl-laurate 37. The composition according to item 21 of the patent application range wherein the mixture is by weight of the mixture in which the mixture is present The compound contains Gan by weight (please read the precautions on the back and then fill in the copy). Oil-based-octanoate printed by the Central Sample Bureau of the Ministry of Economic Affairs Printed by Beigong Consumer Cooperative> 3 /. According to the patent application The composition of Item 21, wherein the compound comprises glyceryl caprate. 39. The composition according to Item 21 of the patent application range, wherein the compound comprises a mixture of glyceryl monocaprylate and glyceryl caprate. 45-The scale of the table paper is in accordance with China Gujia Standard (CNS) Jia 4 Woven (210x297 public goods) AT B7 C7 D7 Six 'patent application garden 40. The composition according to item 21 of the scope of patent application, in which the compound contains glyceryl 1. Myristic acid vinegar. 41. The composition according to item 21 of the patent application scope, wherein the compound contains glyceryl monobranched acid ester. 42. The composition according to item 21 of the patent application scope, The compound contains glyceryl monostearate. 43. The composition according to item 21 of the patent application range, wherein the compound contains glyceryl-oleate. 44. A liquid composition for women ’s hygiene, It contains a pharmaceutically acceptable carrier and a compound selected from the following groups: (a)-a polyhydroxy aliphatic alcohol and a monoester of fatty acids containing eight to eighteen atoms | wherein the monoester has at least one The hydroxyl group is associated with the aliphatic alcohol residue; (b)-a polyhydroxy aliphatic alcohol and a diester containing eight to eighteen fatty acids, wherein the diester has at least one hydroxyl group and its aliphatic alcohol residue Phase association; Μ and (c) the mixture of monoesters and diesters, the above compounds are present in an amount that is effective when the composition is exposed to A, B, F and G Streptococcus Bacteria produce Streptococcus heat-generating exotoxins A, B, CM and hemolysin. Ministry of Economic Affairs Central Standards Bureau Bei Gong Consumption -46-(Please read the precautions on the back before printing this page) Printed by the cooperative-this paper size is applicable China Home Standard (CNS) f 4 Specifications (210x297 mm)
TW80108379A 1991-05-03 1991-10-24 TW205504B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69536691A 1991-05-03 1991-05-03

Publications (1)

Publication Number Publication Date
TW205504B true TW205504B (en) 1993-05-11

Family

ID=51356720

Family Applications (1)

Application Number Title Priority Date Filing Date
TW80108379A TW205504B (en) 1991-05-03 1991-10-24

Country Status (1)

Country Link
TW (1) TW205504B (en)

Similar Documents

Publication Publication Date Title
JP3285600B2 (en) Additives for feminine hygiene products
JP3219807B2 (en) Prevention of toxin production using absorbent products
TWI716374B (en) Sheet paper, manufacturing method thereof, and absorbent article
US5534266A (en) Bovine teat dip
CN107998028A (en) A kind of shower cream and preparation method thereof
RU2306132C2 (en) Hygienic material impregnated with composition that contains a lipid-suspended lactic acid-producing bacterium
CN106038422A (en) Washing composition and preparation method and application thereof
CN110029026A (en) A kind of sterilizing and itch-relieving medicated soap and preparation method thereof
CN110974717B (en) Moisturizing baby wet tissue capable of removing dirt and preparation method thereof
TW205504B (en)
CN104207971B (en) Medical skin-disinfection and -nursing hand-cleaning liquid and preparation method thereof
CN108670893B (en) Amino acid cleansing cream composition and preparation method thereof
CN114763362A (en) Preparation of cocamidopropyl-PG-dimethylammonium chloride phosphate, product and product
CN112263512A (en) Low-irritation and rich-foam cleaning composition and application thereof and shower gel
CN110812283A (en) Anti-inflammation sterilization makeup removing cream and preparation method thereof
EP3871502A1 (en) Antifungal compositions and methods of using same
CN106619164A (en) Antibacterial and anti-allergic shaving cream and preparation method thereof
Oram et al. The tampon: investigated and challenged
RU2354352C1 (en) Woman intimate hygiene preparation
Kumar Pharmaceutico-Analytical Study of Lohakittadi Taila and its Antimicrobial Activity
US5489615A (en) Pharmaceutical ointment being free from skin irritative action and a process for the preparation thereof
CN104490620A (en) Deodorizing preparation containing lysozyme
PT99362B (en) PROCESS FOR THE PREPARATION OF ADDITIVES FOR HYGIENE PRODUCTS INTIMA FEMININA CONTAINING MONOESTERS AND DIESTERS OF POLYHYDRIC ALPHATIC ALCOHOLS
Adriaans The aetiology and pathogenesis of tropical ulcer
There et al. Formulation of Hand Made Soap by using Goat Milk